tsawon wane lokaci ne wadannan alamun suka kasance?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar musamman da shekarunka
da kuma tare da zazzabi
kuma kuma bukatar a duba cholesterol ka jini matsa lamba
kuma yanzu kana da zazzabi?
kuma kuna da wannan ciwon kirji yanzu?
kuma kuma kana da wahalar numfashi
kuma za ku iya gaya mani waɗanne wasu alamun cutar kuke da su tare da wannan?
da kuma yawan zafin jikinka
kuma ina da tari ma
kuma ina da sanyi da tari
kuma ina da ciwon kirji mai tsanani a yau
Kuma wannan ne daidai lokacin da hay zazzabi
kuma yana samun ciwon kirji
kuma ina ganin ina da wani ɗan zazzabi
kuma ina son ka bayyana inda ciwon kirji yake
kuma suna da wasu zazzabi kuma
da kuma ciwon sukari da ya kamu da shi a baya
Kuma ka san yana jin kamar ƙirjin na zai murkushe
Kuma ka san mutane suna yin tari a kaina a duk lokacin
kuma kana da ciwon kirji
kuma kun ce wannan matsin ne a cikin kirjinku
wani a cikin iyali yana da matsalar zuciya ciwon zuciya ciwon zuciya bugun zuciya high cholesterol high hawan jini
duk wani alamun cutar ko matsala da ka lura da ita tare da ciwon tsoka?
akwai wasu mutane marasa lafiya kamar ku a gida da irin wannan alamun cutar?
kuna da wasu alamun cutar?
kana da wani shortness na numfashi?
har yanzu kana da ciwon kirji
saboda wannan lokacin mura ne
amma kuma bai kamata mu sanya shi gefe don zuciya ba asalin zuciya ciwon kirji
Amma wata matsala mafi muhimmanci a yanzu ita ce ciwon kirji
amma ina da matsalar numfashi
Na san mutane da yawa amma suna yin tari a kaina
amma muna bukatar mu bi da kowane ciwon kirji da matuƙar mahimmanci
amma kana numfashi lafiya a yanzu dama?
Saboda wannan ciwon kirji na manta gaba daya
Shin yana jin kamar wani yana matse kirjinka
har yanzu ina jin kamar rashin numfashi
suna kokawa da rashin lafiya irin wannan alamun?
kuna da wani ciwo mai tsanani kamar hawan jini ko wani abu makamancin haka?
kana da wasu cututtuka na kullum matsalar lafiya kamar su ciwon suga?
shin kana da wani karancin numfashi tare da wannan ciwon kirji?
kana da cutar hawan jini?
kana da wani shortness na numfashi tafi tare da cewa?
ka san irin alamun cutar da take da su?
ka ga hoton?
sha ruwa mai yawa a yau
duk da haka ina yin gwaji don ciwon suga
ta na da alamun da suka yi kama da nawa duk da haka
yaya zazzabin jikinka yake?
yaya karfin jininka yake?
idan ka ci gaba da samun zazzabi mai zafi
idan ka sami zazzabi na ɗari da biyu ko sama da haka
idan ka yi tunanin cewa alamominka ko matsalolinka sun cancanci a duba su sosai
Ina da zazzabi a jiya
Ni ma na ɗan yi zazzaɓi kaɗan
Ina da zazzabi a jiya
Ina da ciwo mai zafi a nan a cikin kirji
Ina da wasu matsalolin numfashi ma
Zan aika maka da hoton
ina da wani ciwon kirji a yau
Ina da ciwon kai da zazzabi yau
A ganina, cutar mura ce
a ganina wannan ɗan mura ne
Shin kamar wani mutum mai nauyi ne yake zaune a kan kirjinka?
duk ya fara ne da ciwon kai da zazzabi a lokaci guda
yana ciwo a tsakiyar kirji na
yana da matsi kamar ciwon kirji
yana cikin kirjin na
yana tsakiyar kirji na
yana tsakiyar kirji
Ina jin zafi a cikin kirji
Na damu sosai game da wannan ciwon kirji
Ina so ka gaya mani a cikin bayanin wannan ciwon kirji
kamar hawan jini ko ciwon sukari
kamar a tsakiyar kirji
Yanzu don zazzabi za ku iya shan tachipirina mai dadi
yanzu mary kwana nawa ne da ka samu alamun cutar
Yanzu kun ce kuna da ciwon kirji
wani lokacin ina jin ciwon kirji
lafiya kana da wasu alamomi tare da wannan ban da ciwon kawai
ko kuma wani yana zaune a kan kirjinka?
kusan daidai da zazzabi da tari ciwon kai da ciwon tsoka
daidai a tsakiyar kirji na
nuna min a wannan hoton inda kake jin zafi
tun da kana da zazzabi
To, kuna tsammanin wasu daga cikin wadannan alamun na iya danganta da kasancewa da juna biyu?
don haka yaranka suna da wasu alamun bayyanar guda?
gaya mini game da ciwon kirjin ka
zazzabi ya ƙaru da dare
zazzabin da nake da shi na kwana biyu
zafin ya fara ƙaruwa a daren jiya
Wannan shi ne Dr. Porter a cikin ɗakin gaggawa na cibiyar kulawa
To za ki iya gaya mani kadan game da ciwon kirjinki?
To ina jin ciwo a gaba na jikina a cikin kirji na
To ina da ciwo mai tsanani a kirji na
To, idan ina da wannan ciwo a cikin kirji na
wane irin ciwo kake da shi a cikin kirjinka?
Yaushe wannan ciwo ya fara?
ina kake da ciwon a cikin kirji?
inda kake jin wannan ciwon kirji wannan kirji t
kana jin kamar matsewar a kirjinka
Ka san ina da ciwon sukari da sauran abubuwa
Ka ce kana da wannan ciwon kirji
Saurin haɓaka yawan cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da United Kingdom, 1 Janairu zuwa 15 Maris 2020
Adadin adadin masu kamuwa da cutar coronavirus (COVID-19) yana nuna irin wannan yanayin a cikin Tarayyar Turai/Kasashen Tattalin Arzikin Turai da kuma Burtaniya wanda ke tabbatar da cewa, yayin da yake a wani mataki daban dangane da ƙasar, cutar ta COVID-19 tana ci gaba cikin sauri a cikin dukkan ƙasashe.
Dangane da gogewa daga Italiya, kasashe, asibitoci da kuma sassan kula da lafiya masu tsanani ya kamata su kara shirye-shiryen su don karuwar marasa lafiya da COVID-19 waɗanda za su buƙaci kulawa ta kiwon lafiya, musamman kulawa mai tsanani.
A ranar 31 ga Disamba, 2019, an bayar da rahoton tarin cututtukan huhu na rashin sani a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu 2020, Cibiyar Kula da Cututtuka da Cututtuka ta China ta ba da rahoton cewa mai haifar da cutar a matsayin sabon kwayar cutar coronavirus yanzu ana kiranta da cutar ta cututtukan numfashi mai tsanani coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da ta samo asali daga kamuwa da SARS-CoV-2 an kira shi cutar coronavirus (COVID-19).
Shaida zuwa yanzu ita ce kimanin kashi 80% na mutanen da ke da COVID-19 suna da cutar mai sauki, watau kamuwa da cutar hanyoyin numfashi tare da ko ba tare da ciwon huhu ba, kuma yawancin waɗannan suna warkewa.
A cikin kashi 14 cikin 100, COVID-19 ya zama mai tsanani wanda ke buƙatar asibiti yayin da sauran kashi 6 cikin 100 na masu cutar ke fama da rashin lafiya mai tsanani da ke buƙatar kulawa mai tsanani.
Mutuwar marasa lafiya da aka kwantar saboda COVID-19 ya kai kusan 4%.
A cikin wannan binciken, mun tantance yanayin da ke faruwa a cikin tarin cutar COVID-19 a kowace Tarayyar Turai/Ƙungiyar Tattalin Arzikin Turai (EU/EEA) da kuma Ƙasar Ingila (UK) kuma mun kwatanta su da lardin Hubei, China.
Muna kuma kwatanta adadin COVID-19 na yanzu a cikin ƙasashen EU/EEA da UK tare da na Italiya a 31 Janairu15 Maris 2020.
COVID-19 a cikin ƙasashen EU/EEA da UK
Bayan China, COVID-19 ya sami ƙarin yaduwar yanayin ƙasa kuma yanayin annobar COVID-19 a sauran duniya a halin yanzu yana bin wannan na wannan ƙasar.
A ranar 11 ga Maris, 2020, Babban Daraktan Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurosurveillance 2020, Spiteri et al. sun ba da rahoton farkon shari'o'in COVID-19 da aka tabbatar a Turai bisa ga ma'anar shari'ar WHO.
A cikin EU/EEA, Faransa ta ba da rahoton farkon mutane uku da aka tabbatar da su a ranar 24 ga Janairu 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
Ya zuwa 15 ga Maris, 2020, an gano masu cutar COVID-19 a cikin dukkan ƙasashe 30 na EU/EEA da kuma United Kingdom (UK), inda daga 31 ga Disamba 2019 zuwa wannan ranar, an ba da rahoton mutane 39,768 da mutuwar 1,727, tare da mutane 17,750 da mutuwar 1,441 daga Italiya kadai.
Samun jimillar adadin da kuma yawan adadin COVID-19
A Cibiyar Kula da Cututtuka da Kula da Cututtuka ta Turai (ECDC), adadin adadin COVID-19 da aka sanar a kowace ƙasa a duniya, wanda aka samo daga tushe na hukuma kawai kamar na ƙasashe Ma'aikatar Lafiya, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, ana sabunta su kowace rana a 8:00 na safe.
An yi amfani da waɗannan bayanai don tantance yanayin COVID-19 a cikin EU/EEA da UK, da kuma kwatanta su da na Italiya.
A matsayin wakili na yaduwar masu cutar COVID-19, mun lissafa adadin adadin masu cutar COVID-19 na kwanaki 14, don haka la'akari da yanayin yanayin COVID-19, a kowace EU/EEA da kuma Burtaniya, a lokacin 1 ga Janairu-15 ga Maris 2020.
Mun kuma gabatar da jimlar adadin wadanda aka sanar da su a kowace kasa a ranar 15 ga Maris 2020 karfe 8:00 na safe idan aka kwatanta da na Italiya na 31 ga Janairu zuwa 15 ga Maris 2020.
Yanayin COVID-19 a cikin ƙasashen EU/EEA da UK
Yanayin da aka samu a cikin kwanaki 14 da aka rage na jimlar cutar COVID-19 a cikin ƙasashen EU/EEA da kuma Burtaniya gabaɗaya sun bi na lardin Hubei (China) (Hoto na 1).
Ga EU/EEA da kuma UK gabaɗaya, yawan cutar COVID-19 ya fara ƙaruwa a kusa da 21 ga Fabrairu sannan ya ƙaru sosai a kusa da 28 ga Fabrairu 2020 (Karin bayani).
Wannan galibi ya samo asali ne daga saurin karuwar adadin wadanda aka ba da rahoto daga Italiya, amma duk sauran ƙasashen EU/EEA da Burtaniya sun nuna irin wannan haɓaka na yawan abin da ke faruwa na COVID-19 (Karin kayan aiki).
Hoto na 2 ya nuna adadin adadin COVID-19 a cikin EU/EEA da UK idan aka kwatanta da na Italiya a lokacin 31 ga Janairu-15 ga Maris 2020.
Ya nuna cewa, a ranar 15 ga Maris da karfe 8:00 na safe, wasu ƙasashe 15 na EU/EEA da kuma Burtaniya sun riga sun ba da rahoton jimillar adadin masu cutar da za a iya kwatanta da na Italiya makonni 3 kawai ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin wadanda aka sanar da cutar COVID-19 na karuwa cikin sauri a EU/EEA da UK.
Abubuwan da aka lura a cikin yawan abin da ya faru na COVID-19 ya nuna cewa cutar tana ci gaba da sauri a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, bambancin martani na lafiyar jama'a na ƙasa, da yiwuwar ma'anonin shari'a daban-daban a cikin ƙasashe da kuma ladabi daban-daban don zaɓar marasa lafiya waɗanda dole ne a gwada su don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kusan kashi 10% na marasa lafiya da ke dauke da COVID-19 ke bukatar kulawar ta musamman kuma kafofin watsa labarai sun ruwaito cewa asibitoci da sassan kulawar ta musamman a wadannan yankuna sun riga sun kai iyakar karfin su.
Bayanai kan shigar da masu COVID-19 a asibiti da/ko sashen kulawa mai tsanani a halin yanzu ana samun su a matakin EU/EEA don kashi 6% da 1% na masu cutar, bi da bi (ba a nuna bayanai ba).
Duk da haka, ya kamata a tattara su ta hanyar da ta dace don a cika bayanan sa ido na yanzu da ke mai da hankali kan adadin shari'o'in da aka ruwaito da kuma adadin mutuwar.
Wani bincike da aka yi a 201011 ya nuna bambancin da ke cikin gadon kula da marasa lafiya da kuma gadon kula da marasa lafiya a Turai, daga 29.2 a Jamus zuwa 4.2 a kan kowane mutum 100,000 a Portugal.
Wannan yana nufin cewa kasashe na iya samun karin ko kasa da albarkatun da Italiya (12.5 tsananin kulawa da kula da matsakaici na gado ga kowane 100,000 na yawan jama'a a 2010).
An bayar da yanayin yin samfurin da ya shafi cikar ƙarfin kiwon lafiya, tare da kimantawa ga kowace EU/EEA ƙasa da UK na yaduwar al'amuran COVID-19 da aka kwantar da su a asibiti da ke da alaƙa da &gt; 90% haɗarin wucewa da ƙarfin gado na kulawa mai tsanani, an bayar da su a cikin sabuntawa ta shida na ECDC saurin kimanta haɗari akan COVID-19.
Tun da yake har yanzu an tattara lamuran a wasu yankuna a cikin kasashen EU/EEA da Burtaniya, kuma asibitoci da rukunin kula da masu tsananin cutar yawanci suna ba da sabis ga ƙayyadadden yanki na yanki, ya fi dacewa a ba da bayani game da lamuran da gadajen kula da masu tsananin cutar a matakin Nomenclature of territorial units for statistics 2 (NUTS-2).
Kwarewar Italiya da kuma yanayin da ake ciki a wasu ƙasashe sun nuna cewa cutar COVID-19 tana ci gaba cikin sauri a cikin EU/EEA da Burtaniya.
Saboda haka, ya kamata ƙasashe, asibitoci da rukunin kulawa mai tsanani su shirya kansu don yanayin ci gaba da watsawar al'umma na SARS-CoV-2 da kuma ƙaruwar adadin marasa lafiya da ke da COVID-19 da ke buƙatar kula da lafiya, kuma musamman kula mai tsanani, kamar wanda ke faruwa a yankunan da ke fama da cutar a Italiya.
Kamar yadda aka nuna a cikin sabon saurin binciken ECDC na kwanan nan, hanzari, da himma da kuma cikakkiyar hanya yana da mahimmanci don jinkirta yaduwar SARS-COV-2, tare da sauyawa daga ƙuntatawa zuwa tsarin ragewa, kamar yadda ake sa ran saurin ƙaruwa a cikin adadin lamura na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, yarda da kuma daidaita martani idan ba a aiwatar da su ba kafin lokaci.
Binciken saurin haɗarin ya kuma lissafa matakan kiwon lafiyar jama'a don rage tasirin cutar.
Akwai ɗan gajeren lokacin da ƙasashe ke da damar ƙara ƙaruwa a ƙoƙarin sarrafa su don rage saurin yaduwar SARS-CoV-2 da rage matsin lamba a kan kiwon lafiya.
Idan ba haka ba, da alama tsarin kula da lafiya na sauran kasashen EU/EEA za su fuskanci hauhawar marasa lafiya da ke bukatar kula mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar cutar Coronavirus ta 2019 (COVID-19), wacce cutar ta SARS (SARS) coronavirus 2 (SARS-CoV-2) ta haifar, ya zuwa yanzu ta kashe sama da mutane 3,000 kuma ta kamu da sama da 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'i ga mutane.
Kamar dai kwayar cutar ta SARS-CoV, wacce ta haifar da SARS a cikin dubban mutane a 2003, SARS-CoV-2 na iya kuma watsawa daga jemagu kuma yana haifar da irin wannan alamun ta hanyar irin wannan tsari.
Koyaya, COVID-19 yana da ƙarancin tsanani da mutuwa fiye da SARS amma yana da saurin yaduwa kuma yana shafar tsofaffi fiye da matasa da kuma maza fiye da mata.
Dangane da yawan littattafan da ke ƙaruwa da sauri game da cutar da ke fitowa, wannan labarin yana ƙoƙari ya ba da cikakken bayani game da batun bincike mai saurin haɓaka.
Za mu rufe abubuwan da suka shafi cutar, ilimin cututtuka, ilimin ƙwayoyin cuta, ganewar asali, magani, tsinkaye, da rigakafin cutar.
Kodayake har yanzu akwai tambayoyi da yawa da ke bukatar amsoshi, muna fatan cewa wannan bita zai taimaka wajen fahimta da kawar da cutar da ke barazana.
Bikin bazara a ranar 25 ga Janairu, 2020 ya zama abin tunawa da ba a taɓa mantawa da shi ba ga duk Sinawa waɗanda aka bukace su da su zauna a gida don duk hutun da kuma na makonni da yawa bayan haka saboda barkewar cutar kwayar cutar.
Kwayar cutar tana da matukar kama da kwayar cutar coronavirus (CoV) wacce ta haifar da barkewar cutar cututtukan numfashi mai tsanani (SARS) a 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta sanya shi SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke da alaƙa da ita an sanya wa suna CoV Disease-19 (COVID-19).
Annobar ta fara ne a Wuhan, China, kuma cikin sauri ta bazu a duk fadin kasar nan da kuma wasu kusan 50 a duk fadin duniya.
Ya zuwa 2 ga Maris, 2020, kwayar cutar ta haifar da fiye da 80,000 da aka tabbatar da cutar COVID-19, tare da fiye da 40,000 marasa lafiya da aka sallama kuma fiye da 3,000 marasa lafiya da suka mutu.
WHO ta yi gargadin cewa COVID-19 ita ce babbar maƙiyar jama'a  kuma mai yuwuwa ta fi ta'addanci ƙarfi.
Dangane da PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga takardu sama da 200 akan COVID-19 gami da ilimin ƙwayoyin cuta, cututtukan annoba, ilimin halittar, ganewar asali, da magani tun daga rahoton farko a ranar 7 ga Janairu, 2020 wanda ya ƙayyade jerin ƙwayoyin cutar da aka ware daga marasa lafiya da yawa.
Wannan bita yana ƙoƙari ya taƙaita ci gaban bincike a cikin sabon yanki mai saurin ci gaba.
Duk lokacin da zai yiwu, za mu gwada gwada COVID-19 da SARS da wata cuta da CoV ke haifarwa, cutar numfashi ta Gabas ta Tsakiya (MERS, fashewa a 2012).
Za mu kuma tattauna abin da muka koya har yanzu game da rigakafi da kuma hangen nesa na cutar da kuma wasu tambayoyin da suka rage.
A al'adance ana ɗaukar CoVs a matsayin kwayoyin cuta marasa mutuwa ga mutane, galibi suna haifar da kusan 15% na mura 4.
Koyaya, a cikin wannan karni, mun haɗu da CoVs na mutum masu cutarwa sau biyu, watau, SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar asali a China a 2003 da Saudi Arabiya a 2012, bi da bi, kuma ba da daɗewa ba ta bazu zuwa wasu ƙasashe da yawa tare da mummunan cuta da mutuwa.
Saboda haka, COVID-19 na yanzu shine barkewar CoV ta uku a tarihin da aka rubuta na mutane.
Kamar yadda aka nuna a cikin Fig. Fig.1,1, an fara ba da rahoton tarin cututtukan huhu wanda ba a san asalinsa ba daga Wuhan a ranar 31 ga Disamba, 2019 zuwa Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai an saki jerin CoV.
A ranar 15 ga Janairu, 2020 aka ba da rahoton mutum na farko da ya mutu daga Wuhan.
A wannan lokacin, annobar ta yaɗu da sauri zuwa birane da larduna da kuma ƙasashe da ke kusa da su.
A ranar 20 ga Janairu, an ba da rahoton kamuwa da cutar a ma'aikatan kiwon lafiya, wanda ke nuna cewa mutum-zuwa-mutum yana yiwuwa.
A ranar 23 ga Janairu, an kulle birnin Wuhan tare da dakatar da duk hanyoyin sufurin jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti kan cutar ya ba da rahoton cewa, daga cikin marasa lafiya 41 da aka tabbatar da cutar, 21 ne kawai suka yi hulda kai tsaye da kasuwar abincin teku ta Wuhan da aka yi la'akari da farkon fara kamuwa da cutar daga asalin dabba da ba a sani ba.
A ranar 30 ga Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa na kiwon lafiya na duniya.
A lokacin wannan rahoto, cutar ta riga ta yadu a duk faɗin China da kusan wasu ƙasashe 50 a duk duniya (Fig. (Fig.2).
Yayin da yanayin ke ci gaba da canzawa cikin sauri, har yanzu ba a tantance cikakken yanayin da kuma tsananin barkewar cutar ba.
A ranar 11 ga Fabrairu, 2020, wani binciken da aka yi a cibiyoyi da yawa a kan marasa lafiya 8,866 ciki har da marasa lafiya 4,021 da aka tabbatar da COVID-19 sun gabatar da karin bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane masu shekaru daban-daban, amma galibi a cikin shekaru 30-65.
Kusan rabin (47.7%) na mutanen da suka kamu da cutar sun fi shekaru 50 da haihuwa, kadan ne ke kasa da shekaru 20, kuma mutane 14 ne kawai suka kamu da cutar a karkashin shekaru 10.
SARS-CoV-2 ya kamu da maza da yawa (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ya fadada a cikin gungu galibi a ciki da kewaye da Hubei.
COVID-19 ya ɗauki matsakaicin kwanaki 5 (2-9) daga farawa zuwa ganewar asali.
Matsakaicin lokacin shiryawa ya kasance kwanaki 4. 8 (3. 0 - 7. 2).
Matsakaicin lokacin daga farawa zuwa mutuwa ya kasance 9.5 (4.8-13) kwanaki.
Ƙididdigar ƙididdigar asali (R0) ya kasance 3. 77 (95% CI: 3.51- 4. 05), kuma daidaitaccen R0 ya kasance 2. 23 - 4. 82.
Adadin mutanen da suka kamu da cutar ya karu sosai kafin 23 Jan. 2020, daidai da lokacin jigilar jama'a kafin bikin bazara a China.
Mutuwar marasa lafiya da aka tabbatar da cutar ta kasance 1. 44% (95% CI: 1. 10 - 1. 86%), kuma daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3. 06% (95% CI: 2. 02- 4. 59%).
Abubuwa uku masu haɗari ga COVID-19 sune jima'i (maza), shekaru (≥60), da kuma ciwon huhu mai tsanani.
CoVs wani ƙaramin iyali ne na manyan ƙwayoyin cuta da ke da ƙuƙwalwa waɗanda ke ɗauke da madauki ɗaya na RNA mai ma'ana.
Za a iya raba su zuwa jinsuna huɗu, watau, alpha, beta, gamma, da delta, wanda aka san cewa alpha- da beta-CoVs suna kamuwa da mutane.
Glycoprotein mai ƙwanƙwasa (S) yana ɗaure ga masu karɓar sel na angiotensin-converting enzyme 2 (ACE2) da dipeptidyl peptidase 4 (DPP4) don SARS-CoV da MERS-CoV, bi da bi, sannan haɗuwa da membrane ya faru.
Ana sakin kwayar RNA ta kwayar halitta a cikin cytoplasm; bayan kwafin kwayar kwayar kwayar kwayar kwayar cuta, RNA ta kwayar halitta tare da glycoproteins na envelope da nucleocapsid sunadaran sun hada da kwayar virion, wanda daga baya ya haɗu da membrane na plasma don sakin kwayar cutar.
An ba da rahoton tsarin kwayar halitta na farko na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da fiye da 99.98% na asali na asali tsakanin samfuran 10 da aka tattara daga asalin shafin fashewar cutar, Kasuwar Kayan Kayan Kayan Kayan Kayan Huanan a Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
Ta hanyar watsa microscopy na lantarki, an sami SARS-CoV-2 a cikin sassan ultrathin na epithelium na hanyar numfashi na mutum.
An gano cewa ACE2 na mutum shine mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, S protein na SARS-CoV-2 yana ɗaure ga ACE2 na mutum da rauni fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma na iya samar da sabon gajeren furotin da aka sanya shi ta hanyar orf3b da kuma furotin da aka ɓoye wanda aka sanya shi ta orf8.
The orf3b na SARS-CoV-2 na iya taka rawa a cikin kwayar cutar kwayar cuta da hana bayyanar IFNβ; duk da haka, orf8 ba ya ƙunshe da wani sanannen yanki ko motsi.
A ranar 18 ga Fabrairun 2020, Zhou, et al., sun ba da rahoton tsarin cryo-EM na cikakken tsawon mutum ACE2 a 2.9 Å ƙuduri a cikin hadaddun tare da mai jigilar amino acid B0AT1.
Sun gano cewa hadaddun, wanda ke da budewa da kuma rufewa, an hada shi a matsayin dimer kuma hadadden ACE2-B0AT1 na iya ɗaure sunadarin S guda biyu, wanda ke ba da shaida ga ganewar CoV da kamuwa da cuta.
B0AT1 na iya zama wata manufa ta magani don binciken magunguna don hana kamuwa da SARS-CoV-2.
Asalin asali da mai masaukin matsakaici
An san cewa duka SARS-CoV da MERS-CoV sun samo asali ne daga jemage kuma an watsa su ga mutane ta hanyar kuliyoyi da raƙuma, bi da bi.
Ta hanyar kwatancen phylogenetic na SARS-CoV-2 tare da sauran CoVs, an yi la'akari da jemage a matsayin asalin mai karɓar SARS-CoV-2 kamar yadda sabon kwayar cutar ta kasance kashi 96% daidai da CoVs biyu masu kama da SARS daga jemage da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Koyaya, abin da matsakaiciyar rundunar ta taimaka wa kwayar cutar ta tsallake shingen nau'in don kamuwa da mutane ya kasance ba a san shi ba, kuma hanyar watsawa har yanzu ba a bayyana ba.
Ji, et al., sun ba da shawarar macizai a matsayin mai ɗaukar kwayar cutar daga jemage zuwa mutane wanda ya haɗa da sake haɗuwa da homologous a cikin furotin S.
Dangane da wani bincike, masu bincike a Guangzhou, China, sun nuna cewa pangolins - masu dogon-snouted, masu cin naman dabbobi masu shayarwa da ake amfani da su a cikin maganin gargajiya na kasar Sin - sune masu iya zama matsakaiciyar mai karɓar SARS-CoV-2 bisa ga kashi 99% na kwayar halitta a cikin CoV da aka gano a cikin pangolins da SARS-CoV-2.
Koyaya, bambancin 1% ya bazu a cikin kwayoyin hali guda biyu har yanzu babban bambanci ne; saboda haka, ana jiran sakamako mai gamsarwa don tabbataccen shaida (Fig. (Fig.33).
Har ila yau ba a san yawancin abubuwan da ke tattare da SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin vitro na tsawon awanni 48 a cikin yanayin bushewa har zuwa kwanaki 5 a ƙarƙashin 20 °C da 40% -50% zafi.
SARS-CoV-2 na iya samun irin wannan kaddarorin.
An ba da rahoton cewa SARS-CoV-2 yana da saukin kamuwa da hasken ultraviolet da zafi a 56 °C na mintina 30; ether, 75% ethanol, maganin kashe kwayoyin cuta mai dauke da chlorine, peracetic acid, chloroform, da sauran kayan mai mai, amma ba chlorhexidine ba, na iya kashe kwayar cutar yadda ya kamata.
Gabaɗaya, dukkan jama'ar duniya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna iya kamuwa da sabon kwayar cutar.
A halin yanzu, babu wani cikakken bincike da aka bayar da rahoto game da amsar rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ne kawai ga binciken da aka yi a kan sauran CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
Gabaɗaya, bayan kwayar cutar ta mamaye mai gida, an fara gane ta ta hanyar tsarin garkuwar jiki ta hanyar masu karɓar ƙirar ƙira (PRRs) gami da masu karɓar lectin-like na C, masu karɓar Toll-like (TLR), masu karɓar NOD-like (NLR), da masu karɓar RIG-I-kamar (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan da ke haifar da kumburi, balaga na kwayoyin dendritic, da kuma hada nau'in I interferons (IFN) wanda ke iyakance yaduwar kwayar cutar da hanzarta macrophage phagocytosis na antigens na kwayar cutar.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar tserewa daga halayen garkuwar jiki.
Ba da daɗewa ba, tsarin garkuwar jiki zai soma yaƙar ƙwayoyin cuta.
T lymphocytes ciki har da CD4 + da CD8 + T-cell suna taka muhimmiyar rawa a cikin tsaro.
Kwayoyin T na CD4+ suna motsa kwayoyin B don samar da kwayoyin cutar ƙwayoyin cuta, kuma ƙwayoyin T na CD8+ suna kashe ƙwayoyin da ke dauke da ƙwayoyin cuta kai tsaye.
Kwayoyin T masu taimakawa suna samar da cytokines masu haifar da kumburi don taimakawa sel masu karewa.
Koyaya, CoV na iya hana ayyukan sel T ta hanyar haifar da apoptosis na sel T.
Har ila yau rigakafin humoral wanda ya haɗa da kari kamar C3a da C5a da ƙwayoyin cuta yana da mahimmanci wajen yaƙar kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka ware daga mai warkewa sun kawar da MERS-CoV.
A gefe guda, yawan amsawar tsarin garkuwar jiki yana haifar da adadi mai yawa na 'yanci na gida wanda zai iya haifar da mummunan lahani ga huhu da sauran gabobin, kuma, a cikin mummunan yanayin, gazawar gabobin da yawa har ma da mutuwa.
Cutar SARS-CoV-2, wanda aka nuna ta hanyar farawar, ya fi dacewa ya shafi tsofaffi tare da cututtukan da ke ciki da mata masu ciki.
Yana da yawa ga mutanen da ke fuskantar yawan ƙwayoyin cuta ko kuma waɗanda ayyukan rigakafin su ya lalace, suna da damar kamuwa da cutar fiye da wasu.
An kiyasta matsakaicin lokacin rashin lafiya na SARS-CoV-2 ya kasance kwanaki 1-14, galibi kwanaki 3-7 bisa ga binciken na farko na 425 a Wuhan.
Koyaya, binciken kan lamura 1,099 ya nuna cewa lokacin da ake ciki ya kasance kwanaki 3 a matsakaita kuma ya kasance daga kwanaki 0 zuwa 24.
Wani binciken da aka yi kwanan nan, kamar yadda aka bayyana a sama, ya nuna cewa lokacin kwanciya ya kasance kwanaki 4.8 (3.0-7.2) bisa ga yanayin alƙaluman mutane 8,866.
Yana da matukar muhimmanci ga hukumomin kiwon lafiya su daidaita lokacin da ake yin kwarantani bisa ga mafi ingancin lokacin da ake yi, don haka hana mutane masu dauke da cutar amma ba tare da alamun cutar ba daga yada kwayar cutar ga wasu.
A matsayin al'ada, mutanen da ke da alaƙa da, ko kuma masu kamuwa da cutar, galibi ana buƙatar su keɓe su na tsawon kwanaki 14.
Ya kamata a tsawaita lokacin killacewa zuwa kwanaki 24?
Fiva sau da yawa shine babban kuma farkon alamar COVID-19, wanda zai iya kasancewa tare da rashin bayyanar cututtuka ko wasu alamun kamar tari mai bushewa, rashin numfashi, ciwon tsoka, tashin hankali, ciwon kai, ciwon makogwaro, rhinorrhea, ciwon kirji, zawo, tashin zuciya, da amai.
Wasu marasa lafiya sun sami matsalar numfashi da/ ko rashin iskar jini mako guda bayan farawar cutar.
A cikin lokuta masu tsanani, marasa lafiya da sauri sun ci gaba da ci gaba da ciwon cututtuka na numfashi, da damuwa, da acid acid, da kuma coagulopathy.
Marasa lafiya da zazzabi da/ ko alamun cututtukan numfashi da zazzabi mai tsanani, ko da ba tare da halayen hoto na huhu ba, ya kamata a bincika cutar don ganewar asali.
Nazarin alƙaluma a ƙarshen Disamba na 2019 ya nuna cewa yawan adadin alamun cutar ya kai kashi 98% don zazzaɓi, 76% don tari mai bushewa, 55% don dyspnea, da 3% don zawo; 8% na marasa lafiya sun buƙaci tallafin iska.
An bayar da rahoton irin wannan binciken a cikin binciken biyu na kwanan nan na gungun iyali da gungun da aka haifar da watsawa daga mutum mara alamun.
Daidai haka, wani bincike na alƙaluma a 2012 ya nuna cewa marasa lafiya na MERS-CoV kuma suna da zazzaɓi (98%), tari mai bushe (47%), da kuma dyspnea (55%) a matsayin manyan alamunsu.
Koyaya, 80% daga cikinsu sun buƙaci tallafin iska, fiye da marasa lafiya na COVID-19 kuma daidai yake da yawan mutuwar MERS fiye da na COVID-19.
An kuma lura da zawo (26%) da ciwon makogwaro (21%) a cikin marasa lafiya MERS.
A cikin marasa lafiyar SARS, an nuna cewa zazzabi (99%-100%), tari mai bushe (29%-75%), dyspnea (40%-42%), zawo (20-25%), da ciwon makogwaro (13-25%) sune manyan alamun kuma ana buƙatar tallafin iska don kusan 14% -20% na marasa lafiya.
A ranar 14 ga Fabrairu, yawan mutuwar COVID-19 ya kai kashi 2 cikin dari lokacin da aka tabbatar da cutar ta kai 66,576 a duniya.
A daidai wannan, mutuwar SARS a watan Nuwamban 2002 ya kai kashi 10% na 8,096 da aka tabbatar da cutar.
Ga MERS, bisa ga binciken alƙaluma a watan Yuni 2012, yawan mutuwar ya kasance 37% na 2,494 da aka tabbatar da lambobi.
Wani binciken da ya gabata ya ba da rahoton cewa R0 na SARS-CoV-2 ya kai 6.47 tare da tazarar amincewa 95% (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kasance daga 2 zuwa 4 kawai.
An kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV game da alamun bayyanarsu, mutuwa, da R0 a cikin Table Table1.1.
Figures ɗin da ke sama sun nuna cewa SARS-CoV-2 yana da damar da ta fi ta MERS-CoV da SARS-CoV, amma ba ta da haɗari sosai kamar na biyun.
Saboda haka, yana da matukar wahala a sarrafa annobar SARS-CoV-2 fiye da na MERS-CoV da SARS-CoV.
Clustered farawa sau da yawa yakan faru a cikin iyali ɗaya ko daga taro ɗaya ko abin hawa kamar jirgin ruwa.
Marasa lafiya sau da yawa suna da tarihin tafiya ko zama a Wuhan ko wasu yankuna da abin ya shafa ko kuma sun yi hulda da mutane ko marasa lafiya da suka kamu da cutar a makonni biyu da suka gabata kafin farawar cutar.
Koyaya, an ba da rahoton cewa mutane na iya ɗaukar kwayar cutar ba tare da bayyanar cututtuka ba fiye da makonni biyu kuma marasa lafiya da aka sallama daga asibitoci na iya ɗaukar kwayar cutar sake, wanda ke aika ƙararrawa don ƙara lokacin keɓewa.
Marasa lafiya suna da al'ada ko rage yawan farin jini na jini (musamman lymphocytes) a farkon lokaci.
Misali, an gano cutar lymphopenia tare da adadin farin jini &lt; 4×109/L ciki har da adadin lymphocyte &lt; 1×109/L, da kuma yawan matakan aspartate aminotransferase da viremia a cikin marasa lafiya 1,099 na COVID-19.
Matsayin hanta da ƙwayoyin tsoka da kuma myoglobin sun ƙaru a cikin jinin wasu marasa lafiya, kuma sun karu da sinadarin C- reactive da kuma erythrocyte sedimentation a cikin jinin yawancin marasa lafiya.
A cikin marasa lafiya da ke da mummunar yanayi, matakin D- dimer, wanda ke haifar da lalacewar fibrin a cikin jini, ya karu, kuma yawan ƙwayoyin lymphocyte ya ragu a hankali.
An gano rashin daidaito a cikin hotunan rediyo na kirji a cikin yawancin marasa lafiya na COVID-19 kuma an nuna su ta hanyar inuwa mai banƙyama ta ɓangarori biyu ko rashin haske na gilashi a cikin huhu.
Marasa lafiya sukan kamu da cutar huhu, cutar huhu mai tsanani, da kuma cutar numfashi mai tsanani (ARDS).
Idan ARDS ta faru, kumburi da ba a sarrafawa, da kuma ruwa da ke tarawa, da kuma ciwon ƙwaƙwalwa da ke ci gaba suna sa musayar iskar gas ta yi muni sosai.
Rashin aiki na nau'in-I da nau'in-II pneumocytes yana rage matakin surfactant kuma yana ƙaruwa da tashin hankali na farfajiyar, don haka rage ikon huhu don fadadawa da haɓaka haɗarin faɗuwar huhu.
Saboda haka, mafi munin binciken radiographic na kirji sau da yawa yana daidai da mafi girman cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na ilimin cututtuka na COVID-19 ya nuna rashin ƙarancin pneumocytes, samuwar membrane na hyaline, da kuma shiga cikin lymphocyte na interstitial, da ƙwayoyin syncytial multinucleated a cikin huhu na mai haƙuri wanda ya mutu daga cutar, daidai da ilimin cututtukan ƙwayoyin cuta da ARDS da kuma kama da na marasa lafiya na SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar juyawa (RT-PCR) a matsayin babban ƙa'ida don gano COVID-19.
Koyaya, saboda yawan adadin rashin gaskiya, wanda zai iya hanzarta annobar, an fara amfani da bayyanar cututtuka don ganewar asali (wanda ba ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
Haka kuma ya faru da cutar SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar asibiti, gwajin dakin gwaje-gwaje, da binciken radiology yana da mahimmanci kuma yana da mahimmanci don yin ingantaccen ganewar asali.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata yarjejeniya ta amfani da fasahar CRISPR-SHERLOCK don gano SARS-CoV-2, wanda ke gano sassan RNA na SARS-CoV-2 na roba a 20 × 10-18 mol / L zuwa 200 × 10-18 mol / L (10-100 kwafi a kowace microliter na shigarwa) ta amfani da dipstick a cikin ƙasa da awa ɗaya ba tare da buƙatar kayan aiki mai mahimmanci ba.
Da fatan, sabuwar fasahar za ta iya inganta ƙwarewar da kuma dacewa idan an tabbatar da shi a cikin gwajin asibiti.
Saboda rashin gogewa tare da sabon CoV, likitoci galibi suna iya ba da kulawa mai tallafi ga marasa lafiya na COVID-19, yayin ƙoƙarin magunguna iri-iri waɗanda aka yi amfani da su ko aka ba da shawarar a baya don maganin wasu CoVs kamar SARS-CoV da MERS-CoV da sauran cututtukan kwayar cuta (Table (Table2).2).
Wadannan hanyoyin sun hada da magungunan da ake yi yanzu da kuma wadanda ake yi da magungunan antiviral, immunosuppressants, steroids, plasma daga marasa lafiya da suka warke, maganin kasar Sin, da kuma goyon bayan tunani.
An kuma bayar da shawarar amfani da plasma daga marasa lafiya da suka warke don magani.
Kamfanonin harhada magunguna suna tsere don samar da kwayoyin cutar da kuma alluran rigakafi.
SARS-CoV-2 yafi kai hari ga huhu a farkon kuma mai yiwuwa kuma ya kai hari, zuwa ƙaramin mataki, wasu gabobin da ke nuna ACE2, kamar tsarin narkewar abinci da koda.
Duk da haka, matsalar numfashi da rashin nasara sune babbar barazana ga marasa lafiya da kuma babban dalilin mutuwa.
Saboda haka, tallafin numfashi yana da mahimmanci don sauƙaƙe alamun da ceton rayuka kuma ya haɗa da maganin oxygen na yau da kullun, iskar oxygen mai yawan gaske, ba da iska mai ƙarfi, da iska mai ƙarfi dangane da tsananin cutar.
Marasa lafiya da ke da alamun cututtukan numfashi masu tsanani dole ne a tallafa su da extracorporeal membrane oxygenation (ECMO), wata dabara ce da aka gyara ta hanyar zuciya da huhu da ake amfani da ita don magance bugun zuciya ko numfashi mai barazanar rai.
Bugu da ƙari, kiyaye daidaiton lantarki, rigakafi da magani na kamuwa da cuta na biyu da kuma girgizar ƙasa, da kuma kare ayyukan mahimman gabobin ma suna da mahimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa hadarin cytokine sakamakon yawan karfin tsarin garkuwar jiki ne a cikin marasa lafiya na SARS da MERS.
Cytokine guguwa wani nau'i ne na tsarin kumburi mai amsawa wanda aka nuna ta hanyar sakin jerin cytokines ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ, da MCP-1.
Waɗannan cytokines suna haifar da ƙwayoyin rigakafi don sakin adadi mai yawa na 'yanci waɗanda sune babban dalilin ARDS da gazawar gabobin jiki.
Tattarawar rigakafi yana da mahimmanci a cikin maganin guguwar cytokine, musamman a cikin marasa lafiya masu tsanani.
An yi amfani da corticosteroids da tocilizumab, anti-IL6 monoclonal antibody, don magance cytocin guguwa.
Sauran hanyoyin maganin rigakafin cutar cytokine sun hada da daidaitawar amsawar garkuwar jiki ta hanyar kwayoyin T; toshewar IFN-γ, IL-1, da TNF; hana JAK; blinatumomab; mai hana siginar cytokine 4; da masu hana HDAC.
An yi amfani da steroid, a matsayin masu hana garkuwar jiki, a cikin maganin SARS don rage tsananin lalacewar kumburi.
Koyaya, steroids a manyan allurai ba su da amfani ga mummunan raunin huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako masu illa, musamman osteonecrosis na avascular, yana tasiri sosai ga tsinkaya.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na corticosteroids a ƙananan ƙananan-zuwa-matsakaici don amfani da hankali ga marasa lafiya masu cutar COVID-19.
A lokacin rubuta wannan, ba a tabbatar da maganin maganin cutar ba.
Koyaya, an sami amfani da maganin ƙwaƙwalwa tare da remdesivir, wani analog na nucleotide, don ya zama mai tasiri a cikin wani Ba'amurke mai cutar COVID-19.
Remdesivir wani sabon magani ne na kwayar cutar da Gilead ta kirkira da farko don maganin cututtukan da kwayar cutar Ebola da Marlburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta na RNA guda ɗaya ciki har da ƙwayoyin MERS da SARS.
Dangane da waɗannan, Gilead ta ba da mahaɗin ga China don gudanar da gwaji a kan wasu mutane masu cutar SARS-CoV-2, kuma ana tsammanin sakamakon.
Bugu da kari, an ba da shawarar baricitinb, interferon-α, lopinavir/ritonavir, da ribavirin a matsayin yiwuwar maganin ga marasa lafiya da ke da alamun cututtukan numfashi.
Za a iya samun zawo, tashin zuciya, amai, lalacewar hanta, da sauran cututtukan da ba a so, bayan an yi amfani da lopinavir/ ritonavir.
Ya kamata a lura da hulɗar waɗannan jiyya tare da sauran magungunan da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da kuma samar da kwayoyin cutar
Tattara jinin marasa lafiya da suka warke daga cutar da ake kamuwa da ita don a yi wa wasu marasa lafiya da ke fama da cutar ko kuma don kare lafiyayyun mutane daga kamuwa da cutar na da dogon tarihi.
Hakika, marasa lafiya da suka warke sukan sami matakan rigakafi da yawa akan kwayar cutar a cikin jinin su.
Kwayoyin rigakafi sune immunoglobulin (Ig) wanda kwayoyin B suke samarwa don yaƙar ƙwayoyin cuta da sauran abubuwan da ke baƙo kuma suna gane ƙwayoyin ƙwayoyin cuta na musamman a cikin ƙwayoyin cuta kuma suna kawar da su kai tsaye.
Bisa wannan, an tattara plasma daga jinin ƙungiyar marasa lafiya waɗanda suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 masu rauni allurar.
Alamomin su sun inganta cikin sa'o'i 24, tare da rage ƙonewa da nauyin kwayar cutar da ingantaccen iskar oxygen a cikin jini.
Koyaya, tabbatarwa da bayani sun zama dole don ba da shawarar hanyar don amfani da manyan hanyoyin kafin a ci gaba da samar da takamaiman hanyoyin magani.
Bugu da kari, saboda tasirin warkewa, wasu raunin da ke tattare da plasma ya kamata a yi la'akari da hankali.
Misali, kwayoyin cutar na iya kara karfin garkuwar jiki da haifar da cutar sakin cytokine, wanda ke da barazanar barazanar rayuwa.
Yawan kwayar cutar a cikin jini yawanci yana da ƙarancin gaske, kuma buƙatar plasma yana da yawa don kula da marasa lafiya masu tsanani.
Yana da wuya a samar da ƙayyadaddun ƙwayoyin cuta da sauri don yaƙi da cutar ta duniya.
Saboda haka, ya fi mahimmanci da amfani a ware kwayoyin B daga marasa lafiya da aka warke da kuma gano lambobin kwayoyin halittar da ke ɓoye ƙwayoyin cuta masu tasiri ko kuma bincika ƙwayoyin cuta masu tasiri game da muhimman sunadarai na kwayar cutar.
Ta wannan hanyar, za mu iya ƙara yawan samar da ƙwayoyin cuta.
An yi amfani da TCM don magance cututtuka daban-daban a kasar Sin tsawon dubban shekaru.
Koyaya, tasirin sa ya dogara da haɗuwa da abubuwa da yawa a cikin wani tsari wanda ya bambanta dangane da ganewar cutar dangane da ka'idojin TCM.
Yawancin abubuwan da ke da tasiri ba a sani ba ko kuma ba su da tabbas saboda yana da wuya a cire da kuma tabbatar da irin waɗannan abubuwa ko kuma haɗin su mafi kyau.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM ya zama ɗayan manyan hanyoyin magani na madadin ga marasa lafiya tare da haske zuwa matsakaici alamun cutar ko ga waɗanda suka dawo daga mawuyacin yanayi.
Misali, Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules an gano suna da tasiri don maganin COVID-19.
An lura da mafi girman ƙimar warkewa a cikin jiyya na marasa lafiya na COVID-19 a larduna da yawa a China waɗanda suka yi amfani da TCM a cikin 87% na marasa lafiyar su, gami da Gansu (63.7%), Ningxia (50%), da Hunan (50%), yayin da lardin Hubei, wanda ya yi amfani da TCM a cikin kusan 30% na marasa lafiyar COVID-19, yana da mafi ƙarancin ƙimar warkewa (13%).
Koyaya, wannan kwatankwacin kwatankwacin ne kamar yadda wasu abubuwan tasiri kamar su lamba da tsananin marasa lafiya ya kamata a haɗa su cikin kimantawa.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun wallafa wani bincike don kwatanta maganin maganin yamma (WM) shi kaɗai tare da haɗin maganin WM da TCM.
Sun gano cewa lokutan da ake buƙata don dawo da yanayin zafin jiki, ɓacewar bayyanar cututtuka, da kuma asibiti sun kasance mafi guntu a cikin rukunin WM + TCM fiye da na ƙungiyar WM kawai.
Mafi ban sha'awa, yawan ci gaba da ci gaba da ci gaba (daga haske zuwa mai tsanani) ya kasance mai ban mamaki a cikin rukunin WM + TCM fiye da rukunin WM kawai (7.4% vs 46.2%) kuma mace-mace ta kasance ƙasa a cikin rukunin WM + TCM fiye da rukunin WM kawai (8.8% vs 39%).
Duk da haka, inganci da aminci na TCM har yanzu suna jiran ƙarin gwaji da aka sarrafa sosai a manyan ma'aunai da kuma a cibiyoyi da yawa.
Hakanan zai zama mai ban sha'awa don bayyana yanayin ayyukan da kuma bayyana ingantattun abubuwan da ke cikin maganin TCM ko haɗuwa da su idan ya yiwu.
Marasa lafiya da ake zargi ko tabbatar da COVID-19 galibi suna fuskantar babban tsoro na cutar mai saurin yaduwa har ma da mutuwa, kuma mutanen da ke keɓewa suna fuskantar gundura, kaɗaici, da fushi.
Bugu da kari, alamun kamuwa da cutar kamar zazzabi, rashin isasshen ruwa, da tari da kuma illar jiyya kamar rashin bacci da cututtukan corticosteroids ke haifarwa na iya haifar da karin damuwa da damuwa ta hankali.
A farkon lokacin barkewar SARS, an bayar da rahoton wasu cututtukan cututtukan kwakwalwa da suka hada da ci gaba da damuwa, damuwa, hargitsi, tashin hankali na psychomotor, alamun cututtukan psychotic, delirium, har ma da kashe kansa.
Binciken masu hulɗa da tilastawa da keɓewa, a matsayin wani ɓangare na amsar lafiyar jama'a ga barkewar COVID-19, na iya sa mutane su fi damuwa da laifi game da tasirin kamuwa da cuta, keɓewa, da kuma zargi ga danginsu da abokansu.
Don haka, ya kamata a ba da kulawar lafiyar kwakwalwa ga marasa lafiya na COVID-19, da mutanen da ake zargi, da mutanen da ke hulɗa da su da kuma jama'a gaba ɗaya waɗanda ke da bukata.
Tallafin na tunani ya kamata ya hada da kafa kungiyoyin lafiya na kwakwalwa da ke da fannoni daban-daban, sadarwa mai kyau tare da sabuntawa na yau da kullun game da barkewar SARS-CoV-2 da tsare-tsaren magani da kuma amfani da na'urorin lantarki na ƙwararru da aikace-aikace don guje wa kusanci da juna.
Magungunan rigakafi masu inganci suna da mahimmanci don katse sarkar watsawa daga wuraren ajiyar dabbobi da mutane masu kamuwa da cutar zuwa masu karɓar bakuncin kuma galibi suna dacewa da maganin rigakafin cutar a cikin kula da annobar da ƙwayoyin cuta ke haifar.
An yi ƙoƙari don haɓaka alluran rigakafin da ke da tushen furotin S don samar da magungunan rigakafi na dogon lokaci da ƙarfi da / ko rigakafin kariya game da SARS-CoV.
An kimanta allurar rigakafin da ke raye-raye a cikin nau'ikan dabbobi don SARS.
Koyaya, ingancin in vivo na waɗannan 'yan takarar allurar rigakafi a cikin tsofaffi da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
Wannan wataƙila saboda SARS ya mutu shekaru 17 da suka gabata kuma ba a sake samun wani sabon abin da ya faru ba.
Akasin haka, ana ci gaba da samun karamin lamari da tarin MERS a Gabas ta Tsakiya kuma ya yadu zuwa wasu yankuna saboda ci gaba da tushen zoonotic a yankunan da ake fama da cutar.
An samar da dabarun yin rigakafi ga MERS ta hanyar amfani da kwayar cuta, DNA plasmids, masu daukar kwayar cutar, nanoparticles, kwayar cuta mai kama da kwayar cuta da kuma kwayar kwayar kwayar kwayar halitta kuma an kimanta wasu a cikin samfurin dabbobi.
Ci gaban ingantaccen allurar rigakafi da SARS-CoV-2 ga mutanen da ba su da rigakafi ba aiki ne na gaggawa da mahimmanci don sarrafa annobar da ke gudana.
Duk da haka, yana da kalubale don shawo kan wannan matsala saboda tsawon lokaci (a matsakaita watanni 18) da ake buƙata don ci gaban allurar rigakafi da kuma bambancin ƙwayoyin CoVs.
A matsayin sabon cuta, COVID-19 ya fara nuna cikakkiyar hanyar asibiti a cikin dubban marasa lafiya.
A mafi yawan lokuta, marasa lafiya na iya murmurewa a hankali ba tare da sakamako ba.
Koyaya, kamar SARS da MERS, COVID-19 yana da alaƙa da cutar da mutuwa a cikin marasa lafiya da ke da mummunan lamari.
Saboda haka, gina samfurin tsinkaya don cutar yana da mahimmanci ga hukumomin kiwon lafiya don fifita ayyukan su, musamman a yankunan da ke da iyakance albarkatu.
Dangane da nazarin asibiti da aka ruwaito ya zuwa yanzu, abubuwan da ke biyo baya na iya shafar ko kuma suna da alaƙa da tsinkayen marasa lafiyar COVID-19 (Table (Table33):
Shekara: Shekara ita ce muhimmiyar mahimmanci ga hangen nesa na SARS, wanda kuma gaskiya ne ga COVID-19.
COVID-19 ya faru ne a lokacin da ya kai shekaru 30-65 tare da kashi 47.7% na waɗannan marasa lafiya da suka wuce shekaru 50 a cikin binciken da aka yi na mutane 8,866 kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi yuwuwar samun cututtuka masu haɗari da rikitarwa kuma sun kasance sun fi tsofaffi fiye da waɗanda ba su yi ba (a matsakaicin shekaru 66 da 51), suna ba da shawarar shekaru a matsayin abin da ke haifar da sakamako ga marasa lafiya na COVID-19.
SARS-CoV-2 ya kamu da maza fiye da mata (0.31 cikin 100,000 da 0.27 cikin 100,000), kamar yadda aka bayyana a sama.
Cutar da ke tattare da cuta da kuma rikitarwa: Marasa lafiya da ke da COVID-19 da ke buƙatar kulawa mai tsanani sun fi fuskantar cutar da ke tattare da cutar zuciya da kuma rashin saurin zuciya.
Abubuwan da suka faru na zuciya sune babban dalilin mutuwa a cikin marasa lafiyar SARS.
An ba da rahoton cewa SARS-CoV-2 na iya ɗaurewa zuwa ga ACE2-mai kyau cholangiocytes, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya COVID-19.
Yana da kyau a lura cewa shekaru da kuma rashin lafiya na da alaka sosai kuma suna iya shafar juna.
Abubuwan da aka gano na dakin gwaje-gwaje ba daidai ba: Matsayin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko raunin nama kuma an ba da shawarar zama mai yuwuwar mai saurin cutar, amsawa ga magani, da kuma dawo da lafiya.
An kuma bayar da shawarar alaƙa da matakin CRP zuwa tsananin da tsinkayar COVID-19.
Bugu da ƙari, haɓaka lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana bayyana waɗannan enzymes a cikin gabobin da yawa, musamman a cikin zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, alamun gargajiya ne na rashin aiki na zuciya ko hanta.
Babban alamun asibiti: Ya kamata a yi la'akari da radiography na kirji da ci gaban lokaci na alamun asibiti tare da sauran batutuwa don hasashen sakamakon da rikitarwa na COVID-19.
Amfani da steroids: Kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi wanda aka saba amfani dasu azaman magani mai haɗari ga cututtukan ƙwayoyin cuta don rage tsananin lalacewar kumburi.
Tun da aka yi amfani da babban maganin corticosteroids a cikin marasa lafiya na SARS mai tsanani, yawancin masu tsira sun sha wahala daga osteonecrosis na avascular tare da nakasa na tsawon rai da kuma rashin ingancin rayuwa.
Saboda haka, idan ya cancanta, ya kamata a yi amfani da steroids a ƙananan ƙwayoyi kuma na ɗan gajeren lokaci a cikin marasa lafiya COVID-19.
Damuwa ta tunani: Kamar yadda aka bayyana a sama, yayin barkewar COVID-19 yawancin marasa lafiya sun sha wahala daga damuwa ta musamman kamar yadda galibi suke jurewa da tsawan lokaci na keɓewa da matsanancin rashin tabbas da kuma ganin mutuwar dangi na kusa da abokan haƙuri.
Yana da mahimmanci a samar da shawarwarin kwantar da hankali da tallafi na dogon lokaci don taimakawa wadannan marasa lafiya su warke daga damuwa kuma su koma rayuwa ta al'ada.
Dangane da nazarin yanayin al'umma har zuwa yanzu, COVID-19 kamar yana da siffofin cututtukan cuta daban-daban daga SARS.
Baya ga yin kwafi a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya yin kwafi sosai a cikin hanyoyin numfashi na sama kuma yana haifar da laushi ko babu alamomi a farkon kamuwa da cuta, kama da sauran CoVs waɗanda ke haifar da sanyi na yau da kullun.
Saboda haka, marasa lafiya da suka kamu a farkon lokaci ko lokacin da suke iya samar da kwayar cutar da yawa a yayin ayyukan yau da kullun, wanda ke haifar da babban wahala ga kula da annobar.
Koyaya, an yi la'akari da cewa yaduwar SARS-CoV yana faruwa lokacin da marasa lafiya ke da mummunan rashin lafiya, yayin da yawancin watsawa ba su faru ba a farkon matakin.
Saboda haka, barkewar cutar COVID-19 ta yanzu ta fi tsanani da kuma wahalar sarrafawa fiye da barkewar SARS.
Babban ƙoƙari a halin yanzu yana gudana a China ciki har da kulle Wuhan da biranen da ke kewaye da shi da kuma ci gaba da keɓe kusan kusan dukkanin jama'a a cikin fatan dakatar da watsa SARS-CoV-2.
Kodayake waɗannan ayyukan suna lalata tattalin arziki da sauran sassan ƙasar, yawan sababbin marasa lafiya yana raguwa, yana nuna alamar cutar.
Binciken da ya fi kyau shi ne cewa cutar za ta ƙare a watan Maris kuma za a ci gaba da raguwa na tsawon watanni 3-4.
Amma, wasu masana ba su da irin wannan ra'ayin.
Paul Hunter, et al., sun kiyasta cewa COVID-19, wanda ya bayyana da yafi kamuwa da cutar fiye da SARS, ba zai ƙare a cikin 2020 ba.
Ira Longini, et al., sun kafa wani tsari don hango sakamakon annobar kuma sun ba da shawarar cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiya a Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin tsakiyar turbinate da kuma magungunan hanci na marasa lafiya waɗanda suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon ƙwayar cutar da aka gano na iya zama wani yanayi na zagaye kamar mura.
Koyaya, alamun alkawari sun faru a China bisa la'akari da raguwar adadin sabbin al'amuran, wanda ke nuna cewa dabarun na yanzu na iya aiki.
An yi hasashen cewa cutar Ebola za ta iya haifar da mutane miliyan daya da kuma mutuwar mutane rabin miliyan.
Koyaya, ta hanyar keɓewa da keɓewa, cutar ta ƙarshe an sarrafa ta.
Yana yiwuwa, kama da SARS-CoV, cewa SARS-CoV-2 na iya zama mai rauni a cikin kamuwa da cuta kuma daga ƙarshe ya mutu ko ya zama ƙarancin ƙwayoyin cuta masu haɗari tare da mutane.
An ba da kwatancen cutar COVID-19 tare da na SARS da MERS a ƙasa (Fig. (Fig.55).
SARS-CoV-2 yana da saurin yaduwa ta hanyar tari ko sneezing, kuma mai yiwuwa ta hanyar hulda kai tsaye da kayan da kwayar ta gurbata.
An kuma gano kwayar cutar a cikin najasa, wanda ke haifar da sabon yiwuwar watsawa daga najasa zuwa baki.
Wani binciken da aka yi kwanan nan kan mutane 138 ya ba da rahoton cewa kashi 41 cikin 100 na mutanen da cutar ta kama sun kamu da cutar ne daga asibiti, ciki har da marasa lafiya 17 da ke da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a yi amfani da babban kariya don kare mutane, musamman masu ba da kiwon lafiya, ma'aikatan zamantakewa, 'yan uwa, abokan aiki, har ma da masu wucewa waɗanda ke hulɗa da marasa lafiya ko mutanen da ke da cutar.
Layin farko na kariya wanda za a iya amfani da shi don rage haɗarin kamuwa da cuta shine ta hanyar sanya abin rufe fuska; duka amfani da abin rufe fuska da abin rufe fuska na N95 (jerin # 1860s) na taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Kayan rufe fuska na tiyata yana hana ruwa daga wani mutum mai cutarwa daga tafiya ta cikin iska ko mannewa a saman kayan, inda za a iya watsa su ga wasu.
Koyaya, N95 (series # 1860s) masks ne kawai ke iya karewa daga inhalation na virions masu ƙanƙanta kamar 10 zuwa 80 nm, tare da kashi 5% na virions ne kawai ke iya shiga cikin su gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a cikin girma kuma duka suna da kimanin 85 nm.
Tun da yake barbashi na iya shiga har ma da masks na tiyata guda biyar da aka ɗora tare, masu ba da kula da lafiya da ke hulɗa kai tsaye da marasa lafiya dole ne su sa abin rufe fuska na N95 (jerin # 1860s) amma ba abin rufe fuska na tiyata ba.
Baya ga abin rufe fuska, masu kula da lafiya ya kamata su sa rigunan keɓewa don ƙara rage hulɗa da ƙwayoyin cuta.
Kwayoyin cutar za su iya kamuwa da mutum ta hanyar idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; ƙila kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu kula da lafiya su ma su sanya abin rufe fuska ko tabarau masu haske yayin aiki da marasa lafiya.
Ga jama'a a yankunan da cutar ta shafa ko kuma da za ta iya shafawa, an ba da shawara sosai cewa kowa ya wanke hannayensa da sabulun kashe ƙwayoyin cuta fiye da yadda aka saba, ya yi ƙoƙarin zama a cikin gida don keɓe kansa kuma ya iyakance hulɗa da mutanen da za su iya kamuwa da cutar.
Ana ganin ƙafa uku shine ta dace da mutane su nisanta daga mai haƙuri.
Wadannan ayyuka sune ingantattun hanyoyin rage hadarin kamuwa da cuta da kuma hana yaduwar cutar.
Kodayake SARS-CoV-2 ya zo ne a matsayin sabuwar kwayar cuta ga duniyar ɗan adam, babban kamanninsa da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu 2020 ya kamata ya sa China ta kasance cikin faɗakarwa sosai bisa la'akari da ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar ƙwaƙwalwar SARS a cikin 2003.
Koyaya, har zuwa 19 ga Janairu 2020 ne darektan Cibiyar Kula da Cututtuka na Wuhan ya ta'azantar da 'yan ƙasa ta hanyar cewa sabon kwayar cutar tana da ƙarancin kamuwa da iyakancewar haifuwa daga mutum zuwa mutum kuma ba matsala ba ce don hanawa da ƙuntata cutar.
Wannan sakon ya sa jama'a suka kwantar da hankalinsu, musamman lokacin da duk kasar ke shirin bikin bazara, kuma an rasa lokacin da ya dace don dakile cutar a ƙaramin sikelin ta a Wuhan.
Hukumomin kula da cututtuka a kasar Sin na iya daukar wannan darasi mai wuya kuma su yi gagarumar cigaba a nan gaba.
Misali, wadannan hukumomin yakamata su kasance (1) masu hankali yayin yin sanarwar jama'a kamar yadda kowace kalma tana da mahimmanci ga 'yan ƙasa kuma suna iya canza halinsu da yanke shawara; (2) mafi hankali da amsawa ga bayanai marasa amfani daga gidajen magani maimakon jiran rahotanni na yau da kullun daga likitoci ko jami'ai; (3) mafi ƙuntatawa don ƙuntata cutar da ke iya faruwa a farkon lokacinsa maimakon ƙoƙarin ta'aziyar da jama'a; da (4) sau da yawa don fitar da takamaiman da ingantattun atisaye don haɓaka wayar da kan jama'a game da cututtukan annoba da kuma gwadawa da inganta tsarin amsawa na al'umma lokaci-lokaci.
Cutar COVID-19 da sabon kwayar cutar SARS-CoV-2 ta haifar ta fara ne a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu a duk fadin China da kuma kusan wasu kasashe 50 a duniya a lokacin da ake wannan rubutu.
Tunda kwayar cutar ta yi kama da SARS-CoV kuma alamomin sun yi kama da tsakanin COVID-19 da SARS, barkewar COVID-19 ta haifar da ma'anar SARS da ke sake faruwa.
Koyaya, akwai wasu banbanci masu ban mamaki tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don hana annobar da kuma kula da marasa lafiya.
COVID-19 ya shafi tsofaffi fiye da matasa da maza fiye da mata, kuma tsananin da yawan mutuwar ma sun fi girma a cikin tsofaffi fiye da matasa.
SARS yana da yawan mace-mace fiye da COVID-19 (10.91% da 1.44%).
Marasa lafiya na COVID-19 suna watsa kwayar cutar koda kuwa ba su da alamomi yayin da marasa lafiya na SARS galibi suna yin hakan lokacin da suke rashin lafiya, wanda ke haifar da wahalar da yawa don dakile yaduwar COVID-19 fiye da SARS.
Wannan ya bayyana a wani ɓangare dalilin da ya sa SARS-CoV-2 ya yaɗu da sauri kuma ya fi SARS-CoV.
Gwajin RNA na yau da kullun don SARS-CoV-2 na iya zama mara kyau a cikin wasu marasa lafiya na COVID-19.
A gefe guda, marasa lafiya da aka warkar na iya sake samun kwayar cutar.
Wadannan binciken suna kara yawan hatsarin yaduwar kwayar cutar.
Ganin irin wannan saurin ci gaba a cikin bincike kan COVID-19, da dama daga cikin muhimman batutuwa sun rage da za a warware, kamar haka:
A ina ne SARS-CoV-2 ya fito?
Kodayake an gano 96% na kwayoyin halittar tsakanin SARS-CoV-2 da CoVs biyu masu kama da SARS-CoV, har yanzu ba za mu iya yanke shawarar cewa SARS-CoV-2 daga jemage ba.
Wace dabba ce ta watsa kwayar cutar daga asalin mai karbar bakuncin, a ce jemage, zuwa ga mutane?
Ba tare da sanin amsoshin # 1 da # 2 ba, ba za mu iya yanke watsawa yadda ya kamata ba, kuma barkewar cutar na iya sake dawowa a kowane lokaci.
Kodayake ƙirar ƙwayoyin halitta da gwaje-gwajen ƙwayoyin halitta sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, ta yaya daidai kwayar cutar ke shiga cikin ƙwayoyin hanyoyin numfashi kuma yana haifar da canje-canje na ilimin lissafi?
Shin kwayar cutar kuma tana ɗaure da ƙwayoyin ACE2 a cikin wasu gabobin?
Ba tare da amsoshi masu kyau ga waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma magani mai inganci ba.
Har yaushe ne annobar za ta ci gaba?
Ta yaya kwayar cutar ke bunkasa ta hanyar kwayar halitta yayin watsawa tsakanin mutane?
Shin zai zama annoba a duniya, ya mutu kamar SARS ko kuma ya sake dawowa kamar mura?
Yana da mahimmanci amma yana iya ɗaukar lokaci don bincika amsoshin tambayoyin da ke sama da sauran tambayoyi.
Duk da haka, duk irin kudin da zai iya nema, ba mu da wani zabi face mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu ta yau da kullun.
Asalin kwayar cutar kwayar cutar mutum
Juyin halitta da daidaitawa sun kori co-evolution na coronaviruses (CoVs) da masu karɓar bakinsu, gami da mutane, na dubban shekaru.
Kafin shekara ta 2003, an san CoVs na mutum biyu (HCoVs) da ke haifar da rashin lafiya mai sauƙi, kamar sanyi.
Cutar da ke haifar da cutar sankara mai tsanani (SARS) da cutar sankara ta Gabas ta Tsakiya (MERS) sun jujjuya tsabar kudin don bayyana yadda cutar HCoV mai barazana da rai za ta iya zama.
Bayyanuwar SARS-CoV-2 a tsakiyar China a ƙarshen 2019 ya sake tura CoVs cikin haske kuma ya ba mu mamaki tare da babban watsawa amma rage cututtukan cututtukan idan aka kwatanta da ɗan'uwanta SARS-CoV.
Cutar HCoV cuta ce ta zoonosis kuma fahimtar asalin zoonotic na HCoVs zai taimaka mana sosai.
Yawancin HCoVs sun samo asali ne daga jemage inda ba su da cutar.
An kuma san matsakaicin mai karɓar bakararren wasu HCoVs.
Gano dabbobi masu gida suna da tasirin kai tsaye ga rigakafin cututtukan mutane.
Binciken hulɗar CoV-host a cikin dabbobi na iya kuma samun mahimman bayanai game da cutar ta CoV a cikin mutane.
A cikin wannan bita, muna gabatar da bayyani na ilimin da ake da shi game da HCoVs bakwai, tare da mai da hankali kan tarihin gano su da kuma asalinsu na zoonotic da kuma watsawa tsakanin jinsuna.
Abu mai mahimmanci, muna kwatanta da kuma bambanta HCoVs daban-daban daga hangen nesa na juyin halittar kwayar cuta da sake haɗuwa da kwayoyin halitta.
Ana tattauna cutar ta CoV ta 2019 (COVID-19) a halin yanzu a cikin wannan mahallin.
Bugu da kari, an kuma nuna bukatun da ake bukata don samun nasarar sauya mai gida da kuma tasirin juyin halittar kwayar cutar akan tsananin cutar.
Coronaviruses (CoVs) na cikin iyalin Coronaviridae, wanda ya ƙunshi rukuni na enveloped, mai kyau-mai ji, single-stranded RNA ƙwayoyin cuta.
Wadannan ƙwayoyin cuta da ke ɗauke da mafi girman kwayar halittar jini na 26 zuwa 32 kilobases a tsakanin ƙwayoyin RNA an kira su CoVs saboda yanayin su na kambi a ƙarƙashin microscope na lantarki.
A tsarin, CoVs suna da kwayoyin halittar da ba a rarraba su ba waɗanda ke da irin wannan ƙungiyar.
Kimanin kashi biyu bisa uku na kwayar halitta suna dauke da manyan bangarori biyu masu buɗewa (ORF1a da ORF1b), waɗanda aka fassara zuwa polyproteins pp1a da pp1ab replicase.
Ana kara sarrafa polyproteins don samar da sunadarai 16 wadanda ba na tsari ba, wadanda aka ayyana nsp1 ~ 16.
Sauran ɓangaren kwayoyin halittar yana ƙunshe da ORFs don sunadarai masu tsari, gami da ƙwanƙwasa (S), ambulaf (E), membrane (M) da nucleoprotein (N).
Hakanan akwai wasu nau'ikan CoVs daban-daban da ke yin amfani da sunadarai masu amfani da jinsin.
Dangane da bambanci a cikin jerin sunayen sunadarai, an rarraba CoVs zuwa rukuni huɗu (alpha-CoV, beta-CoV, gamma-CoV da delta-CoV), daga cikinsu beta-CoV rukuni ya ƙunshi yawancin HCoVs kuma an rarraba shi zuwa rukuni huɗu (A, B, C da D).
Shaida ta phylogenetic ta nuna cewa baraguwa da rodents suna aiki ne a matsayin tushen kwayar halittar yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye su ne babban tanadin gamma-CoVs da delta-CoVs.
A cikin dubunnan shekaru, CoVs sun ci gaba da ƙetare shingen nau'in kuma wasu sun fito a matsayin mahimman ƙwayoyin cuta na ɗan adam.
Ya zuwa yanzu, an san CoVs na mutum bakwai (HCoVs).
Daga cikinsu HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs guda biyar sun hada da HCoV-OC43, HCoV-HKU1, mai saurin numfashi mai saurin numfashi coronavirus (SARS-CoV), coronavirus na numfashi na Gabas ta Tsakiya (MERS-CoV) da SARS-CoV-2.
HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 yawanci suna haifar da alamun rashin lafiya, kamar sanyi da/ko gudawa.
Sabanin haka, SARS-CoV, MERS-CoV da SARS-CoV-2 da aka gano kwanan nan suna da cutar sosai, suna haifar da mummunan cututtukan ƙananan hanyoyin numfashi a cikin marasa lafiya da yawa tare da mafi girman damar haɓaka cutar cututtukan numfashi mai tsanani (ARDS) da bayyanar cututtukan ƙwayar cuta.
An ware nau'in HCoV-229E na farko, B814, daga ruwan hanci na marasa lafiya da ke fama da mura a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin ilimi ta hanyar zurfin bincike kan HCoV-229E da HCoV-OC43, duka biyun suna haifar da alamun iyakancewa.
Tabbas, an yarda da ra'ayin cewa kamuwa da HCoVs gabaɗaya ba shi da lahani har zuwa barkewar SARS.
Cutar SARS da ta faru a 2003 tana daya daga cikin mafi munin a tarihin yanzu, ta kamu da mutane sama da 8,000 tare da mummunan mutuwar mutum kusan 10%.
Shekaru goma bayan haka, barkewar cutar numfashi ta Gabas ta Tsakiya (MERS) ta haifar da annoba mai ci gaba a yankin Larabawa tare da yaduwar lokaci zuwa sauran duniya.
Sabuwar HCoV (2019-nCoV) ta 2019, wacce daga baya aka sake masa suna SARS-CoV-2, ita ce mai haifar da cutar cutar kwayar cutar coronavirus ta 2019 (COVID-19), wacce ta dauki rayukan mutane sama da 3,120 kuma ta harba mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi ƙararrawa kuma dole ne duniya ta shirya don annobar SARS-CoV-2 da ke zuwa.
Dukkanin HCoVs bakwai suna da asalin zoonotic daga beyar, mice ko dabbobin gida.
Shaidu da yawa na shaida suna tallafawa asalin juyin halittar dukkan HCoVs daga jemagu, inda ƙwayoyin cuta ke dacewa da kyau kuma ba su da cutar amma suna nuna babban bambancin kwayoyin halitta.
Cutar COVID-19 ta gabatar da babbar matsalar lafiya, kimiyya, zamantakewa da ɗabi'a ga China da duniya.
Binciken asalin zoonotic na HCoVs yana ba da tsari don fahimtar tarihin halitta, ƙarfin motsawa da ƙuntatawa na tsalle-tsalle.
Wannan na iya kuma jagorantar ko sauƙaƙa binciken da ke tattare da ajiyar, tsaka-tsakin da kuma kara girman dabbobi masu karɓar bakuncin SARS-CoV-2, tare da mahimman abubuwan da ke tattare da hana yaduwar gaba.
A cikin wannan bita mun gabatar da wani bayyani na asalin zoonotic, watsa tsakanin jinsuna da kuma cutar HCoVs.
Musamman, muna nunawa da kuma tattauna batun gama gari cewa ƙwayoyin cuta na iyaye na HCoVs yawanci ba su da cutar a cikin masu karɓar bakunan su na halitta amma sun zama masu cutarwa bayan watsawar jinsin zuwa sabon mai karɓar bakuncin.
Mun kuma sake duba yanayin juyin halittar HCoV wanda ƙaruwar watsawa sau da yawa yana zuwa tare da raguwar cutar.
An kuma tattauna sakamakon barkewar SARS-CoV-2 da ke gudana a wannan mahallin.
An san CoVs na dabbobi tun daga ƙarshen 1930s.
Kafin warewar farko na HCoV-229E nau'in B814 daga fitar hanci na marasa lafiya waɗanda suka kamu da sanyi na yau da kullun, an ware CoVs daban-daban a cikin dabbobi daban-daban da suka kamu da cutar, gami da turkey, linzamin kwamfuta, saniya, alade, cat da kare.
A cikin shekarun da suka gabata, an gano HCoVs bakwai.
Takaitaccen tarihin gano HCoV a cikin tsari na zamani (Table 1) zai zama mai bayani da ilimantarwa.
An ware nau'in HCoV-229E na farko daga hanyoyin numfashi na marasa lafiya da ke fama da cutar sama a cikin shekara ta 1966, kuma daga baya aka daidaita shi don haɓaka cikin layin kwayar cutar WI-38.
Marasa lafiya da suka kamu da HCoV-229E sun nuna alamun bayyanar sanyi na yau da kullun, gami da ciwon kai, sneezing, rashin lafiya da ciwon makogwaro, tare da zazzabi da tari da aka gani a cikin 10 ~ 20% na lokuta.
Daga baya a cikin 1967, an ware HCoV-OC43 daga al'adun gabobin jiki da kuma hanyar wucewa ta gaba a cikin kwakwalwar beraye masu shayarwa.
Abubuwan da ke faruwa a asibiti na kamuwa da cutar HCoV-OC43 sun yi kama da wadanda ke haifar da HCoV-229E, wanda ba shi da bambanci daga kamuwa da wasu cututtukan numfashi na numfashi kamar su mura da rhinoviruses.
Dukansu HCoV-229E da HCoV-OC43 suna rarraba a duniya, kuma galibi ana watsa su a lokacin hunturu a cikin yanayi mai laushi.
Gabaɗaya, lokacin ruɗar waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, wanda ya biyo bayan kusan kusan makonni 2.
Dangane da binciken da aka yi a kan masu sa kai, mutane masu lafiya da suka kamu da HCoV-229E sun kamu da cutar sanyi.
Sai dai wasu marasa lafiya da ke da rauni a garkuwar jiki sun nuna mummunan kamuwa da cutar na ƙananan hanyoyin numfashi.
SARS, wanda kuma aka sani da  atypical pneumonia, shine farkon cutar da aka rubuta da kyau ta HCoV a tarihin ɗan adam kuma mai haifar da cutar shine SARS-CoV, HCoV na uku da aka gano.
An fara gano cutar SARS ne a ƙarshen 2002 a lardin Guangdong na China.
Cutar ta SARS ta haifar da rahoton mutane 8,096 da suka kamu da cutar tare da mutuwar 774, wanda ya bazu a cikin kasashe da nahiyoyi da yawa.
Baya ga masu yada cutar, an kiyasta cewa kowace harka za ta iya haifar da kimanin cututtukan cututtuka guda biyu, tare da lokacin shiryawa na kwanaki 4 zuwa 7 kuma mafi girman nauyin kwayar cutar yana bayyana a ranar 10th na rashin lafiya.
Marasa lafiya da ke dauke da SARS-CoV da farko suna da ciwon zuciya, ciwon kai, zazzabi, rashin jin daɗi da sanyi, sannan rashin numfashi, tari da wahalar numfashi a matsayin alamun ƙarshen.
Lymphopenia, gwajin aikin hanta da ya ɓace, da haɓaka haɓaka na kinase sune abubuwan da ba na al'ada ba na SARS.
Hakanan ana lura da lalacewar alveolar, yaduwar kwayar epithelial da kuma karuwar macrophages a cikin marasa lafiya na SARS.
Kimanin kashi 20-30% na marasa lafiya daga baya suna buƙatar kulawa mai mahimmanci da kuma iska mai iska.
Baya ga ƙananan hanyoyin numfashi, gabobin da yawa da suka haɗa da na hanji, hanta da koda na iya kamuwa da cutar a cikin waɗannan lokuta masu tsanani, yawanci ana tare da hadari na cytokine, wanda zai iya zama mai kisa musamman a cikin marasa lafiya marasa lafiya.
An fara ware kwayar cutar ne daga binciken huhu na dangi na mai cutar wanda ya yi tafiya zuwa Hong Kong daga Guangzhou.
Tun daga wannan lokacin, an yi ƙoƙari sosai wajen binciken HCoV.
An ware HCoV-NL63 daga yaro mai wata 7 daga Netherlands a ƙarshen 2004.
Da farko an gano cewa ya fi yawa a cikin yara ƙanana, tsofaffi da marasa lafiya marasa lafiya tare da cututtukan numfashi.
Gabatarwar coryza, conjunctivitis, zazzabi, da kuma bronchiolitis na yau da kullun ne a cikin cutar da HCoV-NL63 ke haifarwa.
Wani binciken da ya biyo baya ya bayyana kebancewar kwayar cutar daga samfurin hanci daga wani yaro dan watanni 8 da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi a cikin Netherlands, an rarraba shi a duniya.
An kiyasta cewa HCoV-NL63 yana da kusan 4.7% na cututtukan numfashi na yau da kullun, kuma yawan faruwar sa yana faruwa ne a farkon lokacin bazara, bazara da kuma hunturu.
HCoV-NL63 yana da alaƙa da laryngitis mai hanawa, wanda aka fi sani da croup.
A cikin wannan shekarar, an ware HCoV-HKU1 daga wani mutum mai shekaru 71 wanda aka kwantar da shi a asibiti da ciwon huhu da kuma cutar huhu a Hong Kong.
Baya ga cutar huhu da kuma cutar huhu, an bayar da rahoton cewa HCoV-HKU1 na da nasaba da cutar asma mai tsanani.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, an gano HCoV-HKU1 a duk duniya, yana haifar da cututtukan numfashi masu sauƙi.
Duk waɗannan HCoVs huɗu da aka samu a cikin al'umma sun dace da mutane kuma gaba ɗaya ba su da damar canzawa don haifar da cututtukan cututtuka masu saurin kamuwa da cuta, kodayake haɗari sun faru ne saboda dalilan da ba a sani ba kamar yadda yake a cikin wani ɗan ƙaramin yanayin da ya fi cutarwa na HCoV-NL63, wanda aka ruwaito kwanan nan don haifar da mummunan kamuwa da cuta na ƙananan hanyoyin numfashi a China.
Gabaɗaya, lokacin da waɗannan HCoVs suka sami ikon watsawa da kyau da kuma ci gaba da kasancewa a cikin mutane, su ma sun zama marasa cutarwa ko cutarwa.
An fara gano MERS-CoV ne a shekarar 2012 daga huhu na wani mai shekara 60 da haihuwa wanda ya kamu da ciwon huhu mai tsanani da kuma gazawar koda a Saudiyya.
Yayin da yawancin lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje sun samo asali ne daga Gabas ta Tsakiya, an ba da rahoton wasu lokuta da aka shigo da su tare da bazuwar bazuwar zuwa kusanci da kusanci a cikin ƙasashen Turai da Tunisia.
Wani ɓarkewar cutar ta biyu ya faru a Koriya ta Kudu a cikin 2015 tare da tabbatar da lamuran 186.
Bayyanannun asibiti na MERS sun yi kama da na SARS, wanda ke da alamun ci gaba da cutar huhu mai tsanani.
Ba kamar SARS ba, yawancin marasa lafiya da ke da MERS sun kuma sami ciwon koda mai tsanani, wanda ya zuwa yanzu ya kasance na musamman ga MERS tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30% na marasa lafiya suna da alamun cututtukan gastrointestinal, kamar su zawo da vomiting.
Ya zuwa ranar 14 ga Fabrairu, 2020, an ba da rahoton sama da 2500 da aka tabbatar da cutar a dakin gwaje-gwaje tare da yawan mace-mace na 34.4%, wanda ya sa MERS-CoV ya zama ɗaya daga cikin ƙwayoyin cuta masu haɗari da aka sani ga mutane.
A tsakiyar zuwa ƙarshen Disamba 2019, an gano tarin cututtukan huhu da aka sani da ke da alaƙa da kamuwa da SARS-CoV-2 a Wuhan, lardin Hubei, China.
Hukumar Lafiya ta Duniya ta ayyana barkewar cutar ta ƙananan hanyoyin numfashi da SARS-CoV-2 ke haifar da ita a matsayin Gaggawa na Kiwon Lafiyar Jama'a na Damuwa ta Duniya kuma ta sanya sunan cutar COVID-19.
Ya zuwa 3 ga Maris, 2020, an tabbatar da mutane 90,053 a duk duniya, tare da ƙarancin mutuwar kashi 3.4%.
Musamman, yawan mutuwar a Hubei, China shine 4.2%, yayin da wanda ke waje da shi shine 1.2%.
SARS-CoV-2 na haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, wanda aka gabatar a matsayin zazzabi, tari da dyspnea.
An kuma ga zawo a wasu marasa lafiya.
Ciwon huhu yana daya daga cikin alamun da ya fi tsanani kuma yana iya ci gaba da sauri zuwa cutar cututtukan numfashi mai tsanani.
Kodayake SARS-CoV da SARS-CoV-2 suna da kama da juna saboda babban jerin nucleotide na homology na 82%, suna haɗuwa zuwa rassa daban-daban a cikin bishiyar phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar amma yana da saurin yaduwa idan aka kwatanta da SARS-CoV da MERS-CoV.
An bayar da rahoton mutanen da ba su da alamun cutar da SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwa a duniya.
Kwatanta da bambance-bambancen SARS-CoV-2 tare da sauran HCoVs shida sun bayyana kamance da banbance-banbanban ban sha'awa.
Na farko, lokacin da ake ciki da kuma tsawon lokacin cutar HCoV suna da kama sosai.
A wannan bangaren, SARS-CoV-2 ya bi tsarin sauran HCoVs guda shida.
Na biyu, tsananin alamun cutar COVID-19 yana tsakanin SARS-CoV da HCoVs guda huɗu da aka samu a cikin al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, kamuwa da SARS-CoV-2 yana nuna halayen da aka fi gani a yayin kamuwa da cutar tare da HCoVs da aka samo daga al'umma, gami da gabatar da rashin takamaiman, mai sauƙi ko ma babu alamomi.
A gefe guda, ana iya ganin ƙananan ƙananan ƙananan cututtukan COVID-19 kamar yadda yake a cikin SARS-CoV, kodayake rabo ya ɗan ƙasa.
Na uku, watsa SARS-CoV-2 kuma yana nuna halaye masu ban sha'awa na duka HCoVs da aka samu a cikin al'umma da SARS-CoV.
A gefe guda, yaduwar SARS-CoV-2 ya fi na HCoVs da ke kamuwa da jama'a yawa.
A gefe guda, ya rage a tabbatar ko iya yaduwar SARS-CoV-2 ya ragu bayan wucewa a cikin mutane kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran ƙura.
Ko watsawar SARS-CoV-2 ta hanyar naushin-bakin-baka yana taka muhimmiyar rawa kamar yadda yake a cikin SARS-CoV aƙalla a ƙarƙashin wasu yanayi har yanzu ana bayyana ta hanyar binciken gaba.
Hakanan yana da matukar ban sha'awa don ganin ko SARS-CoV-2 na iya nuna yanayi kamar yadda yake a cikin al'amuran HCoVs na al'umma.
Koyaya, halayen SARS-CoV-2 gami da iya watsawa, cutar da ci gaba da yaduwa bayan wucewa cikin mutane zai yi tasiri ga makomar ƙarshe na barkewar cutar COVID-19.
Duk HCoVs huɗu da aka samu a cikin al'umma waɗanda ke haifar da alamomi masu sauƙi an daidaita su da kyau ga mutane.
Daga wani hangen nesa, yana iya zama gaskiya cewa mutane sun dace da waɗannan HCoVs huɗu.
A wasu kalmomin, duka biyun na iya zama waɗanda suka tsira daga tsoffin cutar HCoV.
HCoVs da ke haifar da cututtuka masu tsanani a cikin mutane da kuma mutane waɗanda suka ci gaba da cututtuka masu tsanani na HCoV an kawar da su.
Don wannan ya faru, HCoVs dole ne su yi kwafi a cikin mutane har ya isa ya ba da damar tarawa na canjin canji wanda ke magance abubuwan ƙuntatawa na mai karɓar bakuncin.
A wannan ma'anar, tsawon lokacin da barkewar SARS-CoV-2 ta ci gaba kuma yawancin mutanen da ta kamu da su, da mafi girman damar da za ta dace da mutane.
Idan ya daidaita da kyau, watsa shi a cikin mutane zai zama da wuya a dakatar da shi ta hanyar keɓewa ko wasu matakan sarrafa kamuwa da cuta.
Shekaru da yawa, CoVs guda huɗu da aka samu a cikin al'umma suna yawo a cikin mutane, suna haifar da sanyi na yau da kullun a cikin batutuwa masu kariya.
Wadannan ƙwayoyin cuta ba sa buƙatar tanadin dabba.
Akasin haka, SARS-CoV da MERS-CoV masu saurin kamuwa da cuta ba su daidaita da mutane da kyau ba kuma baza a iya ci gaba da watsa su a cikin mutane ba.
Suna buƙatar kiyayewa da kuma yadawa a cikin wuraren ajiyarsu na zoonotic kuma suna neman damar da za su zube zuwa ga maƙasudin ɗan adam mai saukin kamuwa, mai yiwuwa ta hanyar matsakaici ɗaya ko fiye da masu karfafawa.
SARS-CoV-2 yana da halaye waɗanda suke kama da duka SARS-CoV/MERS-CoV da HCoVs guda huɗu da aka samu a cikin al'umma.
Yana da saurin yaduwa kamar HCoVs da aka samu a cikin al'umma, aƙalla a yanzu.
Koyaya, yana da cutar fiye da HCoVs da aka samo daga al'umma kuma ba shi da cutar fiye da SARS-CoV ko MERS-CoV.
Ya rage a gani ko zai dace da mutane sosai kuma ya kewaya a cikin mutane ba tare da ajiya ko dabba mai matsakaici ba.
Kafin tattauna asalin dabbobi na HCoVs, zai yi mana kyau mu tattauna ma'anoni da halaye na juyin halitta, na halitta, na ajiya, na tsaka-tsaki da kuma fadada masu karɓar bakuncin HCoVs.
Dabba tana aiki ne a matsayin mai karɓar juyin halitta na HCoV idan yana da wani magabacin da ke da alaƙa da shi wanda ke da babban haɗin kai a matakin jerin nucleotide.
Kwayar cutar kakanninmu yawanci tana da kyau kuma ba ta da cutar a cikin wannan mai karɓar ba.
Hakanan, mai karɓar bakuncin tanadi yana ɗaukar HCoV a ci gaba kuma na dogon lokaci.
A lokuta biyu, masu karɓar suna da kamuwa da cuta ta halitta kuma sune masu karɓar HCoV na halitta ko kwayar mahaifa.
A akasin haka, idan an gabatar da HCoV ga mai masaukin matsakaici kafin ko kusa da gabatarwarsa ga mutane, ba a daidaita shi da kyau ga sabon mai masaukin ba kuma galibi yana da cutarwa.
Wannan matsakaicin mai gida na iya zama tushen zoonotic na kamuwa da cutar mutum kuma yana taka rawar mai karfafawa ta hanyar ba da damar kwayar cutar ta sake maimaitawa kuma daga baya ta watsa shi ga mutane don haɓaka girman kamuwa da cutar mutum.
HCoV na iya samun kamuwa da cuta idan ba zai iya ci gaba da watsawa a cikin mai masaukin ba.
Akasin haka, HCoVs kuma na iya daidaitawa da mai karɓar bakuncin kuma har ma ya kafa yanayin da ya dace na dogon lokaci.
A wannan yanayin, matsakaici mai karɓa ya zama mai karɓar bakuncin halitta.
Bayanan annoba sun nuna cewa a baya an gano cewa SARS na da tarihin hulda da dabbobin da aka farautar.
Binciken da aka yi a baya ya nuna cewa masu sayar da dabbobi suna da yawan cutar anti-SARS-CoV IgG idan aka kwatanta da sauran mutane.
Masked palm civets (Paguma larvata) da racoon kare a cikin kasuwannin dabbobi masu rai an fara gano su don ɗaukar SARS-CoV-kamar ƙwayoyin cuta waɗanda kusan iri ɗaya ne da SARS-CoV.
Wannan ya sami goyon baya kai tsaye ta hanyar gaskiyar cewa ba a sake samun rahoton SARS ba bayan kashe duk civets a kasuwanni.
Koyaya, an ba da rahoton cewa masked palm civets daga cikin daji ko gonaki ba tare da fuskantar kasuwannin dabbobi masu rai ba sun kasance ba su da kyau ga SARS-CoV, suna ba da shawarar cewa masked palm civets na iya zama matsakaiciyar mai karfafawa ne kawai amma ba ajiyar halitta na SARS-CoV ba.
Musamman, tunda kashi 80% na dabbobi daban-daban a cikin kasuwanni a Guangzhou suna da kwayoyin anti-SARS-CoV, ba za a iya cire yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa da yawa na iya zama masu karɓar SARS-CoV ba.
Duk waɗannan suna bayyana su zama masu ba da izini na SARS-CoV.
Binciken da aka yi na dabba na halitta na SARS-CoV ya bayyana CoV bat da ke da alaƙa da juna, wanda aka kira SARS-related Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3), wanda ke wanzu a cikin bats na China.
Waɗannan ƙwayoyin suna da kyau ga anti-SARS-CoV antibodies da kuma tsarin kwayoyin halittar SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na kuliya suna da alaƙa da 88-92% na jerin nucleotide tare da SARS-CoV.
Wadannan nazarin sun aza harsashin ginin sabuwar manufar cewa, jemage suna daukar nauyin kwayoyin cutar da ke haifar da cutar mutum.
An kuma gano CoVs da yawa masu kama da SARS (SL-CoVs) daga jemage, amma babu wani sai wanda aka sanya WIV1 wanda za a iya ware shi azaman kwayar cuta mai rai.
An san cewa enzyme na jujjuyawar angiotensin na mutum 2 (ACE2) shine mai karɓar SARS-CoV.
An nuna WIV1 da aka samo daga samfurin ƙurar ƙwayoyin kwari don amfani da bat, civet da ACE2 na mutum a matsayin mai karɓar shiga cikin ƙwayoyin halitta.
Abin ban sha'awa, sera na marasa lafiya na SARS sun iya kawar da WIV1.
Ya zuwa yanzu, WIV1 yana wakiltar kakanin SARS-CoV mafi kusa a cikin bats, yana raba kashi 95% na jerin nucleotide.
Duk da babban kamance tsakanin waɗannan ƙwayoyin cuta guda biyu, gabaɗaya an yarda cewa WIV1 ba shine kwayar cutar iyaye ta SARS-CoV kai tsaye kuma beyar ba ita ce mai masaukin ajiyar SARS-CoV kai tsaye ba.
Binciken phylogenetic ya haɗa MERS-CoV zuwa rukuni ɗaya kamar yadda bat CoV-HKU4 da bat CoV-HKU5 suka yi.
Bat Co-HKU4 da MERS-CoV suna amfani da mai karɓar mai masauki iri ɗaya, dipeptidyl peptidase 4 (DPP4), don shigar da kwayar cutar.
RNA-mai dogaro da RNA polymerase jerin MERS-CoV suna da kusanci da takwarorinsu a cikin bat beta-CoVs da aka gano daga Turai da Afirka.
Har zuwa yanzu, ba a iya samun MERS-CoV mai rai a cikin beyar daji ba.
MERS-CoV da dangi mafi kusa na CoV-HKU25 na bat suna da kashi 87% na jerin nucleotide.
Saboda haka, baraguwa bazai zama mai karɓar bakuncin MERS-CoV ba.
A gefe guda, bincike a Gabas ta Tsakiya ya nuna cewa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman ra ra ra raƙuman raƙuman ra raƙuman raƙuman ra ra ra ra ra ra ra raƙuman ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra ra
An ware MERS-CoV mai rai wanda ya yi daidai da kwayar cutar da aka samu a cikin mutane daga swabs na hanci na raƙuman dromedary, yana nuna cewa raƙuman suna aiki a matsayin mai karɓar mai karɓar MERS-CoV.
Hakanan yana da mahimmanci cewa a gabaɗaya alamu masu sauƙi amma an lura da zubar da ƙwayoyin cuta a cikin raƙuman da aka kamu da gwaji tare da MERS-CoV.
Musamman, rakuma masu kamuwa da cutar suna zubar da ƙwayoyin cuta ba kawai ta hanyar numfashi ba har ma ta hanyar hanyar ƙura-baki, wanda kuma shine babbar hanyar zubar da ƙwayoyin cuta daga bats.
Koyaya, har yanzu akwai tambayoyi tunda yawancin lokuta da aka tabbatar na MERS basu da tarihin hulɗa da raƙuma kafin bayyanar cututtuka, mai yiwuwa ana danganta su da watsawar mutum-zuwa-mutum ko hanyoyin watsawa da ba a sani ba wanda ya shafi nau'in dabbobi da ba a san su ba waɗanda ke ɗauke da MERS-CoV.
SARS-CoV-2 yana da kashi 96.2% na kwayar halittar kwayar halittar kwayar halittar kwayar cuta tare da CoV RaTG13 wanda aka ware daga Rhinolophus affinis bats.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin tsari tsakanin SARS-CoV-2 da RaTG13 ya yi yawa don sanya dangantakar iyaye.
Wato, bats bazai zama mai tattara kai tsaye na SARS-CoV-2 ba sai dai idan an gano CoVs na bat kusan iri ɗaya a nan gaba.
Da alama, dabbobi masu ɗaukar SARS-CoV-2 ya kamata su kasance cikin nau'in namun daji da aka sayar da su kuma aka kashe su a Kasuwar Kasuwancin Kasuwancin Kasuwanci na Huanan, wanda yawancin shari'o'in farko na COVID-19 suka danganta da su, wanda ke nuna yiwuwar yiwuwar watsawa daga dabba zuwa mutum.
Yawancin binciken da aka yi kwanan nan dangane da tsarin metagenomic sun nuna cewa ƙungiyar ƙananan dabbobi masu fama da haɗari da aka sani da pangolins (Manis javanica) na iya ɗaukar beta-CoVs na kakannin da ke da alaƙa da SARS-CoV-2.
Wadannan sabbin kwayoyin halittar CoV na pangolin suna raba kashi 85-92% na jerin kwayoyin nucleotide tare da SARS-CoV-2.
Koyaya, suna da alaƙa da RaTG13 tare da kusan 90% daidaito a matakin jerin nucleotide.
Suna haɗuwa zuwa ƙananan layi biyu na ƙwayoyin cuta masu kama da SARS-CoV-2 a cikin bishiyar phylogenetic, ɗayan wanda ke raba yanki mai kama da karɓar karɓar karɓa (RBD) tare da SARS-CoV-2, tare da daidaiton jerin amino acid 97.4%.
A bambance-bambance, RBDs na SARS-CoV-2 da RaTG13 sun fi banbanci, kodayake babban digiri na jerin homology na kwayoyin halitta.
Wani binciken da aka yi a baya kan ƙwayoyin pangolin da ke fama da cutar ya kuma ba da rahoton gano ƙwayoyin cuta na ƙwayoyin cuta daga samfuran huhu, wanda ya juya ya zama daidai da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tarawa da kuma maganin hannu don samar da jerin kwayoyin halittar da ke kunshe da kusan kashi 86.3% na kwayar cutar ta kwayar cutar.
Ba za mu iya ware yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu matsakaici na SARS-CoV-2.
Koyaya, a halin yanzu babu wata shaida da ke tallafawa asalin asalin pangolin na SARS-CoV-2 saboda bambancin tsari tsakanin SARS-CoV-2 da beta-CoVs masu alaƙa da pangolin SARS-CoV-2.
Bugu da kari, tazara tsakanin SARS-CoV-2 da RaTG13 ta fi ta tsakanin SARS-CoV-2 da kuma beta-CoVs masu alaƙa da SARS-CoV-2 na pangolin.
Hanyar juyin halittar SARS-CoV-2 a cikin jemage, pangolins da sauran dabbobi masu shayarwa ya kasance za a kafa.
Yayin da aka sami mafi girman jeri a cikin RBDs tsakanin SARS-CoV-2 da pangolin, SARS-CoV-2-da ke da alaƙa da beta-CoVs, SARS-CoV-2 da RaTG13 suna da mafi girman jeri na jeri a cikin tsarin kwayoyin halitta.
Yana da matukar hasashe cewa babban digiri na kama tsakanin RBDs na pangolin SARS-CoV-2 da ke da alaƙa da beta-CoVs da SARS-CoV-2 ana motsa su ta hanyar zaɓin-tsakanin juyin halitta.
Wani shawarwarin da aka gabatar ya goyi bayan sake haɗuwa tsakanin beta-CoV mai alaƙa da SARS-CoV-2 na pangolin da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin ƙarfin motsawa a cikin juyin halitta, sake haɗuwa yana yaduwa tsakanin beta-CoVs.
Har yanzu ana ci gaba da bincike kan asalin zoonotic na SARS-CoV-2.
Baya ga HCoVs masu cutarwa, an kuma yi nazarin asalin zoonotic na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar phylogenetic ta nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoVs na bat, yayin da aka sami ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An bayar da rahoton cewa wani CoV na bat da ake kira ARCoV.2 (Appalachian Ridge CoV) da aka gano a cikin Batunan Arewacin Amurka masu launin launin launin fata sun nuna kusanci da HCoV-NL63.
A gefe guda, HCoV-229E yana da alaƙa da kwayar halittar wata CoV, mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ana kuma zargin cewa masu kamala ne a matsayin mai matsakaiciyarta.
Don a bayyane, ilimin yanzu game da asalin dabbobi na HCoVs da aka sani an taƙaita shi a cikin Hoto 1 da Tebur 2.
Binciken phylogenetic ya ba da shaidar abubuwan da suka faru na watsawa tsakanin HCoVs a cikin tarihi.
Lokacin da HCoV-OC43 ya tsallake jinsuna don kamuwa da mutane daga dabbobin gida a kusan 1890, an yi rikodin cutar ta kamuwa da cututtukan numfashi.
Tarihin watsawa tsakanin jinsuna na HCoV-229E bai bayyana ba.
An gano bat-alpha-CoVs da ke da dangantaka ta kusa da HCoV-229E.
Tsakanin su akwai alpaca alpha-CoV.
Shaidu da dama sun goyi bayan watsa kwayar cutar daga jemagu zuwa ga mutane kai tsaye.
Na farko, mutane amma ba alpacas za su iya hulɗa da jemage a cikin yanayin muhalli na yau da kullun.
Maimakon haka, mutane suna da dangantaka ta kusa da alpacas.
Na biyu, HCoV-229E-da ke da alaƙa da bat alpha-CoVs sun bambanta kuma ba su da cutar a cikin ƙuda, yayin da alpaca alpha-CoV ya haifar da barkewar cutar numfashi a cikin dabbobin da ke da cutar.
A ƙarshe, ba a gano alpaca alpha-CoV a cikin dabbobin daji.
Saboda haka, ba za a iya kawar da yiwuwar alpacas su sami HCoV-229E-related alpha-CoV daga mutane ba.
A zahiri, jemage sune tushen kai tsaye na ƙwayoyin cuta na ɗan adam ciki har da cutar rabies, cutar Ebola, cutar Nipah da cutar Hendra.
Saboda haka ba abin mamaki ba ne cewa jemagu na iya watsa HCoV-229E kai tsaye ga mutane.
A madadin haka, yayin da alpha-CoVs na bat suna aiki a matsayin tushen kwayar HCoV-229E, alpacas da raƙuman raƙumi na iya zama matsakaiciyar runduna da ke watsa ƙwayoyin cuta ga mutane, daidai kamar yadda yake a yanayin MERS-CoV.
MERS-CoV ya zama kyakkyawan misali na yaduwar tsakanin jinsuna daga jemage zuwa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman
An san asalin juyin halitta na MERS-CoV daga jemage a farkon gano shi kuma an kuma ƙarfafa shi ta hanyar binciken da aka samu daga baya.
A bayyane yake cewa kwari suna samar da wadataccen tarin nau'ikan kwayar cuta don musayar nau'ikan nau'ikan nau'ikan nau'ikan kwayoyin halitta da kuma watsawa tsakanin jinsin.
Tsawon rayuwa, tarin tarin al'ummomi, kusanci da hulda da jama'a da kuma iyawar tashi sama duk yanayi ne masu kyau ga barkonan da za su zama 'mai yada kwayar cutar'.
A gefe guda, an gabatar da MERS-CoV ga raƙuman dromedary na shekaru da yawa.
Ya dace da waɗannan raƙuman da suka juya daga matsakaici zuwa matsakaici da kuma mai tanadi na halitta.
MERS-CoV na haifar da cutar mai laushi kuma yana da karancin canji a cikin wadannan dabbobi.
Cutar ta bazu zuwa ga mutane ta kasance hatsari kuma mutane sun kasance masu karɓar bakuncin MERS-CoV saboda ba za a iya ci gaba da watsa ta ba.
Sabanin rawar raƙuma a cikin watsa MERS-CoV, rawar pangolins, idan akwai, a cikin watsa SARS-CoV-2 ya bambanta.
Musamman, pangolin beta-CoVs suna da cutarwa sosai a cikin pangolins.
Suna iya zama mai masaukin da ba zai iya kawowa ba ga beta-CoVs da ke da alaƙa da SARS-CoV-2, kamar civets a cikin yanayin SARS-CoV.
Dole ne a yi watsi da ko kuma a yi watsi da dama ga yiwuwar watsa SARS-CoV-2 tsakanin jinsuna daga dabbobi zuwa mutane a cikin binciken da za a yi nan gaba.
Na farko, jemagu na iya zama mai karɓar bakuncin kwayar cutar da ke da alaƙa da SARS-CoV-2 kusan daidai yake da SARS-CoV-2.
Mutane na iya raba yanayin yanayin muhalli tare da jemagu ta hanyar yankan nama ko hakar kwal.
Na biyu, pangolins na iya zama ɗaya daga cikin matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan matsakaitan mats matsaka mats mats matsakaitan matsakaitan mats mats mats matsaka mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats mats
Mutane suna kamuwa da kwayar cutar ta hanyar yanka da cin nama.
Yana yiwuwa dabbobi masu shayarwa da yawa ciki har da dabbobin gida suna da saukin kamuwa da SARS-CoV-2.
Binciken dabbobi na gida da na daji don maganin rigakafi ya zama dole.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in uku wanda ke hulɗa da duka jemage da pangolins.
Binciken asalin asalin dabbobi na SARS-CoV-2 har yanzu yana kan ci gaba.
Baya ga nau'ikan nau'ikan dabbobi masu watsa shirye-shirye, manyan abubuwa uku a bangaren kwayar cuta suma suna da mahimmanci wajen sauƙaƙe CoVs don ƙetare shingen nau'in.
Da farko dai, yawan juyin halittarsu a cikin kwafin RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ƙididdigar ƙimar jujjuyawar CoVs za a iya ɗauka a matsayin  matsakaici  zuwa  high  tare da matsakaicin adadin maye gurbin kasancewa ~ 10-4 maye gurbin kowace shekara ta kowane wuri 2, dangane da matakin daidaitawar CoV zuwa sababbin runduna.
CoVs suna da exoribonuclease mai karantawa, wanda ke haifar da lalacewa cikin babban canji da raguwa ko ma rashin aiki.
Abin sha'awa, an san cewa nucleotide analog Remdesivir yana hana CoV ta hanyar hana wannan exoribonuclease da RNA-dependent RNA polymerase.
Remdesivir yana daya daga cikin magungunan anti-SARS-CoV-2 masu sa ran za a gwada su a cikin gwaji na asibiti.
Duk da haka, ƙimar juyin halittar CoVs ya kai na masu karɓar su sau miliyan.
Bugu da ƙari, yawan canjin hali yakan yi yawa idan CoVs ba su dace da mai masaukin ba.
Idan aka kwatanta da SARS-CoV tare da babban canjin canji, yawan canjin SARS-CoV-2 a fili ya yi ƙasa, yana nuna babban matakin daidaitawa ga mutane.
Wataƙila, an riga an daidaita shi da wani mai masaukin da ke kusa da mutane.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman dromedary.
A ka'ida, ba zai yiwu ba cewa jujjuyawar kwayar halitta za ta sa allurar rigakafi da magungunan rigakafi da SARS-CoV-2 ba su da tasiri cikin sauri.
Na biyu, babban RNA genome a CoVs yana da ƙarin filastik a cikin gyaran genome don maye gurbi da sake haɗawa, don haka yana ƙara yiwuwar haɓaka tsakanin jinsunan, wanda ke da fa'ida ga fitowar sabon CoVs lokacin da yanayi ya zama mai dacewa.
Wannan yana tallafawa ta hanyar ɗakunan karatu na buɗewa na musamman da ayyukan furotin da aka sanya su zuwa ƙarshen 3 'na kwayar halittar.
Na uku, CoVs a bazuwar kuma sau da yawa suna sauya samfuri yayin kwafin RNA ta hanyar tsarin 'kwafin-zaɓi' na musamman.
A cikin mai masauki wanda ke aiki a matsayin jirgin ruwa mai haɗuwa, sauyawar igiya yana faruwa sau da yawa yayin kwafin CoV RNA.
Cikakken tsayin daka da RNAs na ƙananan kwayoyin halitta na iya sake haɗuwa don samar da sabbin CoVs.
An sami shaidar kwayar halitta ta sake haɗuwa ta halitta a cikin duka HCoV-HKU1 da HCoV-OC43, da kuma CoVs na dabbobi kamar SL-CoV da batCoV-HKU9.
Hadin kai tsakanin kwayar cuta da mai karba dangane da watsawa
Baya ga abubuwan da ke haifar da kwayar cutar guda uku da aka ambata a sama, hulɗar kwayar cutar da mai karɓar mai karɓar wani mahimmin abu ne mai tasiri kan watsawa tsakanin jinsuna.
A nan, ana ɗaukar sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun, wanda kuma ya nuna tabbacin zaɓi mai kyau yayin abubuwan watsawa tsakanin jinsuna.
Bisa ga kwatancen kwatancen tsakanin SARS-CoVs na mutum da na civet, ana tunanin SARS-CoV yana fuskantar saurin daidaitawa a cikin gidaje daban-daban, musamman tare da maye gurbi a RBD na furotin S.
Gabaɗaya, RBD a cikin furotin S na CoV yana hulɗa tare da mai karɓar kwayar halitta kuma an zaɓi shi sosai ta hanyar amsawar mai karɓar bakuncin.
A cikin SARS-CoV, RBD yana cikin amino acid na 318 zuwa 510 akan ɓangaren S1, wanda ke ɗaure ga ACE2 na ɗan adam da kuma masu karɓar sa don shigar kwayar cutar.
RBD na SARS-CoV na iya gane masu karɓar ACE2 na dabbobi daban-daban, gami da jemage, civet, linzamin kwamfuta da kare raccoon, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A zahiri, an lura da ragowar amino acid 6 ne kawai waɗanda suka bambanta da na mutum da na kwayar cutar a cikin RBD kuma 4 daga cikinsu suna cikin abin da ke ɗaure mai karɓa don hulɗa tare da mai karɓar ACE2.
Civet SARS-CoV yana da maye gurbin K479N da S487T a cikin RBD, wanda zai iya ƙara yawan alaƙar hulɗar furotin mai ƙwanƙwasa tare da mai karɓar ACE2 na ɗan adam.
A wasu kalmomin, waɗannan maye gurbin amino acid guda biyu na iya zama mahimmanci ga daidaitawar kwayar cutar ga mutane.
Yana da mahimmanci cewa SARS-CoV-2 yana da masu karɓar ƙwayoyin halitta iri ɗaya tare da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin rukunin S1 na furotin S yana nuna cewa alaƙar haɗin furotin S tare da ACE2 na ɗan adam na iya canzawa.
Tabbas, binciken cryo-EM ya nuna kusancin wannan haɗin ya ninka na tsakanin 10 zuwa 20 fiye da na tsakanin ACE2 na ɗan adam da SARS-CoV S protein.
Hakanan zai zama mai ban sha'awa don tantance ko ana iya buƙatar wani coreceptor don watsa SARS-CoV-2.
Abin ban sha'awa, HCoV-NL63 kuma yana haɗuwa da ACE2 amma tare da wani ɓangare na S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-acetylated sialic acid don HCoV-OC43.
Hakanan suna iya yin lissafin nasarar daidaitawa na waɗannan CoVs a cikin mutane bayan watsawar interspecies daga dabbobi masu ba da izini.
Baya ga masu karɓar salula, sakamakon watsawar HCoVs tsakanin jinsuna kuma ana sarrafa shi ta wasu abubuwan dogaro da ƙuntatawa na mai masauki.
Bambancin waɗannan sunadarai na mai gida tsakanin mutane da masu karɓar bakuncin HCoVs na halitta kamar bats, raƙuman raƙumi da masu tsinkaye na iya zama shinge ga watsawa tsakanin jinsuna.
HCoVs dole ne su yi amfani da abubuwan dogaro na mai masauki kuma su rushe abubuwan da ke iyakance mai masaukin don samun nasarar watsawa tsakanin nau'in.
A wannan bangaren, ana bukatar a gano da kuma bayyana abubuwan da ke haifar da kwayoyin halitta a wannan muhimmin bangare na hulda da kwayar cutar.
Binciken da ba a nuna bambanci ba na tsarin kwayoyin halittar jiki na dogaro da abubuwan hanawa don SARS-CoV-2 ta amfani da fasahar zamani ta CRISPR na iya zama mai amfani.
Bayyanuwar sabon HCoVs: komawa zuwa ƙasa zero
Bambancin CoVs na bat yana ba da dama ga fitowar sabon HCoVs.
A wannan ma'anar, bat CoVs suna aiki ne a matsayin tarin kwayoyin halittar HCoVs.
Bugu da kari, saurin canji da sake hada kwayoyin halitta suma suna jan HCoV juyin halitta kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, saye ko asarar sabbin kwayoyin halittar da ke yin kwayar sunadarai na iya canza yanayin kwayar kwayar cutar sosai.
Daga cikin sunadarai masu amfani da SARS-CoV, an yi tunanin ORF8 yana da mahimmanci a cikin daidaitawa ga mutane, kamar yadda ƙwayoyin cuta masu alaƙa da SARS-CoV suka keɓe amma an gano su don yin amfani da sunadarai ORF8 daban-daban.
An gano halayen cirewar nucleotide 29 na SARS-CoVs a cikin nau'ikan da aka ware a farkon annobar ɗan adam.
Wannan sharewar ya raba ORF8 zuwa ORF8a da ORF8b kuma ana tsammanin ya zama maye gurbi mai dacewa wanda ke inganta sauyawar rundunar.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa da yiwu tare da layin alpha- da gamma-CoVs, inda aka gano adadi mai yawa na ƙananan yankuna masu haɗuwa a cikin RNA-mai dogaro da RNA polymerase.
An kuma gano wuraren sake haɗuwa a cikin nsp9, yawancin nsp10, da sassan nsp14.
Hakanan, an nuna cewa cutar MERS-CoV ta sami abubuwan da suka faru tsakanin zuriya daban-daban, wanda ya faru a cikin raƙuman raƙuman raƙuman a Saudi Arabiya.
Bayan SARS-CoV da MERS-CoV, an kuma lura da abubuwan da suka faru a cikin wasu HCoVs, wanda HCoVs ke sake haɗuwa da sauran CoVs na dabba a cikin kwayoyin halittarsu.
Hakanan ya kamata a yi la'akari da cewa zaɓin mutum na iya ba da gudummawa ga canje-canje da ba a so a cikin ƙwayoyin cuta, mai yiwuwa sakamakon sauƙaƙe ƙwayoyin cuta daga matsin lamba na zaɓin da aka yi, kamar ta tsarin rigakafin mai masauki.
Misalin waɗannan tasirin shine asarar cikakken ORF4 a cikin nau'in samfurin HCoV-229E, saboda ɓarkewar nucleotide biyu.
Yayin da aka iya lura da ORF4 mai inganci a cikin ƙwayoyin cuta da raƙuman raƙumi da ke da alaƙa da HCoV-229E, alpaca alpha-CoV yana nuna saka nucleotide guda ɗaya, wanda ke haifar da canjin tsari.
A ƙarshe amma ba mafi ƙaranci ba, juyin halittar sabon HCoVs kuma ana tura shi ta hanyar zaɓin matsa lamba a cikin masu karɓar bakinsu.
An gano alamun rashin bayyanar cututtuka ko kuma alamu masu sauƙi kawai lokacin da CoVs suka kamu da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararru.
Ya bayyana cewa jemagu sun dace da CoVs a fannin jiki da kuma ilimin lissafi.
Misali, nakasu a cikin kunnawar amsawar kumburi a cikin bats a cikin rage tasirin cututtukan da CoVs ke haifar.
Bayan haka, aikin kwayar halitta a cikin bats an hana shi saboda haɓakar mai karɓar mai kashewa na halitta mai karɓar NKG2/CD94 da ƙarancin matakin bayyanar manyan kwayoyin halittar haɗin haɗin I.
Bugu da ƙari, babban matakin nau'ikan oxygen mai saurin aiki (ROS) da aka samar daga babban aikin metabolism na bats zai iya hana CoV kwafi da kuma shafar karatun ta hanyar exoribonuclease don haka, samar da matsin lamba don tsarawar ƙwayoyin cuta masu cutarwa sosai lokacin da aka gabatar da su cikin sabon mai karɓa.
Hakanan za'a iya samun ƙarin ƙwayoyin CoV na cututtuka ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don dacewa da mai masauki.
Don haka, ba kwatsam ba ne cewa sabbin HCoV guda uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba masu cutarwa bane ko kuma suna haifar da alamu masu laushi a cikin masu karɓar su kamar jemage da raƙuma.
Suna yin kwafi sosai ba tare da haifar da amsa mai ƙarfi na rigakafi ba.
A nan ne asirin dalilin da ya sa ake ganin masu dauke da cutar ba tare da alamun cutar ba kuma abin da ke haifar da mummunan cututtuka a cikin mutane.
Abubuwan da ke nuna alamun sun fi yawa ne saboda yawan aiki na garkuwar jiki da kuma guguwar cytokine inda ya fi ƙarfin garkuwar jiki, mafi girman cutar da huhu.
Akasin haka, a cikin masu ɗaukar hoto, an cire amsawar rigakafi daga kwafin CoV.
Wannan dabarar na kawar da amsawar garkuwar jiki na iya samun fa'ida a maganin anti-SARS-CoV-2.
Amsar interferon tana da ƙarfi musamman a cikin jemage.
Saboda haka, bayar da interferon na nau'in I aƙalla a farkon farkon kamuwa da cutar SARS-CoV-2 a cikin mutane ya kamata ya zama mai fa'ida.
Bugu da ƙari, kunnawar NLRP3 inflammasome a cikin jemagu ba daidai ba ne.
Ta wannan hanyar tunani, hana NLRP3 inflammasome tare da MCC950 na iya zama da amfani a cikin maganin COVID-19.
Bayyanar SARS-CoV-2 ya bi jigon da SARS-CoV da MERS-CoV suka taso.
Yayin da aka gano beta-CoV na jemage da ke raba kashi 95% na kwayar halittar nucleotide tare da SARS-CoV, akwai kuma bat-CoV da ke raba kashi 96% na kwayar halittar nucleotide tare da SARS-CoV-2.
Duk da yake an gano cewa civets da sauran dabbobi a kasuwanni suna dauke da ƙwayoyin cuta iri ɗaya da SARS-CoV, ba a gano matsakaiciyar matsakaiciyar matsakaiciyar SARS-CoV-2 ba.
An gano beta-CoVs na Pangolin da ke kama da SARS-CoV-2, wanda ke nuna cewa pangolins na iya zama ɗaya daga cikin masu karɓar bakuncin ko kuma beta-CoVs na pangolin na iya ba da gudummawar ɓangarorin kwayoyin halitta ga sigar ƙarshe na SARS-CoV-2.
Kodayake har yanzu akwai tambayoyi, babu wata shaida da ke nuna cewa SARS-CoV-2 mutum ne ya yi shi da gangan ko kuma ba da gangan ba.
CoVs sun dawo cikin hasken rana saboda barkewar SARS-CoV-2 kwanan nan.
Nazarin CoVs a cikin bats da sauran dabbobi ya canza ra'ayinmu sosai game da mahimmancin asalin zoonotic da wuraren ajiyar dabbobi na HCoVs a cikin watsawar ɗan adam.
Shaida mai yawa ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 suna da asalin bat kuma ana watsa su ga mutane ta hanyar matsakaici.
Ganin cewa cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da civets a cikin kasuwanni, rufe kasuwanni masu ruwa da kashe civets a can zai iya kawo ƙarshen cutar SARS.
Ta hanyar wannan tunani, ya kamata a cire pangolin daga kasuwannin da aka yi da ruwa don hana watsawar dabbobi, saboda ganowar zuriya da yawa na beta-CoVs na pangolin da ke da alaƙa da SARS-CoV-2.
Koyaya, ko kuma yadda SARS-CoV-2 ke watsawa ga mutane ta hanyar pangolins da sauran dabbobi masu shayarwa ya kasance a bayyane a cikin binciken nan gaba.
A gefe guda, MERS-CoV ya wanzu a cikin raƙuman dromedary na dogon lokaci.
Waɗannan raƙuman suna aiki a matsayin kayan aiki mai mahimmanci don jigilar kaya da kuma babban tushen nama, madara, fata da kayayyakin ulu ga mutanen yankin.
An rarraba su sosai a duk Gabas ta Tsakiya da Afirka.
Saboda haka ba zai yiwu a sadaukar da dukkan raƙuma don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobi na daji a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar cutar MERS, ya kamata a dauki matakin da ya dace don samar da ingantattun alluran rigakafi kan MERS-CoV ga raƙuma, tare da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sabbin nau'ikan ƙwayoyin cuta na iya bayyana don haifar da barkewar cuta.
Akwai nau'o'in CoVs na zoonotic da ke yawo a cikin daji.
Musamman, CoVs na jemage tare da yuwuwar cutar dabbobi suna da bambanci sosai.
Akwai dama mai yawa da waɗannan CoVs na zoonotic ke haɓaka da sake haɗuwa, wanda ke haifar da fitowar sabbin CoVs waɗanda ke da saurin kamuwa da / ko kisa a cikin mutane a nan gaba.
Ya kamata a daina al'adar cin dabbobin daji a wasu wurare na kasar Sin don rage hulda da ba ta dace ba tsakanin mutane da dabbobi.
Tare da wahalar SARS, MERS da COVID-19, ya kamata a sami kyakkyawan shiri da shirin ba da amsa.
A gaskiya, yawancin ƙwayoyin cuta sun wanzu a duniya na dogon lokaci.
Suna zama a cikin nasu tanadin har sai akwai damar zubar da ruwa.
Kodayake jemagu suna da halaye da yawa da ke taimakawa yaduwar ƙwayoyin cuta, damar da mutane ke da ita na yin hulɗa da jemagu da sauran nau'ikan dabbobin daji za a iya rage su idan aka koyar da mutane su guje musu.
Ana buƙatar ci gaba da lura a cikin dabbobi masu shayarwa don samun kyakkyawar fahimta game da yanayin halittu na CoVs da masu karɓar bakinsu na halitta, wanda zai zama da amfani wajen hana watsa dabba zuwa mutum da ɓarkewar ɓarna a nan gaba.
Don kammala, hanya mafi inganci don hana kwayar cutar zoonosis ita ce mutane su nisanta daga wuraren da kwayar cutar zoonotic ta ke da ita.
Wasu abubuwa da yawa a cikin jigon asalin zoonotic na SARS-CoV-2 har yanzu sun ɓace.
Na farko, idan jemagu sun watsa wata kwayar cutar SARS-CoV-2 ga pangolins, zai zama abin sha'awa don ganin a wane yanayi jemagu da pangolins zasu iya raba irin yanayin muhalli.
Na biyu, idan jemagu suna taka rawa kai tsaye wajen yaduwar cutar a cikin mutane, ya kamata a tantance yadda mutane ke hulɗa da jemagu.
Abu na uku, idan dabba mai shayarwa ta uku ta zama mai masaukin baki na gaskiya, yadda yake hulɗa da nau'ikan daban-daban ciki har da mutane, jemagu da pangolins dole ne a fayyace.
A ƙarshe, tun da yawancin dabbobi masu shayarwa ciki har da dabbobin gida na iya zama masu saurin kamuwa da SARS-CoV-2, ya kamata a gudanar da kula da kamuwa da gwaji.
Idan ya kasance bat, pangolin ko wani dabbobi masu shayarwa, ana tsammanin SARS-CoV-2 ko kuma ƙwayoyin halittarsu waɗanda suke kusan kama da juna za a gano su a cikin mahalarta na halitta a nan gaba.
Ci gaba da bincike a wannan fannin zai fayyace hanyar juyin halittar SARS-CoV-2 a cikin dabbobi, tare da mahimman bayanai a cikin rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ka'idojin bincike na COVID-19  wanda ake zargi da cutar  da  wanda aka tabbatar da cutar 
A ranar 6 ga Fabrairun 2020, ƙungiyarmu ta buga jagorar shawara mai sauri don ganewar asali da magani na cutar 2019 novel coronavirus (2019-nCoV), kuma wannan jagorar ta ba da kwarewarmu kuma ta ba da kyakkyawar tunani don yaƙi da wannan cutar a duniya.
Koyaya, cutar coronavirus ta 2019 (COVID-19) sabuwar cuta ce, wayar da kai da iliminmu suna ƙaruwa a hankali bisa ga binciken bincike da ke gudana da kuma ƙwarewar aikin asibiti; saboda haka, dabarun bincike da magani suma ana ci gaba da sabunta su.
A cikin wannan wasikar, mun amsa wata tsokaci kan ka'idarmu kuma mun samar da sabbin ka'idojin bincike na "mai yiwuwa" da "tabbatarwa" bisa ga sabon ka'idojin bincike da magani na COVID-19 (juzu'i na bakwai) wanda Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin ya bayar.
A watan Disamba na 2019, sabon kwayar cutar coronavirus ta 2019 (2019-nCoV) ta haifar da barkewar cutar, wanda yanzu an sanya masa suna a hukumance a matsayin cutar coronavirus ta 2019 (COVID-19) kuma an sanya wa kwayar cutar suna mai suna coronavirus 2 mai saurin numfashi mai saurin kamuwa da cuta (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta bayyana COVID-19 a matsayin annoba.
Domin yaki da cutar SARS-CoV-2, ƙungiyarmu ta haɓaka jagorar shawara mai sauri kuma an buga ta kan layi a cikin Binciken Likita na Soja a ranar 06 ga Fabrairu 2020.
Ya jawo hankali sosai tun lokacin da aka buga shi.
Amma dai a lura da cewa COVID-19 sabuwar cuta ce, saninmu da iliminmu na kara ƙaruwa ne a hankali bisa ga binciken bincike da ake yi da kuma kwarewar aikin asibiti; saboda haka, dabarun ganewar asali da magani suma ana ci gaba da sabunta su.
Misali, Jagororin Bincike da Magani na COVID-19 da Kwamitin Lafiya na Kasa na Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/), ya bayar tsakanin 16 ga Janairu 2020 zuwa 3 ga Maris 2020, ya bayar da jimillar bugu bakwai tare da wasu mahallin da aka canza sosai.
Yanzu jagorarmu ta sami tsokaci daga Zhou et al., sun gabatar da wata shawara mai sauƙi bisa ga kwarewarsu ta asibiti.
Aikin su ya kara sabbin shaidu ga ka'idarmu kuma ya kuma ba da muhimmin bayani game da wannan annoba a duniya.
Muna goyon bayan aikinsu mai muhimmanci kuma muna nuna godiyarmu.
Koyaya, aikin su kuma yana buƙatar sabuntawa bisa ga sabon Jagororin Bincike da Magani don COVID-19 (Trial na bakwai) da kuma binciken kwanan nan.
Dangane da bugu na bakwai (3 Maris 2020), don tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan tarihin cututtukan cututtukan cuta tare da abubuwa biyu na bayyanar cututtukan cututtukan cuta don yin cikakken bincike, ko kuma ya buƙaci biyan abubuwa uku na bayyanar cututtukan cututtukan cuta idan ba tare da bayyanannen tarihin cututtukan cuta ba:
Tarihin cututtukan cututtuka: (1) tarihin tafiya ko zama a birnin Wuhan da kewaye, ko wasu al'ummomi inda aka ba da rahoton COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) tarihin hulɗa da masu kamuwa da cutar SARS-CoV-2 (tare da gwajin sinadarin nucleic acid mai kyau); (3) tarihin hulɗa da marasa lafiya da ke da zazzabi ko alamun numfashi daga birnin Wuhan da kewaye, ko wasu al'ummomi inda aka ba da rahoton COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) tarihin hulɗa da tarin lokuta da aka tabbatar (≥ 2 da zazzabi da/ko alamun numfashi sun faru a cikin makonni 2 a ƙananan yankuna, kamar gida, ofis, aji na makaranta, da sauransu).
Bayyanar asibiti: (1) zazzabi da/ko alamun numfashi; (2) tare da alamun hoto na kamuwa da COVID-19; (3) jimlar adadin farin jini yana nuna al'ada, raguwa, ko rage ƙididdigar ƙwayoyin cuta a farkon matakin farawa.
Tabbatar da cutar da aka tabbatar ya kamata ya dogara da wanda ake zargi da cutar tare da kowane abu guda na pathogenic ko tabbacin serological kamar haka: (1) gwajin PCR na ainihin lokacin da ke nuna tabbatacce ga SARS-CoV-2; (2) jerin kwayoyin halittar kwayar cutar da ke nuna babban daidaituwa ga sanannun sabbin coronaviruses; (3) tabbatacce ga takamaiman IgM antibody da IgG antibody zuwa SARS-CoV-2 a cikin gwajin magani; ko canjin SARS-CoV-2-takamaiman IgG antibody daga mara kyau zuwa mai kyau, ko ƙimar da ke ƙaruwa sau ≥4 a cikin lokacin dawo da sama da na lokacin mai tsanani.
Muna iya ganin cewa an kara gwajin PCR na ainihin lokacin don nucleic acid a cikin hanyoyin numfashi ko samfurin jini a karo na biyu (18 ga Janairu 2020) da na uku (22 ga Janairu 2020).
An kara gano cututtukan cututtukan jini a cikin na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan kuma an kara shaidar kwayar cuta a cikin na bakwai.
Waɗannan gyare-gyare da aka yi dangane da masu binciken sun ci gaba da aiki don neman ingantaccen kayan gano sinadarin nucleic acid don saurin ganewar asali, da kuma samfuran daga hanyoyin numfashi ciki har da ɗaukar samfurin jini, wanda ya haɓaka kasancewar samfuran daban-daban, kuma ya goyi bayan kawo sakamakon ƙayyadaddun ƙwayar ƙwayar cuta a cikin ingantattun ƙa'idodi.
Bayan haka, akwai ƙarin shaidu da yawa da ke tunatar da mu mu yi hankali tare da marasa lafiya marasa alamun da marasa alamun.
Saboda haka, ya kamata a sabunta jadawalin kwararar Zhou et al. , kamar yadda suka rarraba mutumin da ba shi da alamun asibiti a matsayin  low risk .
Hakanan ana buƙatar tabbatar da ƙimar tsarin a cikin ƙarin aikin asibiti da bincike.
Don kammala, muna fatan ƙarin shaidar kai tsaye da ke zuwa kuma kira ga masu karatu don samar da ra'ayoyinsu.
Don tantance  wanda ake zargi  da  wanda aka tabbatar , muna ba da shawarar a gano da kuma bin sabbin ka'idojin ƙasashensu.
Tawagarmu za ta sabunta ka'idojinmu a kan lokaci don ba da taimako.
Bangladesh ta ba da rahoton sabbin mutuwar biyar saboda COVID-19, mafi girma a kowace rana
A jiya, Bangladesh ta tabbatar da sabbin mutuwar mutum biyar saboda COVID-19 a ranar.
Wannan shi ne adadi mafi yawa na mutuwar a rana guda saboda cutar.
Kamar yadda aka yi a jiya, Cibiyar Kula da cututtuka, Kula da cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton adadin wadanda aka kamu da cutar da aka rubuta sun hada da mutane 114 da ke aiki da kuma 33 da suka warke wadanda ke zama a gida.
An yi rikodin jimillar mutuwar 17.
A wani taron manema labarai na yanar gizo, darektan IEDCR, Dr Meerjady Sabrina Flora, ya ce wadanda suka mutu sun hada da maza hudu da mace daya.
A cewar Dr. Meerjady, mutane biyu sun haura shekaru 60, biyu tsakanin 51 da 60, kuma daya yana da shekaru 41-50.
Ta kuma ce biyu daga cikin wadanda abin ya shafa 'yan Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya gaya wa kamfanin dillancin labarai na Anadolu, cewa daya daga cikin wadanda suka mutu shi ne Jalal Saifur Rahman, darektan Hukumar Yaki da Cin Hanci da Rashawa ta Bengali, wanda aka kula da shi a Asibitin Maitree na Kuwait.
A ranar Asabar, a cikin sanarwar bidiyo ta kan layi, Ministan Sufuri da Jiragen Sama na Bangladesh Obaidul Quader ya ce za a rufe sufuri na jama'a na tsawon lokaci fiye da yadda aka tsara tun farko, har zuwa wannan Asabar mai zuwa.
Wannan rufe jigilar jama'a ya fara ne a ranar 26 ga Maris kuma an shirya shi a ranar Asabar, Afrilu 4.
Har ila yau an yarda da safarar kayayyaki masu muhimmanci -- na likitanci, man fetur da abinci.
Aukuwar farko da aka samu na kamuwa da COVID-19 a Bangladesh ya kasance a ranar 8 ga Maris, a cikin mutane biyu da suka dawo daga Italiya da kuma matar ɗayansu.
Ya zuwa ranar 19 ga Maris, waɗannan ukun sun riga sun warke.
SARS-CoV-2 ya zarce miliyan daya na kamuwa da cutar a duniya
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus ta SARS-CoV-2 ya zarce miliyan ɗaya a duniya, bayanan Jami'ar Johns Hopkins sun nuna.
Akalla mutuwar mutane dubu 52 an danganta su da COVID-19, cutar da kwayar cutar coronavirus ta haifar.
Wannan muhimmin ci gaba ya zo a rana guda da Malawi ta tabbatar da kamuwa da cutar coronavirus ta farko kuma Zambiya ta sami mutuwar farko da ta shafi cutar coronavirus.
Koriya ta Arewa ta yi ikirarin, a ranar Alhamis, cewa tana ɗaya daga cikin 'yan ƙasashe kaɗan da suka rage ba tare da kamuwa da cutar coronavirus ba.
A jiya, Hukumar Lafiya ta Duniya ta ba da rahoton 1,051,635 da aka tabbatar, ciki har da 79,332 da suka kamu da cutar a cikin sa'o'i ashirin da hudu kafin karfe 10 na safe na Tsakiyar Turai (0800 UTC) a ranar 4 ga Afrilu.
A Amurka, an yi rikodin sama da mutane dubu 244 da suka kamu da cutar coronavirus, wanda ya danganta da akalla mutuwar mutane 5,900.
CBS News ta ruwaito, tana mai ambaton bayanan Jami'ar Johns Hopkins, akwai mutuwar Amurka sama da 1,000 a ranar Laraba da cutar coronavirus ta haifar.
A duk duniya, kasashe sun sanar da tsaurara matakan hana yaduwar cutar.
A ranar Alhamis, Sergei Sobyanin, magajin garin Moscow, ya tsawaita kulle birnin har zuwa ranar 1 ga Mayu.
A duk fadin kasar, Shugaba Vladimir Putin ya bayyana cewa za a ci gaba da biyan mutanen Rasha albashi ba tare da sun je aiki ba har sai ranar 30 ga watan Afrilu.
Majalisar dokokin Portugal ta kada kuri'a don tsawaita dokar ta baci ta kasa na kwanaki 15; an yi zaben ne da kuri'u 215 a kan, goma ba su da, kuma kuri'a daya ta ki.
Saudi Arabiya ta tsawaita dokar hana fita a cikin biranen Makka da Madina don ta kasance a cikin yini; a baya, dokar hana fita ta kasance ne kawai tsakanin karfe 3 na yamma zuwa 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar zama a gida har zuwa 1 ga Mayu.
Shaguna a Australia sun rage iyakar takarda bayan gida da ake sayarwa
A ranar Lahadi da Asabar da yamma, Shagunan kantin sayar da kayayyaki na Woolworths da Coles na Australiya sun rage ƙuntataccen sayen takardar bayan gida zuwa biyu da fakiti ɗaya a kowane ma'amala a duk shagunan a matakin ƙasa, bi da bi.
ALDI kuma ya gabatar da iyakar kunshin guda, a ranar Litinin.
An sanya waɗannan iyakokin a matsayin saƙonni a kan rajistan shiga, da kuma a shafukan Facebook na sarƙoƙi.
An bayar da rahoton cewa masu siye suna yin ajiya saboda tsoron COVID-19 idan mutane suna buƙatar keɓe kansu.
A ranar Laraba, Woolworths kuma ya iyakance sayen takardar bayan gida don isar da gida zuwa fakiti daya a kowane tsari.
Waɗannan canje-canjen sun biyo bayan ƙuntatawar ƙwararrun kwastomomi huɗu da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris.
Coles, a cikin sanarwar manema labarai ta 8 ga Maris, ta ba da rahoton cewa tare da ƙuntatawa na kunshin huɗu a wuri, "" yawancin shaguna har yanzu suna siyarwa a cikin sa'a ɗaya na bayarwa"", kuma ya kira buƙatar "" wanda ba a taɓa gani ba"", yayin da ALDI, a cikin wani sakon Facebook a ranar Talata, ya kira shi "" abin da ba a tsammani ba. " "
"Kasuwancin ya karu da yawa a makon da ya gabata, a cewar wani mai magana da yawun Woolworths".
Shagon Costco a Canberra kuma ya iyakance adadin da aka yarda zuwa fakiti biyu a makon da ya gabata.
Don kara rage karancin, Coles ya ba da umarnin manyan kunshe daga masu samarwa da kuma karuwar yawan isar da kaya, Woolworths ya ba da umarnin karin kaya, yayin da ALDI ya sanya kaya don shirin na musamman na Laraba da aka shirya a farkon.
Russell Zimmerman, babban darakta na kungiyar 'yan kasuwa na Australiya, ya ce 'yan kasuwa suna kokarin tara kayayyaki, amma ƙuntatawa na karamar hukuma a kan lokacin isar da motocin da ke kawo kaya yana sa ya zama da wuya.
Yana tsammanin farashin samarwa zai tashi, yayin da masu samarwa ke kokarin biyan bukatun, da kuma karancin na musamman.
A ranar Talata, ALDI ta sanar da cewa bayan fitar da kaya da wuri, wasu shagunan ba za su iya gudanar da na musamman na Laraba ba.
A wani rahoto na News.com.au, Dr Gary Mortimer, kwararren masanin sayar da kaya daga Jami'ar Fasaha ta Queensland, ya ce shagunan suna cika kayan da ake da su a kowane dare.
Ya yi tsokaci cewa takardar bayan gida abu ne mai girma, wanda ke haifar da karancin adadi, kuma, lokacin da aka sayar, ya bar manyan wuraren ajiye kayayyaki, yana kara jin karancin.
"Coles da Woolworths suna da ra'ayi [cewa] idan akwai abubuwa da yawa a kan shiryayye, idan za a iya [saya] samfurori kamar ɗakunan wanka da tsabtace jiki kuma suna cikin adadi, wataƙila za ku rage tsoro" in ji Russell Zimmerman ta hanyar ABC News. "
Kamfanin da ke samar da takardar bayan gida da aka yi amfani da ita ya ce a ranar Laraba da ta gabata ba su da kayayyaki.
Kimberly-Clark, wanda ke samar da Kleenex Toilet Tissue, da Solaris Paper wanda ke samar da Sorbent, sun jaddada cewa suna aiki ne ba dare ba rana don kula da wadatar, a cewar rahoton News.com.au.
Domain.com, wani shafin yanar gizo na dukiya, ya ruwaito wasu masu sayar da dukiya suna ba da takarda gidan wanka kyauta ga mai ba da kyauta a kan gwanjo a Melbourne, lokacin da aka rage ƙarancin gwanjo saboda masu sayen suna da lokaci a ƙarshen mako na ranar ranar aiki.
Buga na ranar Alhamis na NT News, wani jarida na yau da kullum da aka buga a Darwin, ya hada da shafi na sha takwas da aka yi niyya don a yanka shi kuma a yi amfani da shi a matsayin takardar bayan gida.
Shagunan sun kasance da farko sun ƙi sanya takunkumi, a cewar wani rahoto daga ABC Australia a ranar 3 ga Maris wanda suka ce ba su da shirin gabatar da takunkumi kan sayayya.
Russell Zimmerman ya kara da cewa sauran kayayyakin ma suna da matukar bukatarsu, gami da abin rufe fuska, na'urar wanke jiki, kayan da aka bushe, na wanke hannu da fulawa.
Hakazalika, a wajen Ostiraliya, a yammacin Lahadi, an lura da Ocado na Burtaniya ta yanar gizo ta iyakance sayen takardar bayan gida ta Andres zuwa fakitoci biyu na 12.
Hukumar Lafiya ta Duniya ta ayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana barkewar cutar COVID-19  cutar da coronavirus SARS-CoV-2  ke haifarwa a matsayin annoba.
" Ko da yake kalmar "" annoba "" tana nufin yadda cutar ta yadu ne kawai, ba yadda wasu lokuta ke da haɗari ba, WHO ta lura da buƙatar tura gwamnatoci su ɗauki mataki: "
"Duk kasashe na iya canza yanayin wannan annoba. "
"Idan kasashe sun gano, gwada, bi da, ware, ganowa da kuma tattara jama'arsu a cikin martani", in ji Tedros Adhanom Ghebreyesus, Darakta-Janar na WHO. "
"Mun damu matuka saboda yawan yaduwar cutar da kuma tsananin da kuma rashin daukar mataki".
" A cewar Dr. Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Rigakafin Amurka, annobar cutar ta ""ba ta taɓa faruwa ba"." "
" Ya ce, a cikin jawabin da CNN ta wallafa a watan Fabrairu, " ban da mura, babu wata cutar numfashi da aka gano daga fitowa zuwa ci gaba da yaduwa a duniya. " "
" Ghebreyesus ya bayyana irin wannan ra'ayi, yana cewa "" ba mu taɓa ganin annobar da cutar coronavirus ta haifar ba. "" "
Ya ci gaba, "kuma ba mu taɓa ganin annobar da za a iya sarrafa ta a lokaci guda ba".
Sabon matsayin na annoba ya biyo bayan shawarar WHO a watan Janairu don ayyana barkewar cutar a matsayin matsalar lafiyar jama'a ta damuwa ta duniya.
"Darakta na Cibiyar Kula da Allergy da Cutar Cutar Kwayoyin Cutar Amurka, Dr. Anthony Fauci, ya ce game da cutar, "" aƙalla, zai ƙara ta'azzara. "" "
Kamar yadda na Alhamis, Associated Press ta ba da rahoton akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duk duniya, wanda ya haifar da mutuwar sama da 4,600.
201920 annobar cutar coronavirus annoba ce ta cutar coronavirus ta 2019 (COVID-19), wanda ya haifar da cutar coronavirus 2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disamba na 2019, an ayyana ta a matsayin Bala'in Kiwon Lafiyar Jama'a na Damuwar Damuwa ta Duniya a ranar 30 ga Janairu 2020, kuma an gane shi a matsayin annoba a ranar 11 ga Maris 2020.
Ya zuwa 10 ga Afrilu 2020, an ba da rahoton kimanin mutane miliyan 1.61 na COVID-19 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar kusan 97,000.
Kimanin mutane 364,000 ne suka warke.
An kiyasta yawan mace-mace ya kai kashi 4% a China, yayin da a duniya ya kai daga 13.04% a Algeria zuwa 0.08% a New Zealand.
Alamomin da ake yawan gani sun hada da zazzabi, tari da rashin numfashi.
Matsaloli na iya haɗawa da ciwon huhu da cututtukan cututtukan numfashi na numfashi.
Lokacin daga bayyanar da bayyanar cututtuka yawanci kusan kwanaki biyar ne, amma na iya kasancewa daga kwana biyu zuwa goma sha huɗu.
Babu maganin alurar riga kafi da aka sani ko magani na musamman na cutar.
Maganin farko shine maganin alamomi da tallafi. Matakan kariya da aka ba da shawarar sun hada da wanke hannu, rufe bakin mutum lokacin da yake yin tari, kiyaye nesa da wasu mutane, da kuma sa ido da kebe kai ga mutanen da ake zargin sun kamu da cutar.
Hukumomi a duk duniya sun amsa ta hanyar aiwatar da takunkumin tafiye-tafiye, keɓewa, dokar hana fita, sarrafa haɗarin wuraren aiki, da rufe wuraren.
Cutar ta haifar da mummunan rikicewar zamantakewar tattalin arziki na duniya, jinkirta ko soke wasanni, al'adu, siyasa da al'adu, da kuma ƙarancin kayayyaki da yawa wanda sayen tsoro ya tsananta.
An rufe makarantu da jami'o'i ko dai a matakin kasa ko na gida a cikin kasashe 193, wanda ya shafi kusan kashi 99.4 na yawan ɗaliban duniya.
Rashin bayanai game da kwayar cutar ya bazu a yanar gizo, kuma an sami al'amuran ƙiyayya da nuna bambanci ga mutanen Sinawa, sauran mutanen da ke da asalin Gabas da Kudu maso Gabas ta Asiya da bayyanarsu, da kuma wasu daga yankunan da ke da mahimman maganganun cutar.
Saboda rage tafiye-tafiye da rufe masana'antu masu nauyi, an sami raguwar gurɓatar iska da fitar da carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton tarin cututtukan cututtukan huhu na rashin sani a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu 2020.
Yawancin lokuta suna da alaƙa da Kasuwar Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan.
Kwayar cutar da ta haifar da barkewar cutar an san ta da SARS-CoV-2, sabuwar kwayar cutar da aka gano wacce ke da alaƙa da coronaviruses na bat, pangolin coronaviruses, da SARS-CoV. An gano farkon mutumin da aka sani da alamun cutar ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da alaƙa da gungun kasuwar da aka yi rigakafi.
Daga farkon rukunin shari'o'in da aka ruwaito a watan Disamba 2019, kashi biyu bisa uku an gano suna da alaƙa da kasuwa.
A ranar 13 ga Maris 2020, wani rahoto da ba a tabbatar da shi ba daga jaridar South China Morning Post ya nuna cewa wani mutum da aka gano da cutar a ranar 17 ga Nuwamba, 2019, a cikin wani mutum mai shekaru 55 daga lardin Hubei, na iya zama na farko. A ranar 26 ga Fabrairu 2020, WHO ta ba da rahoton cewa, kamar yadda aka ruwaito cewa sabbin masu kamuwa da cutar sun ragu a China amma ba zato ba tsammani sun karu a Italiya, Iran, da Koriya ta Kudu, yawan sabbin masu kamuwa da cutar a wajen kasar Sin ya zarta na sabbin masu kamuwa da cutar a cikin kasar Sin a karon farko.
Za a iya samun karancin rahoto na masu cutar, musamman a tsakanin wadanda ke da alamun rashin lafiya.
Zuwa ranar 26 ga Fabrairu, an ba da rahoto kan karancin masu kamuwa da cutar a tsakanin matasa, wadanda shekarunsu 19 zuwa kasa da haka suna da kashi 2.4% na masu kamuwa da cutar a duniya. Babban mai ba da shawara kan fannin kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60% na yawan jama'ar Burtaniya za su buƙaci kamuwa da cutar kafin a samu garkuwar garkuwar garke mai inganci.
Lamura suna nufin yawan mutanen da aka gwada su don COVID-19, kuma wanda aka tabbatar da gwajinsa ya tabbata daidai da ka'idojin hukuma.
Ya zuwa ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da 3% na yawanta, kuma ƙasashe da yawa suna da manufofin hukuma don kada su gwada waɗanda ke da alamun bayyanar cututtuka, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani binciken da aka buga a ranar 16 ga Maris ya gano cewa a China, har zuwa 23 ga Janairu, an kiyasta kashi 86% na kamuwa da COVID-19 ba a gano ba, kuma waɗannan cututtukan da ba a rubuta su ba sune tushen kamuwa da cutar ga kashi 79% na shari'o'in da aka rubuta.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya kiyasta cewa adadin kamuwa da cutar a Italiya ya fi yawa fiye da adadin da aka ruwaito.
Kimanin farko na lambar haifuwa ta asali (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani binciken da Cibiyar Kula da Cututtuka da Cututtuka ta Amurka ta wallafa ya kammala cewa yana iya zama 5.7.
Yawancin mutane da ke da COVID-19 suna warkewa.
Ga wadanda ba su yi ba, lokacin daga bayyanar cututtuka zuwa mutuwa ya kasance tsakanin kwanaki 6 da 41, tare da mafi yawanci kwanaki 14.
Ya zuwa 10 ga Afrilu 2020, kimanin mutuwar 97,000 aka danganta ga COVID-19.
A China, har zuwa ranar 5 ga Fabrairu kimanin kashi 80% na mutuwar sun kasance a cikin wadanda suka haura 60, kuma kashi 75% suna da yanayin rashin lafiya da suka hada da cututtukan zuciya da na ciwon sukari. Bayanan hukuma na mutuwar daga cutar COVID-19 gabaɗaya suna nufin mutanen da suka mutu waɗanda suka gwada tabbatacce ga COVID bisa ga ƙa'idodin hukuma.
Adadin ainihin mutuwar da COVID-19 ya yi zai iya zama mafi girma, saboda ba zai iya haɗa mutanen da suka mutu ba tare da gwaji ba - misali a gida, a gidajen kula da tsofaffi, da sauransu.
Data na ɓangare daga Italiya ya gano cewa yawan adadin mutuwar da aka yi a lokacin annobar ya wuce adadin mutuwar COVID na hukuma ta hanyar kashi 4-5x.
"Wata mai magana da yawun Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta yarda da cewa" "Mun san cewa [yawan mutanen da aka kashe] an rage su ne", wata sanarwa da rahotanni na rashin ƙididdigewa a Amurka suka tabbatar. Irin wannan rashin ƙididdigar yakan faru ne a cikin annoba, kamar annobar cutar sankara ta H1N1 ta 2009. An tabbatar da mutuwar farko a Wuhan a ranar 9 ga Janairu 2020. "
Mutuwar farko a wajen kasar Sin ta faru ne a ranar 1 ga Fabrairu a Philippines, kuma mutuwar farko a wajen Asiya ta kasance a Faransa a ranar 14 ga Fabrairu.
Zuwa 28 ga Fabrairu, a wajen babban yankin China, an yi rikodin sama da goma sha biyu na mutuwar kowannensu a Iran, Koriya ta Kudu, da Italiya.
Ya zuwa ranar 13 ga Maris, sama da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a kowace nahiya ban da Antarctica. Ana amfani da matakai da yawa don ƙididdige yawan mace-mace.
Wadannan lambobin sun bambanta da yanki da kuma lokaci, kuma suna tasiri da yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan jiyya, lokaci tun farkon barkewar cutar, da halayen jama'a kamar shekaru, jinsi, da kuma lafiyar gaba ɗaya.Hadin mutuwar-zuwa-halin ya nuna yawan mutuwar da aka raba ta da adadin shari'o'in da aka gano a cikin wani lokaci.
Dangane da ƙididdigar Jami'ar Johns Hopkins, ƙimar mutuwar duniya zuwa yanayin shine 6.0% (97,039/1,617,204) kamar yadda na 10 ga Afrilu 2020.
Adadin ya bambanta a yanki.
A China, kimantawa don mutuwar-zuwa-lambar ya ragu daga 17.3% (ga waɗanda ke da bayyanar cututtuka 110 Janairu 2020) zuwa 0.7% (ga waɗanda ke da bayyanar cututtuka bayan 1 Fabrairu 2020). Sauran matakan sun haɗa da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano da ke mutuwa daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan kamuwa da cutar (wanda aka gano da wanda ba a gano ba) wanda ya mutu daga cutar.
Wadannan ƙididdigar ba su da lokaci kuma suna bin wani ƙayyadaddun al'umma daga kamuwa da cutar ta hanyar warware matsalar.
Wasu malaman sun yi ƙoƙarin lissafin waɗannan adadi don wasu mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kimanta cewa yawan mutuwar kamuwa da cutar a cikin cutar a matsayin cikakke yana tsakanin 0.1% da 0.39%.
Ƙididdigar sama na wannan zangon ya yi daidai da sakamakon daga gwajin farko na bazuwar don COVID-19 a Jamus, da kuma nazarin ƙididdiga wanda ke nazarin tasirin gwaji akan ƙididdigar CFR.
Hukumar Lafiya ta Duniya ta ce za a iya shawo kan annobar.
Ba a san lokacin da cutar ta fi girma ba kuma ba a san lokacin da za ta yi ba kuma za ta iya bambanta dangane da wurin da cutar ta auku.
Maciej Boni na Jami'ar Jihar Penn ya bayyana cewa, "Idan ba a kula da shi ba, kamuwa da cututtuka yakan daidaita sannan ya fara raguwa lokacin da cutar ta ƙare daga masu ba da izini".
"Amma kusan ba zai yiwu a yi wani tsinkaya mai ma'ana ba a yanzu game da lokacin da hakan zai kasance".
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin Zhong Nanshan ya yi jayayya cewa " " zai iya zama a watan Yuni " " idan dukkan kasashe za su iya yin amfani da su don bin shawarar WHO kan matakan da za a dauka don dakatar da yaduwar cutar. "
A ranar 17 ga Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Tropical na London ya bayyana cewa SARS-CoV-2 "zai kasance yana yawo, mai yiwuwa na shekara ɗaya ko biyu".
" A cewar binciken Kwalejin Kwalejin da Neil Ferguson ya jagoranci, za a buƙaci nisantar jiki da sauran matakan "" har sai an sami rigakafi (mai yuwuwar watanni 18 ko fiye) " ".
" William Schaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar ta coronavirus, saboda yana da saurin yaduwa, za ta bace gaba ɗaya" kuma "na iya zama cuta ta yanayi, tana dawowa kowace shekara". "
Cutar da ke cikin wannan cutar za ta dogara ne da garkuwar garken da kuma yawan kwayar cutar.
Alamun cutar COVID-19 na iya zama ba na musamman ba kuma mutanen da ke da cutar na iya zama marasa alamun.
Abubuwa biyu da suka fi yawa sune zazzabi (88%) da kuma bushewar tari (68%).
Ƙananan alamun da ke tattare da gajiya, samar da sputum na numfashi (phlegm), asarar ƙanshin, ƙarancin numfashi, tsoka da ciwon haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, hemoptysis, zawo, ko cyanosis. WHO ta bayyana cewa kusan mutum ɗaya cikin shida ya zama mai tsanani rashin lafiya kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Cututtuka ta Amurka (CDC) ta lissafa alamun gaggawa kamar wahalar numfashi, ciwo ko matsin lamba na kirji, rikicewar kwatsam, wahalar farkawa, da fuska mai launin shuɗi ko lebe; ana ba da shawarar kula da likita nan da nan idan waɗannan alamun suna nan. Ci gaban ci gaba na cutar na iya haifar da cutar huhu mai tsanani, ciwon wahalar numfashi mai tsanani, sepsis, girgizawar jini da mutuwa.
Wasu daga cikin wadanda suka kamu da cutar na iya zama marasa alamun cutar, ba tare da alamun asibiti ba amma tare da sakamakon gwajin da ke tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawara cewa waɗanda ke da kusanci da mutanen da aka tabbatar da kamuwa da cutar ya kamata a kula da su sosai kuma a bincika su don kawar da kamuwa da cutar.
Kimantawar kasar Sin na yawan wadanda ba su da alamun cutar daga kadan zuwa kashi 44%.
Lokacin da ake yawan kamuwa da cutar (lokacin da ke tsakanin kamuwa da cutar da kuma bayyanar cututtukan) ya kasance daga kwana ɗaya zuwa 14; yawanci kwanaki biyar ne.A matsayin misali na rashin tabbas, ƙididdigar kashi na mutanen da ke da COVID-19 waɗanda suka rasa jin ƙanshin su ya fara da kashi 30% kuma daga baya ya ragu zuwa 15%.
Har yanzu ana ci gaba da gano wasu bayanai game da yadda cutar ke yaduwa.
Ana tsammanin cutar ta fara yaduwa yayin kusanci da kuma ta kananan ɗigon ruwa da ake samu yayin tari, sneezing, ko magana; tare da kusanci yana tsakanin mita 1 zuwa 2 (3 zuwa 6 feet).
Nazarin ya gano cewa tari ba tare da rufewa ba zai iya haifar da saukad da ruwa har zuwa mita 4.5 (ƙafa 15) zuwa 8.2 (ƙafa 27).
Wasu sun ba da shawarar cewa ana iya yada kwayar cutar ta hanyar kananan saukad da ke kasancewa na tsawon lokaci a cikin iska, wanda za a iya samarwa yayin magana. Hakanan ana iya samar da saukad da numfashi yayin fitar numfashi, gami da lokacin magana, kodayake kwayar cutar ba ta iska ce gaba ɗaya.
Saukad da za su iya sauka a cikin bakuna ko hanci na mutanen da ke kusa ko kuma za a iya shiga cikin huhu.
Wasu hanyoyin kiwon lafiya kamar su intubation da kuma resuscitation cardiopulmonary (CPR) na iya haifar da ɓoyewar numfashi don aerosol kuma ta haka yana haifar da yaduwar iska.
Hakanan yana iya yaduwa lokacin da mutum ya taɓa wani abu da ya kamu da cutar, gami da fata, sannan ya taɓa idanunsu, hanci, ko bakinsu.
Duk da cewa akwai damuwa cewa zai iya yaduwa ta hanyar najasa, ana ganin wannan hadarin yana da ƙaranci.
Gwamnatin kasar Sin ta musanta yiwuwar watsawar SARS-CoV-2 ta hanyar hanci da na baki. Kwayar cutar ta fi kamuwa a cikin kwanaki uku na farko bayan bayyanar alamun cutar, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan baya na cutar.
Mutane sun gwada tabbatacce ga cutar har zuwa kwana uku kafin bayyanar cututtuka wanda ke nuna yiwuwar watsawa kafin bayyanar cututtuka.
Rahotanni kaɗan ne kawai na tabbatar da yanayin rashin bayyanar cutar da aka tabbatar a dakin gwaje-gwaje, amma wasu ƙasashe sun gano cewa ana iya samun cutar ba tare da bayyanar da wata alama ba a lokacin binciken gano mutanen da suka kamu da cutar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta bayyana cewa ko da yake ba a san yadda cutar ke yaduwa ba, mutum daya yakan kamu da wasu biyu zuwa uku. Cutar na iya rayuwa tsawon awanni zuwa kwanaki a kan abubuwa.
Musamman, an gano cewa ana iya gano kwayar cutar har zuwa kwanaki uku akan filastik (polypropylene) da 304 bakin karfe, na kwana daya akan kwali, kuma har zuwa awanni hudu akan jan karfe.
Wannan, duk da haka, ya bambanta dangane da danshi da zafin jiki. Dabbobi da sauran dabbobi sun gwada tabbatacce ga COVID-19.
Babu wata shaida da ta nuna cewa dabbobi za su iya daukar kwayar cutar ga mutane, duk da cewa hukumomin Birtaniya sun ba da shawarar wanke hannayen mutum bayan ya taba dabbobi, kamar bayan ya taba wasu abubuwa da mutanen da suka kamu da cutar suka taba.
Cutar cututtukan cututtukan numfashi na coronavirus 2 (SARS-CoV-2) sabon kwayar cuta ce, wanda aka fara warewa daga mutane uku da ke fama da ciwon huhu da ke da alaƙa da tarin cututtukan cututtukan numfashi a Wuhan.
Dukkanin siffofin sabon kwayar cutar SARS-CoV-2 suna faruwa ne a cikin coronaviruses masu alaƙa a cikin yanayi. A waje da jikin mutum, ana kashe kwayar ta sabulu na gida, wanda ke narkar da amsar kariya.SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Ana tunanin cewa yana da asalin zoonotic.
Binciken kwayoyin halitta ya nuna cewa kwayar cutar ta kwayar halitta ta haɗu tare da Betacoronavirus, a cikin subgenus Sarbecovirus (sunan B) tare da nau'ikan bat-da aka samo.
Ya yi daidai da kashi 96 cikin dari a matakin dukkan kwayoyin halittar wasu samfuran kwayar cutar bat (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambancin amino acid guda daya a wasu sassan tsarin kwayoyin halittar tsakanin ƙwayoyin cuta daga pangolins da na mutane.
Da aka kwatanta kwayar halittar ta gaba daya zuwa yau an sami mafi yawan kashi 92% na kayan halittar da aka raba tsakanin pangolin coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da pangolin ya zama mai tsaka-tsaki ba.
Ana iya gano cutar ta hanyar kwayar cutar a kan alamun bayyanar cututtuka, kodayake tabbaci a ƙarshe ta hanyar hanyar juyawa na polymerase (rRT-PCR) na ɓarkewar ɓoye ko CT.
Wani bincike da aka yi na kwatanta PCR da CT a Wuhan ya nuna cewa CT ya fi PCR hankali sosai, ko da yake ba shi da ƙayyadaddun ƙayyadaddun bayanai, tare da yawancin fasalin hotunansa da ke haɗuwa da sauran cututtukan huhu da kuma hanyoyin cutar.
" A watan Maris na 2020, Kwalejin Ilimin Radiology ta Amurka ta ba da shawarar cewa "" Kada a yi amfani da CT don bincika ko a matsayin gwajin farko don tantance COVID-19"". "
WHO ta wallafa wasu hanyoyin gwajin RNA don SARS-CoV-2, tare da na farko da aka bayar a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin da aka juya jujjuyawar jujjuyawar polymerase (rRT-PCR).
Ana iya yin gwajin a kan samfurin numfashi ko jini.
Sakamakon yawanci ana samun sa a cikin 'yan sa'o'i zuwa kwanaki.
Gabaɗaya ana yin wannan gwajin ne a kan nasopharyngeal swab ko da yake ana iya amfani da swab na makogwaro.Laboratories da kamfanoni da yawa suna haɓaka gwaje-gwajen serological, waɗanda ke gano ƙwayoyin cuta.
A ranar 6 ga Afrilu 2020, babu ɗayan waɗannan da aka tabbatar da cewa ya isa daidai don a amince da amfani da shi sosai.
A Amurka an amince da gwajin kwayar cutar da Cellex ya samar don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu izini kawai.
Abubuwan halayen hoto a kan hotunan radiographs da tomography (CT) na mutanen da ke da alamomi sun haɗa da asymmetric peripheral ground glass opacities da babu pleural effusions.
Ƙungiyar Radiology ta Italiya tana tattara bayanan yanar gizo na duniya na binciken hoton don tabbatar da lamura.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, yin hoton ba tare da tabbatarwa ta hanyar PCR ba yana da ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun COVID-19.
Wani babban bincike a China ya kwatanta sakamakon CT na kirji da PCR kuma ya nuna cewa duk da cewa hoton yana da ƙarancin ƙwarewa ga kamuwa da cuta, yana da sauri kuma ya fi dacewa, yana ba da shawarar la'akari da shi azaman kayan aikin bincike a cikin yankunan annoba.
An kirkiro hanyoyin sadarwa na kwakwalwa na tushen hankali don gano siffofin hoton kwayar cutar tare da duka hotunan rediyo da CT.
Hanyoyi na hana yaduwar cutar sun hada da kiyaye tsaftar jiki, wanke hannu, gujewa taɓa idanu, hanci, ko baki da hannaye marasa wankewa, da yin tari ko yin fitsari a cikin wani takarda da kuma sanya takardar kai tsaye cikin kwandon shara.
An shawarci wadanda suka riga sun kamu da cutar da su sanya abin rufe fuska a bainar jama'a.
Ana kuma ba da shawarar matakan nesanta jiki don hana watsawa. Gwamnatoci da yawa sun takaita ko ba da shawara game da duk tafiye-tafiye marasa mahimmanci zuwa da daga ƙasashe da yankunan da cutar ta shafa.
Duk da haka, cutar ta kai matakin yaduwar al'umma a manyan sassan duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'umma, kuma wasu membobin al'umma ba su san inda ko yadda suka kamu da cutar ba. Ana ba da shawarar masu ba da lafiya da ke kula da wani wanda zai iya kamuwa da cutar su yi amfani da matakan kariya na yau da kullun, matakan kariya na tuntuɓar, da kuma kare ido. Binciken tuntuɓar hanya ce mai mahimmanci ga hukumomin kiwon lafiya don tantance tushen kamuwa da cuta da kuma hana ƙarin watsawa.
Amfani da bayanan wuri daga wayoyin hannu da gwamnatoci suka yi don wannan dalili ya haifar da damuwa game da sirri, tare da Amnesty International da fiye da sauran kungiyoyi 100 da suka ba da sanarwa suna kira ga iyakance wannan nau'in sa ido.
An aiwatar da aikace-aikacen wayar hannu daban-daban ko kuma an ba da shawarar don amfani da son rai, kuma tun daga Afrilu 7, 2020, sama da ƙungiyoyin ƙwararru goma sha biyu suna aiki kan hanyoyin da ke da alaƙa da sirri, kamar amfani da Bluetooth don yin rikodin kusanci na mai amfani da wasu wayoyin hannu.
Masu amfani suna karɓar saƙo idan sun kasance cikin kusanci da wani wanda ya gwada tabbatacce ga COVID-19. Rashin fahimta yana yawo game da yadda za a hana kamuwa da cuta; misali, wanke hanci da gargling da ruwan wanka ba su da tasiri.
Babu rigakafin COVID-19, kodayake ƙungiyoyi da yawa suna aiki don haɓaka ɗaya.
Ana bada shawarar wanke hannu don hana yaduwar cutar.
CDC ta ba da shawarar mutane su wanke hannayensu sau da yawa da sabulu da ruwa aƙalla na daƙiƙa ashirin, musamman bayan sun yi amfani da banɗaki ko kuma idan hannaye sun yi datti; kafin cin abinci; da kuma bayan an hura hanci, tari, ko atishawa.
Wannan saboda a waje da jikin mutum, ana kashe kwayar cutar ta sabulu na gida, wanda ya fashe kumfa mai karewa.
CDC ta kuma ba da shawarar yin amfani da maganin tsabtace hannu na barasa tare da aƙalla kashi 60% na barasa ta girma lokacin da sabulu da ruwa ba su da sauƙi.
WHO ta shawarci mutane su guji taɓa idanu, hanci, ko baki da hannayen da ba a wanke ba.
Za'a iya tsabtace saman da wasu magunguna (a cikin minti ɗaya na fuskantar maganin kashe kwayoyin cuta don saman bakin karfe), gami da 6271% ethanol, 50100% isopropanol, 0.1% sodium hypochlorite, 0.5% hydrogen peroxide, da 0.27.5% povidone-iodine.
Sauran mafita, kamar benzalkonium chloride da chrohexidine gluconate, ba su da tasiri sosai.
CDC ta bada shawarar cewa idan an sami ko an tabbatar da wani mutum da ke da cutar COVID a wani wuri kamar ofishi ko gidan kula da jarirai, ya kamata a tsabtace dukkan wuraren kamar ofisoshin, dakunan wanka, wuraren da ake amfani da kowa, kayan lantarki da ake amfani da su kamar kwamfutar hannu, allon taɓawa, allon maɓalli, na'urorin sarrafawa, da na'urorin ATM da masu cutar ke amfani da su.
Kungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hanci da gwiwar hannu ko kuma tawul lokacin yin tari ko yin hancin, kuma su zubar da duk wani tawul da aka samu nan da nan.
Ana ba da shawarar amfani da abin rufe fuska na tiyata ga waɗanda za su iya kamuwa da cutar, kamar yadda sanya abin rufe fuska na iya iyakance girma da nisan tafiyar saukad da ke yaduwa yayin magana, yin atishawa, da tari.
WHO ta bayar da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
" A cewar Stephen Griffin, masanin ilimin ƙwayoyin cuta a Jami'ar Leeds, "" Sanye da abin rufe fuska na iya rage saurin [mutane] su taɓa fuskokinsu, wanda shine babban tushen kamuwa da cuta ba tare da tsabtace hannu ba. "" An kuma ba da shawarar amfani da abin rufe fuska ga waɗanda ke kula da wani wanda zai iya samun cutar. "
WHO ta ba da shawarar sanya abin rufe fuska ga mutane masu lafiya kawai idan suna cikin haɗari, kamar waɗanda ke kula da mutumin da ke da COVID-19, kodayake sun kuma yarda cewa sanya abin rufe fuska na iya taimaka wa mutane su guji taɓa fuskarsu.
Kasashe da dama sun fara karfafa amfani da abin rufe fuska ga 'yan jama'a.
A Amurka, CDC ta ba da shawarar saka abin rufe fuska wanda ba na likita ba wanda aka yi da masana'anta. China ta ba da shawarar musamman amfani da abin rufe fuska na likita ta hanyar lafiyayyun membobin jama'a, musamman lokacin da suka kusanci (mita 1 ko ƙasa da) tare da wasu mutane.
Hong Kong ta ba da shawarar saka abin rufe fuska na tiyata lokacin da ake amfani da sufuri na jama'a ko zama a wuraren da ake cunkoson mutane.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su yi abin rufe fuska na yadin a gida kuma su wanke su kowace rana.
Jamhuriyar Czech da Slovakia sun haramta fita a cikin jama'a ba tare da sanya abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta nemi kowa ya sanya abin rufe fuska lokacin da yake zuwa wuraren jama'a don kare kansu da sauran mutane.
Gwamnatin Austriya ta ba da umarnin cewa duk wanda ya shiga shagon kayan masarufi dole ne ya sanya abin rufe fuska.
Isra'ila ta nemi dukkan mazauna su sanya abin rufe fuska a bainar jama'a.
Taiwan, wacce ke samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar Maris, ta bukaci fasinjojin jiragen kasa da na bas na cikin gari su sanya abin rufe fuska a ranar 1 ga Afrilu.
Panama ta sanya shi wajibi ne a sanya abin rufe fuska a duk lokacin da ya fita waje, yayin da kuma ya ba da shawarar kera abin rufe fuska na gida ga wadanda ba za su iya siyan abin rufe fuska ba.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Nisawar zamantakewa (wanda kuma aka sani da nisantar jiki) ya haɗa da ayyukan sarrafa kamuwa da cuta da nufin rage yaduwar cutar ta hanyar rage kusanci tsakanin mutane.
Hanyoyin sun haɗa da keɓewa; ƙuntatawa na tafiya; da rufe makarantu, wuraren aiki, filayen wasa, gidajen kallo, ko cibiyoyin cin kasuwa.
Mutane na iya amfani da hanyoyin nisantar da jama'a ta hanyar zama a gida, iyakance tafiye-tafiye, guje wa wuraren da ke cike da jama'a, amfani da gaisuwa mara lamba, da nisantar da kansu daga wasu.
Gwamnatoci da yawa yanzu suna ba da umarnin ko ba da shawarar nisantar da jama'a a yankuna da cutar ta shafa.
An rage girman taron da hukumomin gwamnatin Amurka da kungiyoyin lafiya suka ba da shawarar daga mutane 250 (idan ba a san COVID-19 ya yadu a wani yanki ba) zuwa mutane 50, kuma daga baya zuwa mutane 10.
" A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane fiye da biyu. Tsofaffi da kuma waɗanda ke da cututtukan likita kamar su ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, da kuma tsarin rigakafin da ke fama da haɗarin kamuwa da cututtuka da rikitarwa kuma CDC ta ba su shawara su zauna a gida kamar yadda ya yiwu a yankunan da cutar ta bazu. A ƙarshen Maris 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar "" nisantar zamantakewa "" tare da "" nisantar jiki ", don bayyana cewa manufar ita ce rage hulda ta jiki yayin kiyaye alaƙar zamantakewa, a zahiri ko a nesa. "
" Amfani da kalmar "" nisantar zamantakewa "" ya haifar da ma'ana cewa ya kamata mutane su shiga cikin keɓewar zamantakewar jama'a gaba ɗaya, maimakon ƙarfafa su su ci gaba da hulɗa da wasu ta hanyar wasu hanyoyin.Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i don amfani da su yayin annobar. "
Wadannan sun hada da shawarwari don yin jima'i kawai tare da wanda kuke zaune tare, wanda ba shi da kwayar cutar ko alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda aka gano da COVID-19 da waɗanda suke zargin cewa sun kamu.
Hukumomin kiwon lafiya sun ba da cikakkun umarni don keɓe kai daidai. Gwamnatoci da yawa sun ba da umarni ko kuma sun ba da shawarar keɓe kai ga duka jama'ar da ke zaune a yankunan da abin ya shafa.
An bayar da umarnin killace kai mafi karfi ga wadanda ke cikin kungiyoyin hadari.
An shawarci waɗanda wataƙila sun kamu da wani da ke da COVID-19 da waɗanda kwanan nan suka yi tafiya zuwa ƙasa ko yankin da ke da yaduwar watsawa da su keɓe kansu na kwanaki 14 daga lokacin da aka kamu da cutar.
Dabaru a cikin sarrafa fashewar cuta sune ƙuntatawa ko dakilewa, da kuma ragewa.
Ana gudanar da tsarewa a farkon matakan barkewar cutar kuma ana nufin ganowa da ware wadanda suka kamu da cutar tare da gabatar da wasu matakan kula da kamuwa da cutar da allurar rigakafi don dakatar da yaduwar cutar zuwa sauran jama'a.
Lokacin da ba zai yiwu a hana yaduwar cutar ba, sai a koma matakin ragewa: ana daukar matakai don rage saurin yaduwa da rage tasirinsa ga tsarin kiwon lafiya da al'umma.
Za'a iya aiwatar da hadewar matakan dakilewa da kuma ragewa a lokaci guda.
Rashin matsin lamba yana buƙatar ƙarin matakan matsananci don sauya cutar ta hanyar rage adadin haifuwa na asali zuwa ƙasa da 1. Wani ɓangare na sarrafa barkewar cutar mai saurin kamuwa da cuta shine ƙoƙarin rage ƙwanƙwasa annoba, wanda aka sani da daidaita yanayin annoba.
Wannan yana rage haɗarin ayyukan kiwon lafiya da aka mamaye kuma yana ba da ƙarin lokaci don samar da alluran rigakafi da magani.
Hanyoyin da ba na magunguna ba da za su iya magance barkewar cutar sun hada da matakan kariya na mutum, kamar tsabtace hannu, sanya abin rufe fuska, da killace kai; matakan al'umma da ke nufin nisantar da jiki kamar rufe makarantu da soke taron taro; sadaukar da al'umma don karfafa yarda da shiga cikin irin wannan aikin; da kuma matakan muhalli kamar tsabtace farfaji. An dauki ƙarin matakan da aka yi niyyar dakile barkewar cutar a China da zarar tsananin barkewar ya zama bayyananne, kamar keɓewar dukkanin biranen da kuma sanya takunkumi mai tsauri.
Sauran ƙasashe ma sun ɗauki matakai daban-daban da nufin rage yaduwar cutar.
Koriya ta Kudu ta gabatar da yawan bincike da keɓewa na gida, kuma ta ba da faɗakarwa game da motsi na mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda ke da cutar waɗanda suka keɓe kansu kuma suka ɗora manyan tarar ga waɗanda suka kasa yin hakan.
Taiwan ta kara samar da abin rufe fuska da kuma hukunta tara kayan kiwon lafiya.Kasuwancin kwaikwayo na Burtaniya da Amurka sun nuna cewa ragewa (a hankali amma ba a dakatar da yaduwar annoba) da kuma dakile (dawo da ci gaban annoba) suna da manyan ƙalubale.
Ingantattun manufofin ragewa na iya rage yawan bukatar kiwon lafiya da kashi biyu da rabi da kuma mutuwa da rabi, amma har yanzu yana haifar da dubban dubban mutuwar da kuma tsarin kiwon lafiya da ake mamayewa.
Za a iya fifita dakile amma ana buƙatar kiyaye shi har tsawon lokacin da kwayar cutar ke yawo a cikin yawan mutane (ko har sai an sami rigakafi, idan hakan ya fara), kamar yadda watsawa da sauri ya sake dawowa lokacin da aka sassauta matakan.
Tsoma baki na dogon lokaci don dakile annobar yana haifar da tsadar zamantakewa da tattalin arziki.
Babu takamaiman magungunan antiviral da aka amince da su don COVID-19, amma ana ci gaba da ƙoƙarin ci gaba, gami da gwajin magungunan da ake da su.
Shan magungunan sanyi, shan ruwa, da kuma hutawa zai iya taimakawa wajen sauƙaƙa alamun.
Dangane da tsananin, ana iya buƙatar maganin oxygen, ruwan jini, da taimakon numfashi.
Amfani da steroids na iya yin illa ga sakamakon.
Ana binciken wasu magungunan da aka amince da su a baya don maganin wasu cututtukan ƙwayoyin cuta don amfani da su wajen magance COVID-19.
" WHO ta kuma bayyana cewa wasu "" magungunan gargajiya da na gida "" na iya samar da sauƙi daga alamun da SARS-CoV-19 ke haifarwa. "
WHO ta bayyana haɓaka iyawa da daidaita kiwon lafiya don bukatun marasa lafiyar COVID-19 a matsayin matakan amsawa na asali.
ECDC da ofishin yanki na Turai na WHO sun ba da jagorori ga asibitoci da sabis na kiwon lafiya na farko don sauya albarkatu a matakai da yawa, gami da mai da hankali kan ayyukan dakin gwaje-gwaje zuwa gwajin COVID-19, soke ayyukan zaɓin duk lokacin da ya yiwu, raba da ware marasa lafiya masu cutar COVID-19, da haɓaka ƙarfin kulawa ta hanyar horar da ma'aikata da haɓaka adadin masu saurin numfashi da gadaje.
Akwai ra'ayoyi daban-daban game da inda yanayin farko (wanda ake kira mai haƙuri sifili) na iya samo asali.
Sanannen farko na sabon coronavirus na iya komawa zuwa 1 ga Disamba 2019 a Wuhan, Hubei, China.
A cikin wata guda, adadin masu cutar coronavirus a Hubei ya karu a hankali.
Waɗannan galibi suna da alaƙa da Kasuwar Kasuwancin Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan Kayan K
"A ranar 30 ga Disamba, wani rukuni na likitoci a asibitin Wuhan Central Hospital sun gargadi abokan aikinsu game da ""SARS-kamar coronavirus"". "
Takwas daga cikin wadannan likitocin, ciki har da Li Wenliang, 'yan sanda sun yi musu gargadi saboda yada jita-jita na karya, kuma wani, Ai Fen, ya yi wa manyan mata tsawata saboda tayar da ƙararrawa.
Hukumar Kula da Lafiya ta Wuhan daga baya ta fitar da sanarwa ga jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
An bayar da rahoton isassun masu cutar nimoniya da ba a san ko su waye ba ga hukumomin kiwon lafiya a Wuhan don fara bincike a farkon watan Janairu. A farkon barkewar cutar, yawan masu cutar ya ninka kusan sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairu 2020, cutar ta bazu zuwa wasu lardunan China, wanda ya taimaka ta hanyar ƙaura na Sabuwar Shekarar China da Wuhan kasancewar cibiyar sufuri da kuma babbar hanyar jirgin ƙasa.
A ranar 20 ga Janairu, China ta ba da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da ɗaya a Shenzhen.
Bayanai na baya-bayan nan sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar a ranar 20 ga Janairu 2020.A ranar 26 ga Maris, Amurka ta wuce China da Italiya tare da mafi yawan adadin wadanda aka tabbatar da cutar a duniya.A ranar 9 ga Afrilu 2020, an ba da rahoton sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu kuma sama da 364,000 sun warke.
Kusan kasashe da yankuna 200 sun sami akalla mutum guda da ya kamu da cutar.
Saboda annobar cutar a Turai, ƙasashe da yawa a Yankin Schengen sun takaita yunkuri na kyauta kuma sun kafa ikon kan iyaka.
Amsoshin ƙasa sun haɗa da matakan ƙuntatawa kamar su keɓewa (wanda aka sani da umarnin zama a gida, umarnin mafaka a wurin, ko kullewa) da kuma dokar hana fita. Kamar yadda aka yi a ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan jama'a, suna ƙarƙashin wasu nau'ikan kullewa a Amurka, fiye da mutane miliyan 50 suna cikin kullewa a Philippines, kusan mutane miliyan 59 suna cikin kullewa a Afirka ta Kudu, kuma mutane biliyan 1.3 suna cikin kullewa a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani nau'in kulle-kulle, wanda ya karu zuwa mutane biliyan 2.6 kwana biyu bayan haka - kusan kashi uku na yawan mutanen duniya.
An tabbatar da farkon cutar COVID-19 a ranar 1 ga Disamba 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya kasance a ranar 17 ga Nuwamba.
Likita Zhang Jixian ta lura da tarin cututtukan huhu na sanadin da ba a sani ba a ranar 26 ga Disamba, wanda asibitin nata ya sanar da Wuhan Jianghan CDC a ranar 27 ga Disamba.
Gwajin kwayar halitta na farko na samfuran marasa lafiya a ranar 27 ga Disamba 2019 ya nuna kasancewar kwayar cutar corona ta SARS.
Kwamitin Lafiya na Wuhan ya ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a wannan rana.
" Yayin da wadannan sanarwar ta faru, 'yan sanda sun gargadi likitoci a Wuhan saboda " yada jita-jita " game da barkewar cutar. "
" Hukumar Lafiya ta Kasa ta kasar Sin da farko ta yi ikirarin cewa babu wata "'hujja bayyananniya' ta yaduwar cutar daga mutum zuwa mutum".
" A ƙarshen Janairu, gwamnatin China ta ƙaddamar da kamfen mai zurfi wanda Sakatare Janar na Jam'iyyar Kwaminisanci na kasar Sin Xi Jinping ya bayyana a matsayin "" yaƙin mutane "" don hana yaduwar cutar. "
"A cikin abin da aka bayyana a matsayin "" mafi girma a keɓewa a tarihin ɗan adam"", an sanar da wani cordon sanitaire a ranar 23 ga Janairu don dakatar da tafiye-tafiye a ciki da wajen Wuhan, wanda aka faɗaɗa zuwa jimlar garuruwa 15 a Hubei, wanda ya shafi jimlar kusan mutane miliyan 57".
An haramta amfani da motocin masu zaman kansu a cikin birni.
An soke bikin Sabuwar Shekarar Sinanci (25 ga Janairu) a wurare da yawa.
Hukumomin sun kuma sanar da gina asibitin wucin gadi, Asibitin Huoshenshan, wanda aka kammala a cikin kwanaki 10.
An gina wani asibiti bayan haka, Asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sababbin asibitocin da aka gina, China ta kuma sauya wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa ƙarin matakan dakile barkewar COVID-19, gami da bayar da sanarwar kiwon lafiya ga matafiya da kuma tsawaita hutun Bikin bazara.
An kuma rufe jami'o'i da makarantu a duk fadin kasar.
Yankin Hong Kong da Macau sun kafa matakai da yawa, musamman game da makarantu da jami'o'i.
An kafa matakan aiki daga nesa a yankuna da dama na kasar Sin.
An sanya takunkumin tafiye-tafiye a ciki da wajen Hubei.
An sauya sufuri na jama'a, kuma gidajen tarihi a duk faɗin China an rufe su na ɗan lokaci.
" An yi amfani da sarrafa motsi na jama'a a birane da yawa, kuma an kiyasta cewa kimanin mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa na waje. Bayan barkewar cutar ta shiga matakin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana kwayar cutar daga "" shigowa "" daga wasu ƙasashe. "
Misali, Beijing ta sanya dokar killacewa ta kwanaki 14 ga duk matafiya na kasa da kasa da suka shiga birnin. A ranar 23 ga Maris, kasar Sin ta samu mutum daya ne kawai da cutar ta kama a cikin gida a cikin kwanaki biyar da suka gabata, a wannan yanayin ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya ba da rahoton cewa an toshe yaduwar masu kamuwa da cutar a cikin gida kuma an sarrafa barkewar cutar a China.
A wannan rana aka sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan da aka sanya dokar kulle-kulle. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris 2020 cewa za a dakatar da shigar masu izinin zama ko biza daga ranar 28 ga Maris zuwa gaba, ba tare da cikakken bayani kan lokacin da wannan manufar za ta ƙare ba.
Wadanda suke son shiga kasar Sin za su nemi takardar iznin shiga kasar Sin a ofisoshin jakadancin kasar Sin ko kuma ofisoshin jakadancin kasar.
Gwamnatin China ta karfafawa kamfanoni da masana'antu gwiwa don sake buɗewa a ranar 30 ga Maris, kuma ta ba da kayan tallafi na kuɗi ga kamfanoni. Majalisar Jiha ta ayyana ranar makoki don farawa tare da minti uku na nutsuwa na ƙasa a ranar 10:00 4 ga Afrilu, daidai da Bikin Qingming, kodayake gwamnatin tsakiya ta nemi iyalai su biya girmamawarsu ta kan layi cikin kiyaye nesa da jiki don kauce wa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya yadu zuwa Koriya ta Kudu a ranar 20 ga Janairu 2020 daga China.
Hukumar lafiya ta kasar ta bayar da rahoton karuwar yawan wadanda aka tabbatar da cutar a ranar 20 ga Fabrairu, wanda aka danganta shi da wani taro a Daegu na wani sabon tsarin addini da aka sani da Cocin Shincheonji na Yesu.
Shincheonji masu ibada da suka ziyarci Daegu daga Wuhan an yi zargin cewa sune asalin barkewar cutar.
A ranar 22 ga Fabrairu, daga cikin mabiya 9,336 na cocin, 1,261 ko kusan 13% sun ba da rahoton alamun. Koriya ta Kudu ta ayyana matakin tsaro mafi girma a ranar 23 ga Fabrairu 2020.
A ranar 28 ga Fabrairu, an ba da rahoton fiye da 2,000 da aka tabbatar da cutar a Koriya, wanda ya tashi zuwa 3,150 a ranar 29 ga Fabrairu.
An killace dukkan sansanonin sojin Koriya ta Kudu bayan gwajin da aka yi ya tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi jadawalin jirgin sama don haka aka canza su. Koriya ta Kudu ta gabatar da abin da aka ɗauka a matsayin mafi girma da mafi kyawun tsari a duniya don bincika yawan mutanen da ke fama da cutar, da keɓe duk wani mutum da ke fama da cutar da kuma ganowa da keɓe waɗanda suka tuntube su.
Hanyoyin bincike sun haɗa da tilasta kai rahoto game da alamun cututtuka ta hanyar sabbin masu zuwa na duniya ta hanyar aikace-aikacen wayar hannu, gwajin drive-thru don cutar tare da sakamakon da aka samu a rana mai zuwa, da kuma ƙara ƙarfin gwaji don ba da damar a gwada mutane 20,000 kowace rana.
Ana ganin shirin Koriya ta Kudu ya yi nasara wajen sarrafa barkewar cutar duk da cewa ba a kebe dukkanin biranen ba. Da farko al'ummar Koriya ta Kudu sun yi taho-mu-da-kawo kan yadda Shugaba Moon Jae-in ya mayar da martani ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman a tsige Moon kan abin da suka yi iƙirarin cewa rashin kulawar gwamnati game da barkewar cutar, ko kuma yabon amsar da ya bayar.
A ranar 23 ga Maris, an ba da rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin cutar a cikin mako huɗu.
A ranar 29 ga Maris an bayar da rahoton cewa daga ranar 1 ga Afrilu duk sabbin masu shigowa daga ƙasashen waje za a keɓe su na makonni biyu.
A cewar rahotannin kafofin watsa labarai a ranar 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatun taimako don gwajin kwayar cutar daga ƙasashe daban-daban 121.
Iran ta ba da rahoton farkon wadanda aka tabbatar da cutar ta SARS-CoV-2 a ranar 19 ga Fabrairu a Qom, inda, a cewar Ma'aikatar Kiwon Lafiya da Ilimin Likita, mutane biyu suka mutu daga baya a wannan ranar.
Matakan farko da gwamnati ta sanar sun hada da soke kide-kide da sauran al'amuran al'adu, wasannin motsa jiki, da sallar Juma'a, da rufe jami'o'i, manyan makarantun ilimi, da makarantu.
Iran ta ware riyal tiriliyan biyar don yakar cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu 2020 cewa babu wani shiri na keɓe wuraren da cutar ta shafa, kuma mutane ne kawai za a keɓe.
An sanar da tsare-tsaren rage zirga-zirga tsakanin biranen a watan Maris, kodayake zirga-zirgar ababen hawa tsakanin biranen kafin Sabuwar Shekarar Farisa Nowruz ta ci gaba.
Wuraren Shi'a a Qom sun kasance a buɗe ga mahajjata har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A cikin ikirarin rufewa game da girman cutar a Iran, sama da kasashe goma sun gano shari'unsu zuwa Iran har zuwa 28 ga Fabrairu, wanda ke nuna cewa yawan cutar na iya zama mafi tsanani fiye da shari'u 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, tare da 23 daga cikin mambobinta 290 da aka ba da rahoton sun gwada tabbatacce ga cutar a ranar 3 ga Maris.
A ranar 12 ga Maris, Human Rights Watch ta bukaci hukumomin kurkukun Iran da su saki masu kare hakkin bil'adama da aka tsare saboda rashin jituwa ta lumana, da kuma barin duk fursunonin da suka cancanta a wani lokaci.
Ya bayyana cewa akwai hadarin da ya fi girma na yaduwar kwayar cutar a cikin cibiyoyin rufe kamar cibiyoyin tsare, waɗanda kuma ba su da isasshen kulawar likita.
A ranar 15 ga Maris, gwamnatin Iran ta ba da rahoton mutuwar 100 a cikin rana guda, mafi yawan wadanda aka yi a kasar tun lokacin da cutar ta fara.
Akalla 'yan siyasa 12 da ke aiki ko tsoffin' yan siyasa na Iran da jami'an gwamnati sun mutu daga cutar zuwa 17 ga Maris.
Ya zuwa ranar 23 ga Maris, Iran na samun sabbin mutane 50 a kowace awa da kuma sabon mutuwar mutum daya a kowane minti goma saboda coronavirus.
A cewar wani jami'in WHO, akwai yiwuwar kamuwa da cutar sau biyar a Iran fiye da yadda aka bayar da rahoton.
An kuma ba da shawarar cewa takunkumin Amurka a kan Iran na iya shafar damar da kasar ke da shi na bayar da martani ga barkewar cutar.
Babban Kwamishinan Majalisar Dinkin Duniya na kare hakkin dan adam ya bukaci a sassauta takunkumin tattalin arziki ga kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da cewa cutar ta yadu zuwa Italiya a ranar 31 ga watan Janairu, lokacin da wasu 'yan yawon bude ido biyu na kasar Sin suka kamu da cutar SARS-CoV-2 a Roma.
Lamarin ya fara tashi sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da dawowa daga China da kuma ayyana dokar ta baci.
Daga baya an gano tarin mutanen da ba su da alaka da COVID-19 ba, wanda ya fara da mutane 16 da aka tabbatar da su a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da sabon doka-doka don dakile barkewar cutar, gami da keɓewa fiye da mutane 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
"Firai Minista Giuseppe Conte ya ce, "A yankunan da cutar ta bazu, ba za a samar da shiga da fita ba. "
" An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗancan yankuna. " "A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar yayin da Italiya ta kai 100 mutuwar. "
Duk manyan wasannin motsa jiki, gami da wasannin kwallon kafa na Serie A, za a gudanar da su a bayan kofofin da aka rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasanni gaba daya na aƙalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci ban da manyan kantunan sayar da kayayyaki da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiya ta Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI) ta wallafa shawarwarin halayyar likitanci game da ka'idojin da za a iya amfani da su.
A ranar 19 ga Maris, Italiya ta zarce China a matsayin ƙasar da ta fi yawan mutuwar da ke da alaƙa da coronavirus a duniya bayan ta ba da rahoton mutuwar 3,405 daga cutar.
A ranar 22 ga Maris, an ba da rahoton cewa Rasha ta aika da jiragen sama guda tara na soja tare da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, an tabbatar da mutum 128,948, mutum 15,887 suka mutu, kuma 21,815 sun warke a Italiya, tare da yawancin waɗannan lamuran da ke faruwa a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffi na Italiya da rashin iya gwada duk waɗanda ke da kwayar cutar har zuwa yau na iya ba da gudummawa ga yawan mutuwar.
Amsar da United Kingdom ta bayar ga cutar da farko ta fito a matsayin daya daga cikin mafi sassauci na ƙasashe da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane nau'i na nisantar da jama'a ko matakan keɓewa ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami suka saboda rashin saurin da take da shi da kuma tsananin da take yi a cikin mayar da martani ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya yi sanarwa yana mai ba da shawara game da duk tafiye-tafiye da ba su da mahimmanci da hulɗar zamantakewa, yana ba da shawarar mutane su yi aiki daga gida inda ya yiwu kuma su guji wuraren taro kamar mashaya, gidajen abinci, da gidajen kallo.
A ranar 20 ga Maris, gwamnati ta ba da sanarwar cewa duk wuraren nishaɗi kamar su mashaya da wuraren motsa jiki za su rufe da wuri-wuri, kuma ta yi alkawarin biyan kashi 80% na albashin ma'aikata zuwa iyakar £ 2,500 a wata don hana rashin aikin yi a cikin rikicin. A ranar 23 ga Maris, Firayim Ministan ya ba da sanarwar tsaurara matakan nesanta jama'a, haramta tarurrukan mutane fiye da biyu da kuma iyakance tafiye-tafiye da ayyukan waje zuwa abin da ake ganin ya zama dole.
Ba kamar matakan da suka gabata ba, 'yan sanda sun tilasta waɗannan ƙuntatawa ta hanyar ba da tarar kuɗi da kuma tarwatsa tarurruka.
" An umarci yawancin kasuwancin da su rufe, ban da kasuwancin da aka ɗauka "mai mahimmanci", gami da manyan kantunan sayar da kayayyaki, kantunan magani, bankuna, shagunan kayan masarufi, tashoshin mai, da kuma gareji. "
A ranar 20 ga Janairu, an tabbatar da farkon wanda aka sani da cutar COVID-19 a jihar Washington da ke Arewa maso Yammacin Pacific a cikin wani mutum wanda ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rukunin aiki na White House Coronavirus a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta ayyana gaggawar lafiyar jama'a, kuma ta sanya takunkumin shiga ga matafiya daga China.
A ranar 28 ga Janairun 2020, Cibiyar Kula da Cututtuka - babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka - ta ba da sanarwar cewa sun kirkiro kayan gwajin nasu.
Duk da yin hakan, Amurka ta fara a hankali a cikin gwaji, wanda ya ɓoye ainihin yanayin barkewar cutar a lokacin.
Gwajin ya kasance ne ta hanyar kayan gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwajin da ba na gwamnati ba (ta fannin ilimi, kamfanoni da asibitoci) har zuwa karshen Fabrairu, da kuma ƙuntataccen ƙa'idoji don mutane su cancanci yin gwaji har zuwa farkon Maris (an buƙaci umarnin likita daga baya).
Ya zuwa ranar 27 ga Fabrairu, The Washington Post ta ba da rahoton cewa an yi gwajin kasa da 4,000 a Amurka.
A ranar 13 ga Maris, The Atlantic ta ba da rahoton cewa an gudanar da gwaje-gwaje kasa da 14,000.
"A ranar 22 ga Maris, Kamfanin dillancin labarai na Associated Press ya ba da rahoto: ""Mutane da yawa waɗanda ke da alamun cutar da kuma umarnin likita sun jira na sa'o'i ko kwanaki don gwaji.""Bayan da aka ba da rahoton mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta-baci, matakin da wasu jihohi ba da daɗewa ba suka bi. "
Makarantu a yankin Seattle sun soke azuzuwan a ranar 3 ga Maris, kuma a tsakiyar watan Maris, makarantu a duk faɗin ƙasar suna rufewa. A ranar 6 ga Maris, 2020, an ba da shawara ga Amurka game da hasashen tasirin sabon coronavirus a kan ƙasar ta hanyar ƙungiyar masana ilimin cututtuka a Kwalejin Imperial na London.
A wannan rana Shugaba Trump ya rattaba hannu a kan Dokar Shirye-shiryen Coronavirus da Dokar Karin Karin Karin Kudade, wanda ya ba da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don amsa barkewar cutar.
Kamfanoni sun sanya takunkumi kan tafiye-tafiyen ma'aikata, sun soke taro, kuma sun karfafa ma'aikata su yi aiki daga gida.
An soke abubuwan wasanni da yanayi.A ranar 11 ga Maris, Trump ya ba da sanarwar takunkumin tafiye-tafiye ga yawancin Turai, ban da United Kingdom, na kwanaki 30, wanda ya fara aiki a ranar 13 ga Maris.
Kashegari, ya fadada ƙuntatawa don haɗa da United Kingdom da Ireland.
A ranar 13 ga Maris, ya ayyana gaggawa na kasa, wanda ya samar da kudaden tarayya don amsa rikicin.
Farawa a ranar 15 ga Maris, yawancin kasuwancin sun rufe ko rage sa'o'i a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da annobar a jihohi 50 da kuma Gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa New York City na da mutane 10,700 da suka kamu da cutar korona, wanda ya fi adadin wadanda suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nisantar zamantakewar da alama yana aiki, yayin da kimantawa game da ninka lamura ya ragu daga kwanaki 2.0 zuwa kwanaki 4.7.
Ya zuwa 28 ga watan Maris, akwai mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu daga cutar. A ranar 26 ga Maris, an ba da rahoton cewa Amurka tana da karin mutanen da suka kamu da cutar coronavirus fiye da kowace kasa a duniya, ciki har da China da Italiya. Ya zuwa 8 ga Afrilu, an tabbatar da mutane 400,335 da suka kamu da cutar a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotannin kafofin watsa labarai a ranar 30 ga Maris, Shugaban Amurka Trump ya yanke shawarar tsawaita ka'idojin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan rana, USNS Comfort, wani asibiti mai asibiti tare da gadaje 1000, ya yi anga a New York.
A ranar 3 ga Afrilu, Amurka ta yi rikodin mutuwar 884 sakamakon cutar coronavirus a cikin sa'o'i 24.
A jihar New York, adadin mutanen da suka kamu da cutar ya zarce mutane 100,000 a ranar 3 ga Afrilu. An soki Fadar White House da yin watsi da barazanar da kuma sarrafa saƙonnin ta hanyar umurtar jami'an kiwon lafiya da masana kimiyya don daidaita bayanan jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin Mataimakin Shugaban Mike Pence.
Gabaɗaya amincewa da gudanar da rikicin Trump ya kasance yana rarrabuwar kawuna tare da layin bangare.
Wasu jami'an Amurka da masu sharhi sun soki Amurka da dogara ga shigo da kayan aiki masu mahimmanci, gami da kayan aikin likita masu mahimmanci, daga China.
An yi amfani da nazarin tsarin tafiye-tafiye na iska don tsarawa da kuma hango fashewar yaduwar kuma an buga shi a cikin Jaridar Magungunan Tafiya a tsakiyar Janairu 2020.
Dangane da bayanan 2018 daga Ƙungiyar Jirgin Sama ta Duniya, Bangkok, Hong Kong, Tokyo, da Taipei suna da mafi yawan matafiya daga Wuhan.
Dubai, Sydney, da Melbourne suma an ba da rahoton a matsayin wuraren da aka fi so ga mutanen da ke tafiya daga Wuhan.
Bali an ba da rahoton cewa ba shi da ƙarancin ƙarfi a cikin biranen da aka fi sani da 20 a cikin yanayin shiri, yayin da biranen Ostiraliya aka ɗauka mafi ƙarancin ƙarfi. Ostiraliya ta fitar da Tsarin Amsar Gaggawa don Sabon Coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya bayyana cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19, kuma Ostiraliya za ta jaddada kula da kan iyaka da sadarwa a cikin martani ga cutar.
A ranar 21 ga Maris, an ayyana gaggawa na kare lafiyar mutum a Australia.
Saboda ingantaccen keɓewar jigilar jama'a a Wuhan da Hubei, ƙasashe da yawa sun shirya kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen da aka yi hayar ƙasar, tare da hukumomin China suna ba da izini.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand suna cikin na farko da suka shirya fitar da 'yan kasashensu.
Pakistan ta ce ba za ta kwashe wani dan kasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu ban da' yan Poland hudu, da dan China, da dan Indiya.
'Yan ƙasar Poland, China, da Indiya sun sauka a Poland, inda jirgin Brazil ya yi tsayawa kafin ya bi hanyarsa zuwa Brazil.
'Yan kasar Brazil da suka je Wuhan an killace su a sansanin soji kusa da Brasília.
A wannan rana, an kwashe 'yan Kanada 215 (176 daga jirgin farko, da 39 daga jirgin na biyu da gwamnatin Amurka ta yi) daga Wuhan zuwa CFB Trenton don a keɓe su na tsawon makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama na 'yan Kanada 185 daga Wuhan ya sauka a CFB Trenton.
Hukumomin Ostiraliya sun kwashe 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake amfani da shi azaman cibiyar keɓewa, inda suka kasance na tsawon kwanaki 14.
Jirgin kwashe New Zealand ya isa Auckland a ranar 5 ga Fabrairu; an kebe fasinjojinsa (ciki har da wasu daga Ostiraliya da Pacific) a sansanin sojin ruwa a Whangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta ba da sanarwar cewa za ta kwashe Amurkawa a cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, wani jirgin sama dauke da fasinjoji 'yan Kanada 129 wadanda aka kwashe daga Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran. A ranar 14 ga Maris wani jirgin saman Afirka ta Kudu wanda gwamnatin Afirka ta Kudu ta yi hayar ya dawo da 'yan Afirka ta Kudu 112.
An gudanar da binciken likita kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu waɗanda ke nuna alamun cutar coronavirus don rage haɗari.
'Yan Afirka ta Kudu ne kawai aka dawo da su da ba su da cutar.
Sakamakon gwajin ya tabbatar da duk 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji wanda, a matsayin matakan kariya, duk sun kasance a karkashin kallo da keɓewa na tsawon kwanaki 14 a The Ranch Resort.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga Fabrairu, ma'aikatar harkokin wajen kasar Sin ta bayyana cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar, da Iran) sun aika da taimako zuwa kasar Sin.
Wasu ɗaliban China a jami'o'in Amurka sun haɗu don taimakawa wajen aika taimako zuwa ɓangarorin da cutar ta shafa a China, tare da ƙungiyar haɗin gwiwa a cikin babban yankin Chicago da aka ruwaito sun sami damar aikawa da masks N95 50,000 zuwa asibitoci a lardin Hubei a ranar 30 ga Janairu. Kungiyar agaji ta Direct Relief, tare da haɗin gwiwa tare da FedEx, ta aika da abin rufe fuska 200,000 tare da sauran kayan kariya na sirri, gami da safofin hannu da riguna, ta hanyar jigilar gaggawa zuwa Asibitin Wuhan Union zuwa ranar 30 ga Janairu.
"A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken rigakafi da kokarin magani tare da kare "" mutanen da ke cikin haɗari a Afirka da Kudancin Asiya. " "
Interaksyon ta ba da rahoton cewa gwamnatin kasar Sin ta ba da kyautar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan Sanata Richard Gordon ya tura abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga Fabrairu, kungiyar Red Cross ta Singapore ta sanar da cewa za ta aika da tallafin dala miliyan 2.26 zuwa China.
Japan ta ba da kyautar abin rufe fuska miliyan daya zuwa Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta ba da sanarwar bayar da gudummawar safofin hannu na likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban-daban ciki har da sutturar Hazmat 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 a cikin tallafin kuɗi ga ƙasashe da abin ya shafa.Bayan da lamura a China suka yi kamar sun daidaita, kasar ta aika da taimako ga ƙasashe daban-daban da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan kiwon lafiya da kwararru don taimakawa Italiya wajen magance annobar cutar coronavirus.
Dan kasuwa Jack Ma ya aika kayan gwaji miliyan 1.1, masks na fuska miliyan 6, da kuma suturar kariya 60,000 zuwa Addis Ababa, Habasha don rarraba ta kungiyar Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, 100,000 masks na fuska da masu aikin numfashi 5 zuwa Panama.
Ma ya kuma ba da gudummawar kayan aikin likita ga Kanada. Netherlands, Spain, Turkey, Georgia, da Czech Republic sun nuna damuwarsu game da abin rufe fuska da kayan gwaji da aka yi a China.
Misali, Spain ta janye kayan gwajin coronavirus 58,000 da aka yi a China tare da daidaito na kashi 30%, a halin yanzu, Netherlands ta sake dawo da abin rufe fuska na Sin 600,000 wanda ke da lahani.
Belgium ta sake dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda ake tunanin daga China ne, amma a zahiri daga Kolumbia ne.
A bangaren, an samu karbuwa sosai ga taimakon da kasar Sin ta bayar a wasu sassan Latin Amurka da Afirka. A ranar 2 ga watan Afrilu, Bankin Duniya ya kaddamar da ayyukan bada agajin gaggawa ga kasashen da ke tasowa.
WHO ta yaba da kokarin da hukumomin kasar Sin suka yi wajen sarrafa da dakile annobar.
" WHO ta lura da bambanci tsakanin barkewar SARS a 20022004, inda aka zargi hukumomin China da yin asiri wanda ya hana rigakafi da kokarin dakilewa, da kuma rikicin na yanzu inda gwamnatin tsakiya ta ""ta samar da sabuntawa na yau da kullun don kauce wa firgici kafin hutun Sabuwar Shekara ta Lunar"". "
" A ranar 23 ga Janairu, a matsayin martani ga shawarar hukumomin tsakiya na aiwatar da haramcin jigilar kayayyaki a Wuhan, wakilin WHO Gauden Galea ya yi tsokaci cewa yayin da yake "" tabbas ba shawarar da WHO ta yi ba ce"", shi ma "" muhimmin alama ne na sadaukar da kai don dakile annobar a wurin da ta fi karfafawa"" kuma ya kira shi "" wanda ba a taɓa gani ba a tarihin lafiyar jama'a"".A ranar 30 ga Janairu, bayan tabbatar da watsawar mutum-da-mutum a wajen China da kuma ƙaruwar adadin masu cutar a wasu ƙasashe, WHO ta ayyana barkewar cutar a matsayin Gaggawa na Kiwon Lafiyar Jama'a na Duniya (PHEIC), PHEIC na shida tun lokacin da aka fara amfani da matakin a lokacin annobar cutar alade ta 2009".
" Babban Daraktan WHO Tedros Adhanom ya ce PHEIC ya kasance ne saboda "" haɗarin yaduwar duniya, musamman ga ƙasashe masu ƙarancin kuɗi da matsakaita ba tare da ingantattun tsarin kiwon lafiya ba. "
Da yake mayar da martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya bayyana cewa "babu wani dalili da zai sa a dauki matakan da za su hana tafiye-tafiye da cinikayya a tsakanin kasa da kasa ba tare da wata bukata ba" kuma "WHO ba ta bayar da shawarar takaita kasuwanci da motsi ba".
" A ranar 5 ga Fabrairu, WHO ta yi kira ga al'ummar duniya don bayar da gudummawar dala miliyan 675 don tallafawa shirye-shiryen dabaru a ƙasashe masu ƙarancin kuɗi, inda ta yi kira da gaggawar tallafawa waɗannan ƙasashe waɗanda "" ba su da tsarin da za su iya gano mutanen da suka kamu da cutar, ko da kuwa ya fito. " "
Tedros ya kuma yi karin bayani inda ya bayyana cewa "mu masu karfi ne idan mun kasance mafi rauni" kuma ya bukaci al'ummar duniya su " zuba jari a yau ko su biya karin kudi daga baya". A ranar 11 ga Fabrairu, WHO a wani taron manema labarai ta bayyana COVID-19 a matsayin sunan cutar.
" A wannan rana, Tedros ya bayyana cewa Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince ya samar da" "ikon dukkanin tsarin Majalisar Dinkin Duniya a cikin martani". "
" An kunna Kungiyar Kula da Rikicin Majalisar Dinkin Duniya a sakamakon haka, wanda ya ba da damar daidaita dukkan matakan mayar da martani na Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar " "mai da hankali kan ba da amsa kan kiwon lafiya yayin da sauran hukumomin za su iya kawo ƙwarewarsu don yin tasiri kan tasirin zamantakewa, tattalin arziki da ci gaban ɓarkewar cutar". "
" A ranar 14 ga Fabrairu, an kunna Kungiyar Hadin Gwiwa ta WHO tare da China don samar da masana na duniya da WHO a kasar Sin don taimakawa wajen gudanar da aikin gida da kimantawa "" tsananin da kuma yaduwar cutar "" ta hanyar karbar bita da tarurruka tare da manyan cibiyoyin matakin kasa da gudanar da ziyarar filin don tantancewa "" tasirin ayyukan amsawa a matakan lardi da na gunduma, gami da birane da yankunan karkara. " "A ranar 25 ga Fabrairu, WHO ta ba da sanarwar cewa "" ya kamata duniya ta yi ƙarin don shirya don yiwuwar annobar coronavirus, "" tana mai cewa yayin da har yanzu da wuri ne a kira shi annobar, ya kamata ƙasashe su kasance "" a cikin matakin shiri. " "
" A sakamakon barkewar cutar a Iran, WHO ta tura tawagar hadin gwiwa zuwa can don tantance yanayin. A ranar 28 ga Fabrairu, jami'an WHO sun ce za a kara yawan barazanar cutar coronavirus a matakin duniya daga ""mai girma"" zuwa ""mai girma sosai"", matakinsa mafi girma na faɗakarwa da kuma kimanta haɗari. "
Mike Ryan, babban daraktan shirin gaggawa na WHO na kiwon lafiya, ya yi gargadin a cikin wata sanarwa cewa ""Wannan gwajin gaskiya ne ga kowace gwamnati a duniya: Tashi. "
" Wannan kwayar cutar na iya zuwa kuma kana bukatar ka kasance a shirye, " yana mai cewa matakan da suka dace na iya taimakawa duniya kauce wa" mafi munin shi. "
" Ryan ya kara bayyana cewa bayanan da ake da su yanzu ba su ba jami'an kiwon lafiyar jama'a damar ayyana annobar duniya ba, yana mai cewa irin wannan ayyanawar na nufin "" muna karbar cewa kowane mutum a duniya zai kamu da wannan kwayar cutar. " "
A ranar 11 ga Maris, WHO ta ayyana barkewar cutar coronavirus a matsayin annoba.
Babban Daraktan ya ce WHO na da " damuwa sosai game da yadda cutar ke yaduwa da kuma yadda take da tsanani, da kuma yadda ba a dauki mataki ba. " WHO ta fuskanci zargi mai yawa kan abin da ake ganin rashin iya magance cutar, ciki har da sanar da gaggawa ga lafiyar jama'a da kuma rarraba kwayar cutar a matsayin annoba. "
Sakamakon martani ya hada da takardar neman babban daraktan WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, dubun-dubatar ƙwararrun masanan haƙƙin ɗan adam na Majalisar Dinkin Duniya sun jaddada girmama haƙƙin kowane mutum yayin annobar COVID-19.
Kungiyar kwararru ta bayyana cewa kowa na da hakkin yin aikin ceto rai kuma gwamnati tana da wannan alhakin.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba zai taba zama dalilin nuna bambanci ga wani rukuni na musamman ba.
Masana sun jaddada cewa kowane mutum yana da 'yancin kiwon lafiya, gami da mutanen da ke da nakasa, wadanda ke cikin kungiyoyin marasa rinjaye, tsofaffi, mutanen da ke cikin gida, marasa gida, wadanda ke rayuwa cikin matsanancin talauci, mutanen da ke tsare, da' yan gudun hijira da sauran kungiyoyin da ba a tantance ba da ke bukatar tallafin gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Kungiyar Hadin Gwiwa da Ci Gaban Tattalin Arziki ta kaddamar da wani dandamali don samar da bayanai na kan lokaci da kuma cikakke kan matakan da ake dauka a kasashe a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don karfafa tsarin kiwon lafiya da tattalin arzikin duniya zuwa magance tasirin kullewa da takunkumin tafiye-tafiye, cibiyar dijital ta haɗa da Mai Kula da Manufofin Kasashe, kuma yana da nufin taimakawa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta sha suka daga Amurka, Ministan Ministan Ministan Birtaniya Michael Gove, da kuma dan shugaban kasar Brazil Jair Bolsonaro Eduardo Bolsonaro don yadda ake kula da cutar, wadda ta fara a lardin Hubei na China.
An kori wasu masu gudanarwa na lardi na Jam'iyyar Kwaminis ta Sin (CPC) saboda yadda suka gudanar da kokarin killacewa a Tsakiyar China, alamar rashin gamsuwa da yadda tsarin siyasa ya mayar da martani ga barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin na da nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a kan barkewar cutar coronavirus.
Wasu jami'an kasar Sin, misali Zhao Lijian sun yi watsi da amincewa da cutar ta coronavirus da ta fara a Wuhan, suna goyon bayan ka'idojin makirci game da COVID-19 da ya samo asali daga Amurka ko Italiya.
" Gwamnatin Amurka ta Donald Trump ta ambaci cutar coronavirus a matsayin ""kwayar cutar China"" ko ""Wuhan virus"" tana cewa "tsinkayar China ta kara yawan kwayar cutar da yanzu ta zama annoba ta duniya"", wanda hakan ya sa wasu masu suka suka suka suka suka zarge shi da wariyar launin fata da kuma ""kusawa da gazawar gwamnatinsa na shawo kan cutar"". "
"Kwalmar Daily Beast ta sami wata kafar gwamnatin Amurka da ke bayyana dabarun sadarwa da ke da asali a cikin Kwamitin Tsaron Kasa, tare da ambaton dabarar da aka ambata a matsayin" "Dukkanin ya shafi China. "
"An gaya mana mu yi kokarin fitar da wannan sakon ta kowace hanya mai yiwuwa, gami da taron manema labarai da kuma fitowar talabijin. ""Wasu kafofin kamar Politico, Foreign Policy, da Bloomberg sun yi ikirarin cewa kokarin China na aika da taimako ga kasashen da cutar ta shafa wani bangare ne na yunkurin farfaganda don tasirin duniya. "
" Babban jami'in kula da harkokin wajen EU Josep Borrell ya yi gargadin cewa akwai "wani bangare na siyasa wanda ya hada da gwagwarmayar samun tasiri ta hanyar yin amfani da 'yanci da kuma 'siyasa na karimci'"".
Borrell ya kuma ce, "Kasar Sin tana tura sakon cewa, ba kamar Amurka ba, tana da alhaki kuma amintacciyar abokiyar hulda ce".
China ta kuma yi kira ga Amurka da ta dage takunkuman da ta kakaba wa Syria, Venezuela da Iran, yayin da ake bayar da rahoton aikawa da taimako ga kasashe biyu na baya.
Kyautar Jack Ma na 100,000 masks zuwa Cuba an toshe shi ta hanyar takunkumin Amurka a ranar 3 ga Afrilu.
An kuma zargi hukumomi da karkatar da taimakon da aka yi nufin wasu ƙasashe na Amurka zuwa ƙasarsu.
Kuma an samu rahotannin rigima da suka shafi abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland; da Jamhuriyar Czech da Italiya.
Bugu da kari, Turkiyya ta kwace daruruwan na'urorin na yin numfashi da aka shirya aikewa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin haɗin kan Tarayyar Turai da Italiya da cutar coronavirus ta shafa.
" Maurizio Massari, jakadan Italiya a EU, ya ce " "China ce kawai ta amsa ta biyu. "
" Tabbas, wannan ba alama ce mai kyau ba ta hadin kan Turai. "
A ranar 22 ga Maris, bayan wani kiran waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da likitocin soja, motocin kashe cututtuka na musamman, da sauran kayan aikin likita zuwa Italiya.
" Jaridar La Stampa ta Italiya ta yi tsokaci kan wani "babban tushen siyasa" da ba a san ko waye ba cewa kashi 80 cikin dari na taimakon Rasha "marasa amfani ne ko kuma ba shi da amfani ga Italiya".
" Majiyar ta zargi Rasha da fara wani " " siyasa da diflomasiyya " " " " yaudara. " "
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahotannin kafofin watsa labaru kuma sun nuna godiyarsu.
Rasha kuma ta aika jirgin jigilar kaya tare da kayan agaji zuwa Amurka.
"Magana da yawun Kremlin Dmitry Peskov ya ce ""a lokacin da yake ba da taimako ga abokan aikin Amurka, [Putin] ya ɗauka cewa lokacin da masana'antun Amurka na kayan aikin likita da kayan aiki suka sami ƙarfi, su ma za su iya yin hakan idan ya zama dole. ""
"Daga shirin NATO na aikin soja na ""Defender 2020"" a Jamus, Poland, da kuma kasashen Baltic, babban aikin yaki na NATO tun bayan karshen Cold War, za a gudanar da shi a kan karamin sikelin. "
" Babban sakataren Kamfen na Nukiliya na Rashin Kashewa Kate Hudson ya soki aikin Defender 2020: "" A cikin rikicin lafiyar jama'a na yanzu, yana jefa rayukan ba kawai sojojin daga Amurka da ƙasashen Turai da ke shiga ba amma mazaunan ƙasashen da suke aiki a ciki. "" Gwamnatin Iran ta sha wahala sosai daga cutar, tare da kusan 'yan majalisa ashirin da suka kamu da cutar da kuma wasu mutane goma sha biyar na yanzu ko tsoffin' yan siyasa. "
Shugaban Iran Hassan Rouhani ya rubuta wasika ga shugabannin duniya yana neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa tana gwagwarmaya don yakar barkewar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin Amurka kan Iran. Cutar ta haifar da kira ga Amurka ta dauki manufofin zamantakewar da aka saba da ita a sauran kasashe masu arziki, gami da kula da lafiyar duniya, kula da yara na duniya, hutun iyali da aka biya, da kuma karin kudade don kiwon lafiyar jama'a.
Manazarta siyasa sun yi hasashen hakan na iya yin tasiri ga damar Donald Trump na sake zaɓewa a zaɓen shugaban ƙasa na 2020. Dangantaka ta diflomasiyya tsakanin Japan da Koriya ta Kudu ta lalace saboda cutar.
"Koriya ta Kudu ta soki Japan game da "ƙoƙarin keɓewa da ba shi da ma'ana" bayan da Japan ta sanar da duk wanda ya zo daga Koriya ta Kudu za a sanya shi cikin keɓewa na makonni biyu a wuraren da gwamnati ta tsara. "
Kungiyar Koriya ta Kudu ta kasance da farko ta kasance a kan shugaban Moon Jae-in na amsawa ga rikicin.
Yawancin 'yan Koriya sun sanya hannu kan takardun neman ko dai a tsige Moon a kan abin da suka yi iƙirarin cewa gwamnati ta yi ba daidai ba game da barkewar cutar, ko kuma yabon martanin da ya bayar. Cutar ta ba ƙasashe damar zartar da dokar ta baci don amsawa.
Wasu masu sharhi sun nuna damuwar cewa zai iya ba da damar gwamnatoci su ƙarfafa ikon su.
A Hungary, majalisar dokokinta ta kada kuri'a don ba wa firaminista, Viktor Orbán, damar yin mulki ta hanyar doka ba tare da iyaka ba, dakatar da majalisar da kuma zabuka da kuma hukunta wadanda ake ganin sun yada bayanan karya game da cutar da kuma yadda gwamnati ke magance matsalar.
An zargi barkewar cutar coronavirus da yawa na rashin wadatar kayayyaki, wanda ya samo asali ne daga karuwar amfani da kayan aiki a duniya don yaƙi da barkewar cutar, sayayya da tsoro, da kuma rushewar masana'antu da ayyukan dabaru.
Hukumar Kula da Abinci da Magunguna ta Amurka ta ba da gargadi game da karancin magunguna da kayan aikin likita saboda karuwar bukatar masu amfani da kuma matsalar masu samar da kayayyaki.
Ƙananan yankuna da yawa sun ga sayayyar fargaba wanda ya haifar da tsaftace shelves na kayan masarufi kamar abinci, takarda bayan gida, da ruwan kwalba, wanda ke haifar da karancin wadata.
Musamman masana'antar fasaha ta yi gargadin game da jinkirin jigilar kayayyakin lantarki.
A cewar babban darakta na WHO Tedros Adhanom, bukatar kayan kare kai ya karu sau 100.
Wannan bukatar ta haifar da hauhawar farashin har sau ashirin na farashin da aka saba da shi kuma ya haifar da jinkiri kan samar da kayan aikin likita na tsawon watanni hudu zuwa shida.
Hakanan ya haifar da karancin kayan kariya na mutum a duk duniya, tare da WHO ta yi gargadin cewa wannan zai jefa ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen daigou don sayar da kayayyakin Australiya zuwa China.
Wannan aikin ya haifar da karancin kayan jarirai a wasu manyan kasuwanni kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan cutar COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban bukatar kayayyakin abinci, duka yankunan sun sami kariya daga ƙarancin abinci mai tsanani.
Matakan da China da Italiya suka dauka game da tara kayan da ake yi da kuma cinikin haram na kayayyakin da suka dace sun yi nasara, ta yadda aka kauce wa karancin abinci da aka yi hasashen a Turai da kuma Arewacin Amurka.
Arewacin Italiya tare da yawan amfanin gona mai yawa ba ta ga raguwar da yawa ba, amma farashin zai iya ƙaruwa bisa ga wakilan masana'antu.
An sami shelves na abinci marasa komai na ɗan lokaci, har ma a cikin birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka saki ajiyar naman alade don tabbatar da wadataccen abinci ga jama'a.
Akwai irin wannan dokokin a Italiya da ke bukatar masu samar da abinci su ajiye kayan don irin wannan gaggawa.
An ji rauni ga tattalin arzikin duniya a China: bisa ga rahoton kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya sami mummunan rauni a farkon watanni biyu na farko na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar kwayar cutar, kuma tallace-tallace na dillalai ya ragu da kashi 20.5%.
Kamar yadda kasar Sin babban cibiyar tattalin arziki da masana'antu ce, ana ganin barkewar cutar na haifar da babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na sashen binciken tattalin arziki ya yi hasashen cewa kasuwannin za su ci gaba da kasancewa masu saurin canzawa har sai an sami cikakken hoto game da sakamakon da zai iya faruwa.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin cutar a kan ci gaban duniya na iya wuce wanda ya faru a 20022004 SARS.
Wani ƙididdiga daga wani gwani a Jami'ar Washington a St. Louis ya ba da tasirin dala biliyan 300 + akan sarkar samar da duniya wanda zai iya wucewa har zuwa shekaru biyu.
" Kungiyar Kasashen da ke Fitar da Man Fetur (OPEC) ta "kwana" bayan faduwar farashin man fetur sakamakon karancin bukatar da ake samu daga China. "
Kasuwancin hannayen jari na duniya sun faɗi a ranar 24 ga Fabrairu saboda ƙaruwar adadin COVID-19 a waje da babban yankin China.
A ranar 27 ga Fabrairu, saboda hauhawar damuwa game da barkewar cutar coronavirus, alamun hannun jari na Amurka da dama da suka hada da NASDAQ-100, S & P 500 Index, da Dow Jones Industrial Average sun ba da rahoton raguwarsu mafi girma tun daga 2008, tare da Dow sun fadi da maki 1,191, mafi girma a rana guda tun lokacin rikicin kudi na 2007 08.
Dukkan alamomin uku sun ƙare makon da suka wuce 10%.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ya tabbatar da darajar darajar darajar kasar Sin, amma ya ci gaba da kasancewa da mummunan hangen nesa.
Hannun jari sun sake faduwa bisa tsoron coronavirus, mafi girman faduwar a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arzikin duniya zai iya yin kasa.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa na bankunan tsakiya da jihohi.
Bankunan tsakiya suna amsawa da sauri fiye da yadda suka yi a cikin bala'in tattalin arziki na 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da suka fi fama da cutar saboda hana tafiye-tafiye, rufe wuraren jama'a ciki har da wuraren yawon shakatawa, da kuma shawarar gwamnatoci game da duk wata tafiya a duk faɗin duniya.
Sakamakon haka, kamfanonin jiragen sama da yawa sun soke jirage saboda karancin bukatar, ciki har da British Airways, China Eastern Airlines, da Qantas, yayin da kamfanin jirgin saman yankin na Flybe ya rushe.
Tasirin da ya shafi masana'antar jirgin ruwa ya kasance a matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da dama.
Cutar ta faru ne a lokacin Chunyun, babban lokacin tafiye-tafiye da ke da alaƙa da hutun Sabuwar Shekarar Sinawa.
Yawancin abubuwan da suka shafi taron jama'a da yawa sun soke ta gwamnatocin ƙasa da na yanki, gami da bukukuwan Sabuwar Shekara na shekara-shekara, tare da kamfanoni masu zaman kansu kuma suna rufe shagunan su da wuraren yawon buɗe ido kamar Hong Kong Disneyland da Shanghai Disneyland.
An rufe yawancin abubuwan da suka faru na Sabuwar Shekarar Lunar da wuraren yawon shakatawa don hana taro, gami da Haramtaccen Birni a Beijing da kuma bukukuwan gidan ibada na gargajiya.
A cikin larduna 24, birni da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara zuwa 10 ga Fabrairu, suna ba da umarnin cewa yawancin wuraren aiki kada su sake buɗewa har zuwa wannan ranar.
Wadannan yankuna sun wakilci kashi 80% na GDP na kasar da kashi 90% na fitarwa.
Hong Kong ta ɗaga matakin magance cututtukan cuta zuwa mafi girma kuma ta ba da sanarwar gaggawa, rufe makarantu har zuwa Maris da kuma soke bukukuwan Sabuwar Shekara. An shafi ɓangaren sayar da kayayyaki a duniya, tare da rage lokutan kantin sayar da kayayyaki ko rufewa na ɗan lokaci.
Ziyarar zuwa dillalai a Turai da Latin Amurka sun ragu da 40%.
Kasuwancin Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar 5060%.
Wannan kuma ya haifar da raguwar zirga-zirgar ƙafa zuwa cibiyoyin cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duniya sun sanya ƙarin matakan, kamar inganta tsafta, shigar da na'urori masu duba zafi don bincika yanayin zafin jiki na masu siye, da kuma soke abubuwan da suka faru.Dangane da ƙididdigar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan da cutar ta haifar na iya barin tsakanin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka fiye da yadda za su kasance a cikin wannan yanayin ba tare da cutar ba.
A cikin Janairu da Fabrairu 2020, a lokacin da annobar ta kasance a Wuhan, kimanin mutane miliyan 5 a China sun rasa ayyukansu.
Da yawa daga cikin kusan ma'aikata masu ƙaura miliyan 300 na ƙasar Sin sun makale a gida a lardunan cikin gida ko kuma suka makale a lardin Hubei.A watan Maris na 2020, sama da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Annobar cutar korona na iya kashe ayyuka miliyan 47 a Amurka kuma rashin aikin yi na iya kaiwa 32%, a cewar ƙididdigar Bankin Kula da Tarayya na St. Louis. Kullewar da ke Indiya ya bar miliyoyin ma'aikatan ƙaura na Indiya (waɗanda ake biyan su ta hanyar albashin yau da kullun) marasa aikin yi. Binciken daga Cibiyar Angus Reid ya gano cewa kashi 44% na gidajen Kanada sun sami wani nau'in rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka kulle shi a tsakiyar Maris 2020.
A cikin rabin rabin watan Maris, ma'aikatan Faransa miliyan 4 sun nemi tallafin rashin aikin yi na wucin gadi kuma ma'aikatan Burtaniya miliyan 1 sun nemi tsarin bashi na duniya. Kusan kamfanoni miliyan daya da rabi a Jamus sun tura ma'aikatansu a kan tsarin aiki na gajeren lokaci wanda gwamnati ke tallafawa da ake kira Kurzarbeit.
Tsarin biyan kuɗi na Jamus na ɗan gajeren lokaci ya karɓa ta Faransa da Birtaniya.
Yunkurin da aka yi na al'adun gargajiya da al'adun gargajiya ya sha wahala sosai daga annobar, wanda ya shafi ayyukan kungiyoyi da kuma mutane - duka ma'aikata da masu zaman kansu - a duniya.
Kungiyoyin al'adu da al'adu sun yi kokarin kiyaye aikinsu (wanda galibi ana samun kuɗaɗen jama'a) don samar da dama ga al'adun al'adu ga al'umma, kiyaye lafiyar ma'aikatanta da jama'a, da tallafawa masu fasaha a duk inda zai yiwu.
A cikin Maris 2020, a duk faɗin duniya kuma zuwa digiri daban-daban, gidajen tarihi, ɗakunan karatu, wuraren wasan kwaikwayo, da sauran cibiyoyin al'adu an rufe su har abada tare da nune-nunen su, abubuwan da suka faru da kuma wasan kwaikwayon da aka soke ko aka jinkirta.
A sakamakon haka, an yi kokari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani abin da ya faru kwanan nan da kuma saurin saurin cutar shi ne soke ayyukan addini, manyan abubuwan da suka faru a wasanni, da sauran abubuwan zamantakewa, kamar bukukuwan kiɗa da kide-kide, taron fasaha, da nunin kayan kwalliya.
Masana'antar fina-finai ma ta sami cikas. Vatican ta sanar da cewa an soke bukukuwan sati mai tsarki a Rome, wanda ke faruwa a makon da ya gabata na lokacin tuba na Kirista na Lent.
Dioceses da yawa sun ba da shawarar tsofaffin Kiristoci su zauna a gida maimakon halartar Mass a ranakun Lahadi; wasu majami'u sun sanya ayyukan coci ta hanyar rediyo, watsa shirye-shiryen kai tsaye ta yanar gizo ko talabijin yayin da wasu ke ba da bautar drive-in.
Tare da Diocese na Roman Katolika na Roma rufe majami'u da majami'u da kuma St. Peter's Square ba tare da mahajjata na Kirista ba, sauran ƙungiyoyin addinai sun soke ayyukan da iyakance taron jama'a a majami'u, masallatai, majami'u, gidajen ibada da gurdwaras.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa kuma daga baya aka rufe wuraren ibada, yayin da Saudiyya ta hana shiga mahajjata 'yan kasashen waje da mazauninta zuwa wurare masu tsarki a Makka da Madina.
Cutar ta haifar da babbar matsala ga kalandar wasanni a duniya tun bayan Yaƙin Duniya na Biyu.
An soke ko kuma jinkirta yawancin manyan abubuwan wasanni, gami da 201920 UEFA Champions League, 201920 Premier League, UEFA Euro 2020, 201920 NBA season, da 201920 NHL season.
"Cutar ta katse shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka tsara farawa a ƙarshen Yuli; Kwamitin Olympic na Duniya ya sanar a ranar 24 ga Maris cewa za a "" sake tsara taron zuwa kwanan wata bayan 2020 amma ba daga baya fiye da lokacin bazara na 2021"".Casinos da sauran wuraren wasan caca a duk duniya an rufe kuma an jinkirta ko soke wasannin karta kai tsaye. "
Wannan ya sa yawancin masu caca suka koma kan layi, tare da shafukan yanar gizo da yawa na caca na kan layi suna ba da rahoton ƙaruwar ƙaruwar ƙididdigar sababbin rajista. Masana'antar nishaɗi ma an shafa, tare da ƙungiyoyin kiɗa daban-daban da ke dakatar da ko soke waƙoƙin waƙoƙi.
Yawancin manyan gidajen wasan kwaikwayo kamar waɗanda ke Broadway suma sun dakatar da duk wasan kwaikwayo.
"Wasu masu fasaha sun bincika hanyoyin da za su ci gaba da samarwa da raba aiki a kan intanet a matsayin madadin wasan kwaikwayon raye-raye na gargajiya, kamar su raye-raye na raye-raye ko ƙirƙirar " bukukuwa " na yanar gizo don masu fasaha su yi, rarraba, da kuma tallata aikinsu. "
A kan layi, yawancin labaran yanar gizo masu taken coronavirus sun bazu kamar yadda mutane da yawa suka juya zuwa cikin nishaɗi da shagala a cikin rashin tabbas.
Tun bayan barkewar COVID-19, an lura da karuwar nuna bambanci, ƙiyayya da wariyar launin fata ga mutanen da ke da asalin Sinawa da na Gabashin Asiya, da kuma mutanen da ke fitowa daga wuraren da ake samun ƙaruwar cutar a Turai, Amurka da sauran ƙasashe.
An lura da tsoro, tuhuma, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Amirka ta Arewa, da yankin Asiya da na Pacific.
Rahotanni daga watan Fabrairu (lokacin da yawancin shari'o'in suka kasance a China) sun yi nuni da ra'ayoyin wariyar launin fata da aka bayyana a cikin kungiyoyi daban-daban a duniya na mutanen China da suka cancanci cutar ko kuma karɓar abin da aka yi iƙirarin cewa ya zama adalci.
Wasu ƙasashe a Afirka ma sun ga karuwar nuna adawa da kasar Sin.
Yawancin mazauna Wuhan da Hubei sun ba da rahoton nuna bambanci bisa ga asalin yankin su.
An samu tallafi ga Sinawa, a ciki da wajen, da kuma ga waɗanda ke cikin wuraren da cutar ta shafa.
Bayan ci gaban barkewar cutar zuwa sabbin kasashe masu zafi, mutane daga Italiya, kasar farko a Turai da ta fuskanci mummunar barkewar COVID-19, suma za su iya fuskantar tuhuma da ƙiyayya da baƙi. 'Yan ƙasa a ƙasashe da suka haɗa da Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun sanya hannu kan takaddama da ke neman hana Sinawa shiga ƙasashensu a ƙoƙarin dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama abin da ake amfani da shi a Twitter.
Sinawa da sauran 'yan Asiya a Burtaniya da Amurka sun ba da rahoton karuwar yawan cin zarafin launin fata, da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ambaton cutar coronavirus a matsayin "'Chinese Virus"", kalmar da masu sukar ke ganin tana nuna wariyar launin fata da adawa da China. "
Masu zanga-zangar a Ukraine sun kai hari kan motocin bas da ke jigilar 'yan Ukraine da na kasashen waje daga Wuhan zuwa Novi Sanzhary.
Daliban da suka fito daga Arewa maso gabashin Indiya, wanda ke da iyaka da China, kuma suna karatu a manyan biranen Indiya sun sami matsala da ke da alaƙa da barkewar cutar coronavirus.
" Shugaban jam'iyyar Bharatiya Janata a jihar Bengal Dilip Ghosh ya bayyana cewa, Sinawa sun lalata yanayi kuma "wannan shine dalilin da ya sa Allah ya yi musu ramuwar gayya".
Bayanin daga baya ya yi tir da kwansandan kasar Sin a Kolkata, yana mai cewa "ba daidai ba ne". A China, cutar ta haifar da tsanar baki da wariyar launin fata ga mazauna da ba Sinawa ba, tare da bayyana baƙi a matsayin "dukiyar waje" da kuma " zubar da su".
Yawancin jaridu da ke da bangon biyan kuɗi sun cire su don wasu ko duk ɗaukar hoto na coronavirus.
Yawancin masu wallafa kimiyya sun sanya takardun kimiyya da suka shafi barkewar cutar a cikin damar samun dama.
Wasu masana kimiyya sun zaɓi raba sakamakon su da sauri akan sabobin shirye-shirye kamar bioRxiv.
Cutar da ke tasowa  Cutar da ke tasowa ta sabon kwayar cutar, sau da yawa sabon abu a cikin yanayin ɓarna ko hanyar watsawa
Duniya da cuta  Bayani na duniya da yaduwar cutar
Jerin annoba da annobar cutar  Jerin mutuwar da ke faruwa a sakamakon cutar
Fashin dabbobin daji da cutar zoonosis  Haɗarin kiwon lafiya da ke tattare da cinikin dabbobin daji
Gwajin dakin gwaje-gwaje na cutar coronavirus na 2019 (COVID-19) da kuma kwayar cutar SARS-CoV-2 da ke hade da ita ya haɗa da hanyoyin da ke gano kasancewar kwayar cutar da waɗanda ke gano ƙwayoyin cuta da aka samar a matsayin amsa ga kamuwa da cuta.
Ana tabbatar da kasancewar ƙwayoyin cuta a cikin samfurori ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin na musamman ne kuma an tsara shi ne don gano RNA na kwayar SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da kwanan nan ko kamuwa da cuta.
Ana iya amfani da ganowar kwayoyin cuta (serology) don tantancewa da kuma sa ido kan yawan jama'a.
Gwajin antibody ya nuna yadda mutane da yawa suka kamu da cutar, gami da wadanda alamun cutar ba su da yawa don bayar da rahoto ko kuma wadanda ba su da alamun cutar.
Ana iya tantance ainihin adadin mutuwar cutar da kuma matakin rigakafin garken a cikin jama'a daga sakamakon wannan gwajin.
Saboda ƙarancin gwaji, a watan Maris na 2020 babu wata ƙasa da ke da ingantaccen bayanai kan yaduwar cutar a cikin jama'arta.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da 3% na yawan mutanen da ke cikinta, kuma akwai bambance-bambancen da yawa a cikin yawan gwajin da aka yi a tsakanin ƙasashe.
Wannan bambancin na iya yin tasiri sosai ga adadin mutuwar da aka ruwaito, wanda wataƙila ana iya kimanta shi sosai a wasu ƙasashe.
Amfani da ainihin lokacin da aka sake yin amfani da polymerase chain reaction (rRT-PCR) ana iya yin gwajin a kan samfurin numfashi da aka samu ta hanyoyi daban-daban, gami da nasopharyngeal swab ko samfurin sputum.
Sakamakon yawanci yana samuwa a cikin 'yan sa'o'i zuwa kwanaki 2.
Gwajin RT-PCR da aka yi da swabs na makogwaro yana da aminci ne kawai a mako na farko na cutar.
Daga baya kwayar cutar za ta iya ɓacewa a cikin makogwaro yayin da take ci gaba da ninkawa a cikin huhu.
Ga mutanen da suka kamu da cutar da aka gwada a mako na biyu, a madadin haka za a iya ɗaukar samfurin kayan daga zurfin hanyoyin numfashi ta hanyar tsotse catheter ko kuma za a iya amfani da kayan tari (sputum).
An kirkiro daya daga cikin gwajin PCR na farko a Charité a Berlin a watan Janairu 2020 ta amfani da ainihin lokacin da aka yi amfani da sarkar polymerase (rRT-PCR), kuma ya zama tushen kayan aiki 250,000 don rarraba ta Hukumar Lafiya ta Duniya (WHO).
Ƙasar Ingila ma ta haɓaka gwajin ta 23 Janairu 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya haɓaka ƙwararren ƙwararren likita, PCR-tushen SARS-CoV-2 kit ɗin bincike (PowerChek Coronavirus) a ranar 28 Janairu 2020.
Yana neman ""E"" gene da aka raba ta dukkan beta coronaviruses, da RdRp gene na musamman ga SARS-CoV-2.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da suka sami izinin amfani da gaggawa daga Hukumar Kula da Kayan Kiwon Lafiya ta China don kayan bincike na SARS-CoV-2 na PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna rarraba 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel zuwa dakunan gwaje-gwajen kiwon lafiyar jama'a ta hanyar International Reagent Resource. "
Daya daga cikin gwajin kwayoyin halitta guda uku a cikin tsofaffin sigar kayan gwajin ya haifar da sakamako mara kyau saboda ƙarancin reagents, da kuma ƙarancin gwaji a CDC a Atlanta; wannan ya haifar da matsakaicin ƙasa da samfuran 100 a rana da aka aiwatar cikin nasara cikin duka Fabrairu 2020.
Ba a tantance gwaje-gwaje da ke amfani da abubuwa biyu masu amfani da su a matsayin abin dogaro ba har sai 28 ga Fabrairu 2020, kuma ba a ba da izinin cibiyoyin gwaje-gwaje na jihohi da na gida ba har sai lokacin.
Hukumar Kula da Abinci da Magunguna ta amince da gwajin a karkashin Izinin Amfani da Gaggawa.Laburorin kasuwanci na Amurka sun fara gwaji a farkon Maris 2020.
Tun daga ranar 5 ga Maris, 2020 LabCorp ya ba da sanarwar samun gwajin COVID-19 a duk ƙasar bisa ga RT-PCR.
Quest Diagnostics ya kuma samar da gwajin COVID-19 a duk fadin kasar nan daga ranar 9 ga Maris 2020.
Ba a sanar da iyakance adadin ba; dole ne a tattara samfurin da sarrafawa bisa ga bukatun CDC.
A Rasha, Cibiyar Bincike ta Jihar Virology da Biotechnology VECTOR ce ta haɓaka gwajin COVID-19 kuma ta samar da shi.
A ranar 11 ga Fabrairu 2020 an yi rajistar gwajin ta Hukumar Kula da Kula da Kula da Lafiya ta Tarayya. A ranar 12 ga Maris 2020, Mayo Clinic an ba da rahoton cewa sun haɓaka gwajin don gano cutar COVID-19. A ranar 13 ga Maris 2020, Roche Diagnostics sun sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 a cikin babban girma, don haka yana ba da damar injin ɗaya don yin kimanin gwaje-gwaje 4,128 a cikin sa'o'i 24.
A ranar 19 ga Maris 2020, FDA ta ba da izinin amfani da gaggawa (EUA) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott; FDA ta ba da izinin kama da Hologic, LabCorp, da Thermo Fisher Scientific.
A ranar 21 ga Maris 2020, Cepheid ta karɓi EUA daga FDA don gwaji wanda ke ɗaukar kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar karfafa kwayar nucleic acid mai zafi maimakon PCR.
Tun da wannan ba ya buƙatar jerin zafin jiki na zazzabi na wannan hanya zai iya ba da sakamako mai kyau a cikin minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan na'urori a cikin Amurka kuma Abbott yana tsammanin haɓaka masana'antu don isar da gwaje-gwaje 50,000 a kowace rana. Ana yin gwajin da ke amfani da kwayar cutar monoclonal wanda ke da alaƙa da musamman ga ƙwayoyin nucleocapsid (N protein) na sabon coronavirus a Taiwan, tare da fatan cewa zai iya ba da sakamako a cikin mintuna 15 zuwa 20 kamar gwajin mura mai sauri.
"Binciken adabi na Maris 2020 ya kammala cewa "" radiographs na kirji ba su da ƙimar ƙididdiga a farkon matakai, yayin da CT [computed tomography] binciken na iya kasancewa tun kafin bayyanar cututtuka. """
Hanyoyin da ke cikin CT sun haɗa da haɗin kai na biyu na multilobar-glass tare da rarrabawar gefen, asymmetric da na baya.
Subpleural iko, haukace da ƙarfafawa suna haɓaka yayin da cutar ke haɓaka.
Nazarin kwatancen PCR zuwa CT a Wuhan a asalin cutar na yanzu ya nuna cewa CT ya fi PCR hankali sosai, kodayake ba shi da ƙayyadaddun bayani, tare da yawancin abubuwan da ke cikin hoton sa tare da sauran cututtukan huhu da hanyoyin cutar.
" Daga Maris 2020, Kwalejin Ilimin Radiology ta Amurka ta ba da shawarar cewa ""Kada a yi amfani da CT don bincika ko a matsayin gwajin farko don tantance COVID-19"". " Daga Maris 2020, CDC ta ba da shawarar PCR don binciken farko. "
Wani ɓangare na amsawar garkuwar jiki ga kamuwa da cuta shine samar da magungunan rigakafi ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta a cikin mutane farawa kwanaki 7 ko makamancin haka bayan bayyanar cututtuka, don ƙayyade rigakafi, da kuma cikin sa ido kan yawan jama'a. Ana iya yin gwaje-gwaje a cikin dakunan gwaje-gwaje na tsakiya (CLT) ko ta hanyar gwajin kulawa (PoCT).
Tsarin sarrafa kansa mai karfin gaske a dakunan gwaje-gwaje da yawa na asibiti zai iya yin waɗannan gwaje-gwajen amma wadatar su zata dogara ne da yawan samar da kowane tsarin.
Don CLT ana amfani da samfurin guda ɗaya na jini na jini, kodayake ana iya amfani da samfuran samfuran don bin amsawar garkuwar jiki.
Don PoCT ana samun samfurin jini guda ɗaya ta hanyar huda.
Ba kamar hanyoyin PCR ba ana buƙatar matakin fitarwa kafin a gwada. A ranar 26 ga Maris, 2020, FDA ta ambaci ƙungiyoyi 29 waɗanda suka ba da sanarwa ga hukumar kamar yadda ake buƙata kuma saboda haka yanzu suna iya rarraba gwaje-gwajen antibody ɗin su.
A ranar 7 ga Afrilu, 2020, gwaji guda ɗaya ne kawai FDA ta amince da shi a ƙarƙashin izinin amfani na gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan gwajin su, wanda zai iya gano IgG da IgA antibodies akan kwayar cutar a cikin samfurin jini.
Ikon gwajin yana da samfuran ɗaruruwan a cikin awanni kuma saboda haka ya fi sauri fiye da gwajin PCR na RNA na hoto.
Kwayoyin cutar na iya ganowa kwanaki 14 bayan fara kamuwa da cutar. A farkon watan Afrilu, Birtaniya ta gano cewa babu wani daga cikin kayan gwajin kwayar cutar da ta saya da ke da inganci da za a iya amfani da su.
Hong Kong ta kafa wani tsari inda marasa lafiya da ake zargi za su iya zama a gida, "" sashen gaggawa zai ba da bututun samfurin ga mai haƙuri, za su tofa a ciki, su mayar da shi kuma su sami sakamakon gwaji bayan wani lokaci. NHS na Burtaniya ya ba da sanarwar cewa yana gwada wani shiri don gwada waɗanda ake zargi da cutar a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu idan sun zo asibiti ko kuma ya yi amfani da motar asibiti don kashe ƙwayoyin cutar idan aka yi amfani da ɗaya. A cikin gwajin tuki don COVID-19 don waɗanda ake zargi da cutar, ƙwararren likitanci yana ɗaukar samfurin ta amfani da matakan kariya. "
Cibiyoyin da aka yi amfani da su a cikin mota sun taimaka wa Koriya ta Kudu wajen yin wasu daga cikin gwaje-gwaje mafi sauri, mafi yawa na kowace ƙasa. A Jamus, Ƙungiyar Ƙwararrun Likitocin Inshorar Lafiya ta Ƙasa ta ce a ranar 2 ga Maris, tana da damar yin gwaje-gwaje kusan 12,000 a kowace rana a cikin yanayin motsa jiki kuma an yi gwaji 10,700 a cikin makon da ya gabata.
A duk lokacin da likita ya ba da umarnin yin gwajin, inshorar lafiya ce ke biyan kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus na da damar yin gwajin 160,000 a mako.
Ya zuwa 19 Maris, an ba da gwajin tuki a cikin manyan biranen da yawa.
A ranar 26 ga Maris 2020 ba a san adadin gwajin da aka yi a Jamus ba, saboda sakamakon da aka samu ne kawai aka bayar.
"Binciken lab na farko ya nuna cewa daga makon kalanda 12/2020 an gwada jimlar aƙalla samfura 483,295 har zuwa kuma sun haɗa da mako 12/2020 da kuma samfura 33,491 (6.9%) sun gwada tabbatacce ga SARS-CoV-2.A cikin Isra'ila, masu bincike a Technion da Asibitin Rambam sun haɓaka da gwada wata hanya don gwajin samfura daga marasa lafiya 64 a lokaci ɗaya, ta hanyar haɗa samfuran da kuma kawai yin ƙarin gwaji idan an sami samfurin haɗuwa yana da kyau.A Wuhan an buɗe wani dakin gwaje-gwaje na gano gaggawa na murabba'in mita 2000 mai suna "" Huo-Yan "" (Sinanci: 火眼, ko "" Wurin Wuta "" a Turanci) a ranar 5 ga Fabrairuwar 2020 ta BGI, wanda zai iya sarrafa sama da samfura 10,000 a rana. "
Tare da aikin da wanda ya kafa BGI Wang Jian ya kula kuma ya ɗauki kwanaki 5, yin samfurin ya nuna cewa shari'o'i a Hubei da za su kasance 47% mafi girma kuma farashin da ya dace na magance keɓewa zai ninka idan wannan ƙarfin gwajin bai zo kan layi ba.
An bi dakin gwaje-gwajen Wuhan da sauri ta hanyar dakunan gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing, da Shanghai, a jimillar birane 12 a duk fadin kasar Sin.
Ya zuwa 4 ga Maris 2020 jimillar yawan adadin da ake yi a kowace rana ya kai 50,000 a kowace rana.An saki kayayyaki masu buɗewa, masu yawa da aka saki ta Origami Assays waɗanda za su iya gwada samfuran marasa lafiya 1122 don COVID19 ta amfani da gwaji 93 kawai. Waɗannan ƙirar masu daidaitaccen tsari za a iya gudanar da su a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar masu sarrafa ruwa na mutum-mutumi ba.
A watan Maris, karancin da kuma isasshen adadin reagent ya zama matsala ga gwajin taro a EU da UK da Amurka.
Wannan ya sa wasu marubutan binciken binciken shirye-shiryen samfurin da suka shafi yin zafin samfura a 98 °C (208 °F) na mintina 5 don sakin RNA genomes don ƙarin gwaji.A ranar 31 ga Maris aka sanar da United Arab Emirates yanzu tana gwada yawan jama'arta don Coronavirus a kowane kai fiye da kowace ƙasa, kuma tana kan hanya don haɓaka matakin gwaji don isa ga yawancin jama'a.
" Wannan ya kasance ta hanyar haɗuwa da damar tuki, da kuma siyan dakin gwaje-gwaje mai yawa daga yawan jama'a daga Group 42 da BGI (bisa ga dakin gwaje-gwajen gano gaggawa na "" Huo-Yan "a China). "
An gina shi cikin kwanaki 14, dakin binciken na iya gudanar da dubun dubatar gwaje-gwajen RT-PCR a kowace rana kuma shine na farko a duniya na wannan sikelin da zai yi aiki a waje da China.
An kirkiro hanyoyin gwaji daban-daban da ke niyya ga bangarori daban-daban na bayanan kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan, da Amurka.
Hukumar Lafiya ta Duniya ta karɓi girke-girke na Jamus don ƙera kayan kwalliya da aka aika zuwa ƙasashe masu ƙarancin kuɗi ba tare da albarkatun da za su haɓaka nasu ba.
An buga girke-girke na Jamus a ranar 17 ga Janairu 2020; ba a sami yarjejeniyar da Cibiyar Kula da Cututtuka ta Amurka ta tsara ba har zuwa 28 ga Janairu, wanda ya jinkirta gwajin da ke akwai a Amurka. China da Amurka suna da matsaloli tare da amincin kayan gwajin a farkon fashewar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isassun kayan aiki don biyan buƙatu da shawarwarin gwaji ta masana kiwon lafiya ba.
Akasin haka, masana sun ce yawan gwajin Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Ƙarfin gwaji, galibi a cikin dakunan gwaje-gwaje na masu zaman kansu, an gina shi tsawon shekaru da dama daga gwamnatin Koriya ta Kudu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau ta rage saurin cutar COVID-19. Babban bukatar yin gwaji saboda yaduwar cutar ya haifar da koma-baya na dubban daruruwan gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, kuma samar da swabs da magungunan sinadarai ya zama mai wahala.
A watan Maris na 2020 China ta ba da rahoton matsaloli tare da daidaito a cikin kayan gwajin su.
A Amurka, kayan gwajin da CDC ta samar suna da ""kwatance;"" gwamnati ta cire shingen hukuma da suka hana gwajin mai zaman kansa. Spain ta sayi kayan gwajin daga kamfanin kasar Sin na Shenzhen Bioeasy Biotechnology Co Ltd, amma ta gano cewa sakamakon ba daidai ba ne. "
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon rashin tattara samfurori ko amfani da kayan aikin daidai.
Ma'aikatar ta Spain ta ce za ta janye kayan gwajin da suka dawo da sakamakon da ba daidai ba, kuma za ta maye gurbin su da wani kayan gwajin daban da Shenzhen Bioeasy ya bayar. 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon da ba daidai ba.Slovakia ta sayi kayan gwaji miliyan 1.2 daga China wanda aka gano ba daidai ba.
Firayim Minista Matovič ya ba da shawarar a zuba wadannan a cikin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da "" babban kuskure"" kuma ba su "" yi amfani da su ba. "" Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China amma a farkon Afrilu 2020 ta sanar da cewa ba za a iya amfani da su ba. "
Gwajin, wanda ya biyo bayan keɓewar waɗanda suka gwada tabbatacce da kuma gano waɗanda waɗanda waɗanda ke da SARS-CoV-2 masu cutar suka yi hulɗa da su, ya haifar da sakamako mai kyau.
Masu bincike da ke aiki a garin Vò na Italiya, wurin da aka fara samun mutuwar COVID-19 a Italiya, sun gudanar da zagaye biyu na gwaji a kan dukkan mutanen da ke da kusan mutane 3,400, kusan kwanaki goma.
Kimanin rabin mutanen da aka gwada sun kamu da cutar ba su da alamun cutar, kuma duk wadanda aka gano sun kamu da cutar an killace su.
Tare da ƙuntata tafiya zuwa al'umma, wannan ya kawar da sabbin kamuwa da cuta gaba ɗaya.
Tare da bin diddigin masu cutar, ƙuntatawa na tafiya, gwaji, da keɓewa, annobar coronavirus ta 2020 a Singapore ta ci gaba da hankali fiye da sauran ƙasashe masu tasowa, amma ba tare da ƙuntatawa mai tsanani ba kamar tilasta rufe gidajen abinci da wuraren sayar da kayayyaki.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida a ranar 28 ga Maris, amma makarantu sun sake buɗewa a kan lokaci bayan hutun hutu a ranar 23 ga Maris.
Wasu ƙasashe da yawa sun kuma gudanar da annobar ta hanyar bin diddigin masu hulɗa, ƙuntatawa na tafiye-tafiye, gwaji, da keɓewa, amma tare da ƙarancin kullewa, kamar Iceland da Koriya ta Kudu.
Wani binciken kididdiga ya gano cewa kasashen da suka yi gwaji sosai, dangane da yawan wadanda suka mutu, suna da karancin wadanda suka mutu, mai yiwuwa saboda wadannan kasashe sun fi iya gano wadanda ke da sauki ko kuma ba su da wata alama.
WHO ta ba da shawarar cewa kasashen da ba su da damar yin gwaji da kuma dakunan gwaje-gwaje na ƙasa da ƙarancin ƙwarewa a kan COVID-19 su aika da samfuran COVID-19 na farko da suka fara da kuma na farko da ba su da kyau ba zuwa ɗayan dakunan gwaje-gwaje na WHO na 16 don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16 da aka ambata, 7 suna cikin Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amurka da 1 a Ostiraliya.
A cikin jadawalin da ke ƙasa, shafi  Positive as % of tests yana da tasiri ta hanyar manufofin gwaji na ƙasar.
Ƙasar da ke gwada mutane kawai da aka shigar da su asibiti za ta sami sakamako mai kyau a matsayin % na gwaje-gwaje fiye da ƙasa da ke gwada duk 'yan ƙasa, ko suna nuna alamun cutar ko a'a, sauran abubuwa daidai suke.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, shine aikin tsabtace hannaye don cire ƙura, mai, ƙananan ƙwayoyin cuta, ko wasu abubuwan da ba a so.
" Wanke hannu da sabulu a kai a kai a wasu "' muhimman lokuta "' a cikin yini yana hana yaduwar cututtuka da yawa, misali zawo da kwalara, waɗanda ake watsawa ta hanyar faecaloral. "
Mutane kuma na iya kamuwa da cututtukan numfashi kamar mura ko kuma mura, misali, idan ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci, ko bakinsu (watau, mucous membranes).
Lokaci biyar masu mahimmanci a cikin rana inda wanke hannu da sabulu yake da mahimmanci sun haɗa da: kafin da bayan fitar maniyyi, bayan wanke bayan yaro ko canza diapers, kafin ciyar da yaro, kafin cin abinci da kafin da bayan shirya abinci ko sarrafa raw nama, kifi, ko kaji.
Idan babu ruwa da sabulu, za a iya wanke hannu da toka. Hukumar Lafiya ta Duniya ta ba da shawarar wanke hannu:
Kafin, lokacin, da kuma bayan an dafa abinci.
Kafin da kuma bayan kula da marar lafiya.
Bayan an canja diapers ko kuma bayan an tsabtace bayan an yi amfani da bayan gida.
Bayan ka busa hanci, tari ko yin atishawa.
Bayan taɓa dabba, abincin dabba, ko ƙazantar dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace jiki da suka shafi hanyoyin likita.
Wanke hannu kafin a ba da magani ko kulawar likita zai iya hana ko rage yaduwar cuta.
Babban manufar likitancin wanke hannu shine tsaftace hannaye daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙananan ƙwayoyin cuta waɗanda zasu iya haifar da cuta) da kuma sunadarai waɗanda zasu iya haifar da lahani ko cututtuka.
Wannan yana da mahimmanci musamman ga mutanen da ke hulɗa da abinci ko aiki a fagen likita, amma kuma muhimmin aiki ne ga jama'a gaba ɗaya.
Wanke hannu yana da amfani mai yawa ga lafiya, gami da rage yaduwar mura, coronavirus, da sauran cututtukan da ke yaduwa; hana cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan numfashi;
da kuma rage yawan mutuwar jarirai a haihuwar gida.
Wani bincike na 2013 ya nuna cewa inganta ayyukan wanke hannu na iya haifar da ƙananan ci gaba a cikin haɓakar tsawo a cikin yara 'yan ƙasa da shekaru biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke da alaƙa da cututtukan numfashi da na zawo ta hanyar gabatar da sauƙin canje-canje na ɗabi'a, kamar wanke hannu da sabulu.
Wannan aikin mai sauki zai iya rage yawan mutuwar da ke faruwa daga wadannan cututtukan da kusan kashi 50%.
Sa hannu a ayyukan da ke inganta wanke hannu na iya rage cututtukan zawo da kusan kashi uku, kuma wannan yana da kama da samar da tsabtataccen ruwa a yankunan da ke da karancin kuɗi.
48% na raguwar cututtukan zawo na iya kasancewa tare da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da mara tsada don hana zawo da cututtukan numfashi mai tsanani (ARI), azaman aikin atomatik da ake yi a gidaje, makarantu, da al'ummomi a duk duniya.
Ciwon huhu, babban ARI, shine lambar farko na mutuwar yara a cikin shekaru biyar, yana ɗaukar rayukan kimanin yara miliyan 1.8 a kowace shekara.
Zuba jini da ciwon huhu tare suna kashe kusan yara miliyan 3.5 a kowace shekara.
A cewar UNICEF, juya wanke hannu da sabulu kafin cin abinci da kuma bayan amfani da bayan gida a cikin al'ada mai kyau na iya ceton rayuka fiye da kowane rigakafi ko aikin likita, rage mutuwar da zazzabi da kusan rabi da kuma mutuwar da ke faruwa daga cututtukan numfashi mai tsanani da kashi ɗaya bisa huɗu.
Ana haɗa wanke hannu tare da sauran ayyukan tsafta a matsayin wani ɓangare na shirye-shiryen ruwa, tsafta da tsafta (WASH).
Wanke hannu kuma yana karewa daga impetigo wanda ake watsawa ta hanyar saduwa ta zahiri kai tsaye.
Wani ɗan illa na wanke hannu shine cewa yawan wanke hannu na iya haifar da lalacewar fata saboda bushewar fata.
Wani binciken na Danish da aka gudanar a 2012 ya gano cewa yawan wanke hannu zai iya haifar da yanayin fata mai saurin fata da ake kira eczema ko dermatitis na hannu, wanda ya zama ruwan dare a tsakanin ma'aikatan kiwon lafiya.
Yin wanke hannu sau da yawa ana ganin shi ne daya daga cikin alamomin rashin lafiyar damuwa (OCD).
Akwai lokuta masu mahimmanci guda biyar a cikin rana inda wanke hannu da sabulu yana da mahimmanci don rage watsawar cutar ta hanyar fecal-oral: bayan amfani da banɗaki (urination, defecation), bayan tsabtace ƙasan yaro (canza diapers), kafin ciyar da yaro, kafin cin abinci da kafin / bayan shirya abinci ko sarrafa ɗanyen nama, kifi, ko kaji.
Sauran lokutan da ya kamata a yi amfani da hanyar wanke hannu daidai don hana watsa cuta sun haɗa da kafin da kuma bayan kula da yankewa ko rauni; bayan yin ƙaiƙayi, tari, ko busa hanci; bayan taɓa ƙazantar dabbobi ko sarrafa dabbobi; da kuma bayan taɓa shara.
A ƙasashe da yawa, akwai ƙarancin wanke hannu da sabulu.
Binciken wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita, kashi 38.7% na gidaje sun yi wanke hannu da sabulu. Binciken na shekarar 2014 ya nuna cewa Saudi Arabiya tana da mafi girman kashi 97 cikin dari; Amurka kusa da tsakiyar da kashi 77; da kuma China tare da mafi ƙarancin kashi 23 cikin dari. Hanyoyi da yawa na canjin hali yanzu suna wanzuwa don haɓaka halayen wanke hannu da sabulu a lokuta masu mahimmanci. Wanke hannu na rukuni ga yaran makaranta a lokutan da aka sa na rana shine zaɓi ɗaya a cikin ƙasashe masu tasowa don haɓaka wanke hannu a cikin halayen yara.
" "Shirin Kula da Lafiya na Muhimmanci" wanda Ma'aikatar Ilimi ta aiwatar a Philippines misali ne na matakin da za a yi don inganta lafiyar yara da ilimi. "
Deworming sau biyu a shekara, tare da wanke hannu yau da kullun da sabulu, goge hakora yau da kullun tare da fluoride, shine ainihin wannan shirin na ƙasa.
An kuma samu nasarar aiwatar da shi a Indonesia.
Ana inganta cire ƙwayoyin cuta daga fata ta ƙara sabulu ko kayan wanki zuwa ruwa.
Babban aikin sabulu da kayan wanki shine rage shingen zuwa bayani, da kuma kara yawan solubility.
Ruwa shi kaɗai ba zai iya tsabtace fata ba domin kitse da furotin, waɗanda suke cikin ƙasa, ba sa narkewa cikin ruwa.
Tsabtace, duk da haka, yana taimakawa ta hanyar kwararar ruwa mai kyau.
Sabulu mai kauri, saboda yanayin da ake iya amfani da shi, na iya riƙe ƙwayoyin cuta da aka samu daga amfani da baya.
Studysan ƙananan karatun da suka bincika canja wurin ƙwayoyin cuta daga gurɓataccen sabulu mai ƙarfi sun kammala cewa canja wuri ba zai yiwu ba saboda ana wanke ƙwayoyin cuta tare da kumfa.
" CDC har yanzu ta ce "sabulu mai ruwa tare da sarrafawa kyauta don bayarwa ya fi dacewa". "
An yi amfani da sabulu mai kashe ƙwayoyin cuta a wajen mutane masu kula da lafiyar jikinsu.
Zuwa yau, babu wata shaida da ke nuna cewa amfani da magungunan kashe kwayoyin cuta ko magungunan kashe kwayoyin cuta yana zaban kwayoyin da ke da rigakafin kwayoyin cuta a yanayi.
Koyaya, sabulu masu kashe kwayoyin cuta suna dauke da magungunan antibacterial na yau da kullun kamar triclosan, wanda ke da jerin sunayen kwayoyin cuta masu tsayayya.
Don haka, ko da kwayoyin da ke jure maganin rigakafi ba za a zaɓa su ta sabulun antibacterial ba, ba za su iya zama masu tasiri kamar yadda ake tallata su ba.
Bayan surfactant da kuma kare fata, magungunan da aka tsara na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai daidaita pH, benzoic acid mai aiki da ƙwayoyin cuta da sauran kayan gyaran fata (aloe vera, bitamin, menthol, tsirrai na tsire-tsire). A cikakken bincike daga Jami'ar Oregon School of Public Health ya nuna cewa sabulu masu sauƙi suna da tasiri kamar sabulu masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙunshe da triclosan wajen hana rashin lafiya da cire ƙwayoyin cuta daga hannaye.
Ruwan zafi wanda yake da dadi don wanke hannu ba shi da zafi sosai don kashe kwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37 °C).
Koyaya, ruwan dumi mai sabulu yafi tasiri fiye da ruwan sanyi mai sabulu wajen cire man fetur na halitta wanda ke riƙe da ƙasa da ƙwayoyin cuta.
Akasin abin da aka yarda da shi, binciken kimiyya ya nuna cewa yin amfani da ruwan dumi ba shi da tasiri a rage yawan kwayar cutar a hannu.
Mai tsabtace hannu ko maganin kashe kwayoyin cuta na hannu shine mai tsabtace hannu wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon karni na 21, abubuwan da ke shafawa na barasa ba tare da ruwa ba (wanda aka fi sani da rubs na hannu na barasa, rubs na antiseptic, ko kuma masu tsabtace hannu) sun fara samun farin jini.
Yawancin suna dogara ne akan isopropyl alcohol ko ethanol wanda aka tsara tare da wakili mai kauri kamar Carbomer (polymer na acrylic acid) a cikin gel, ko mai danshi kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da kuma rage tasirin bushewa na barasa.
Ƙara ruwa mai narkar da ruwa yana ƙara haɓaka aikin antimicrobial. Sanitizers na hannu wanda ke da ƙarancin barasa 60 zuwa 95% suna da inganci masu kashe ƙwayoyin cuta.
Alcohol rub sanitizers kashe kwayoyin cuta, kwayoyin cuta masu jurewa da magunguna da yawa (MRSA da VRE), tarin fuka, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, vaccinia, influenza, da hepatitis) da fungi.
Magungunan wanke hannu da ke dauke da kashi 70% na barasa suna kashe kashi 99.97% (3.5 log ragewa, kwatankwacin rage decibel 35) na kwayoyin cuta a hannu 30 seconds bayan aikace-aikace da 99.99% zuwa 99.999% (4 zuwa 5 log ragewa) na kwayoyin cuta a hannu 1 minti bayan aikace-aikace. Magungunan wanke hannu sun fi tasiri akan kwayoyin cuta kuma basu da tasiri akan wasu ƙwayoyin cuta.
Abubuwan da ke amfani da giya na hannu suna da kusan rashin tasiri gaba ɗaya akan nau'in kwayar cutar norovirus (ko Norwalk), wanda shine mafi yawan sanadin cutar cututtukan gastroenteritis. Dole ne a yi amfani da maganin antiseptic na hannu ko barasa mai yawa don yin rigakafi sosai ko rufe duka hannayen biyu.
Ana shafa gaban da bayan hannu biyu da tsakanin da kuma ƙarshen dukkan yatsunsu na kimanin dakika 30 har sai ruwa, kumfa ko gel ya bushe.
Dole ne a wanke yatsun yatsun hannu sosai, a shafa su a hannu biyu. Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka ta ba da shawarar wanke hannu a kan gogewa da na'urar wanke hannu, musamman idan hannaye sun yi datti.
Ƙara yawan amfani da waɗannan abubuwa ya dogara ne akan sauƙin amfani da kuma saurin kashewa akan ƙwayoyin cuta; duk da haka, bai kamata su zama madadin wanke hannu daidai ba sai dai idan sabulu da ruwa basu samuwa.
Amfani da magungunan tsabtace hannu na barasa na iya haifar da bushewar fata sai dai idan an ƙara emollients da / ko masu sanyaya fata zuwa tsarin.
Za'a iya rage ko kawar da tasirin bushewar giya ta hanyar ƙara glycerin da / ko wasu abubuwan sanyayawa zuwa tsarin.
A cikin gwajin asibiti, maganin wanke hannu na tushen giya wanda ke dauke da emollients ya haifar da ƙarancin ƙazantar da fata da bushewa fiye da sabulu ko maganin wanke-wanke na antimicrobial.
Allergic lamba dermatitis, lamba urticaria ciwo ko hypersensitivity ga barasa ko additives ba a barasa rub hannaye ba safai faruwa.
Rashin ƙarancin haifar da cututtukan fata na tuntuɓar mai ƙyama ya zama abin jan hankali idan aka kwatanta da wanke hannu da sabulu da ruwa.
Duk da ingancin su, abubuwan da ba ruwa ba ba sa tsabtace hannaye na kayan ƙwayoyin halitta, amma kawai suna kashe su.
Saboda wannan ne, maganin wanke hannu ba shi da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, tunda ƙwayoyin cuta har yanzu suna kan hannu.
Ingancin maganin tsabtace hannu ba tare da barasa ba ya dogara ne akan abubuwan da aka haɗa da kuma tsari, kuma a tarihi ya yi ƙasa da barasa da barasa.
Kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna cewa suna da aiki mai tsauri da tarawa na antimicrobial bayan aikace-aikace, ba kamar barasa ba, wanda aka nuna ya rage inganci bayan amfani da shi, mai yiwuwa saboda ci gaba da halayen fata.
Mutane da yawa a cikin al'ummomin da ke da ƙarancin kuɗi ba za su iya sayan sabulu ba kuma suna amfani da toka ko ƙasa a maimakon.
Ash ko ƙasa na iya zama mafi inganci fiye da ruwa shi kaɗai, amma na iya zama ƙasa da sabulu.
Wani abin damuwa shi ne cewa idan ƙasa ko toka ta gurɓata da ƙwayoyin cuta na iya ƙara yaduwar cuta maimakon ragewa.
Kamar sabulu, toka ma wakili ne na kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana samar da wani bayani mai mai.
WHO ta ba da shawarar ash ko yashi a matsayin madadin sabulu lokacin da sabulu bai samu ba.
Tsarin wanke hannu daidai wanda Cibiyar Kula da Cututtuka ta Amurka ta ba da shawarar don hana yaduwar cuta ya haɗa da waɗannan matakan:
Ruwa hannuwanku da ruwan dumi ko ruwan sanyi.
Ana bada shawarar ruwa mai gudana saboda ɗakunan ruwa na iya gurɓata, yayin da zafin ruwan ba ze yin wani bambanci ba.
Lather hannaye ta hanyar shafa su da yawan sabulu, gami da bayan hannu, tsakanin yatsun hannu, da kuma karkashin kusoshi.
Sabulu yana cire kwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna wanke hannayensu sosai idan aka yi amfani da sabulu maimakon ruwa kawai.
Ka wanke aƙalla na tsawon dakika 20.
Gogewa yana haifar da gogayya, wanda ke taimakawa cire ƙwayoyin cuta daga fata, kuma gogewa na tsawon lokaci yana cire ƙarin ƙwayoyin cuta.
A wanke da kyau a ƙarƙashin ruwa mai gudu.
Rashin wankewa a cikin kwano na iya sake gurɓata hannuwan.
Ka bushe da tawul mai tsabta ko kuma ka bar iska ta bushe.
Hannun da ke da danshi da kuma danshi suna da saukin sake kamuwa da cutar. Yankunan da aka fi yawan mantawa da su sune babban yatsan yatsa, wuyan hannu, yankunan tsakanin yatsun hannu, da kuma karkashin yatsun hannu.
Ƙusa na wucin gadi da kuma ƙusa mai ƙwanƙwasawa na iya ɗauke da ƙwayoyin cuta.
Ana ba da shawarar moisturizing lotion sau da yawa don kiyaye hannayen daga bushewa; busassun fata na iya haifar da lalacewar fata wanda zai iya ƙara haɗarin watsa kamuwa da cuta.
Za a iya yin zaɓuɓɓuka masu ƙarancin farashi don sauƙaƙe wanke hannu inda ba a samun ruwan famfo da/ko sabulu ba misali zuba ruwa daga jerrycan mai rataye ko gourd tare da ramuka masu dacewa da/ko amfani da toka idan an buƙata a cikin ƙasashe masu tasowa. A cikin yanayi tare da iyakance wadataccen ruwa (kamar makarantu ko yankunan karkara a cikin ƙasashe masu tasowa), akwai hanyoyin adana ruwa, kamar "" tippy-taps "" da sauran zaɓuɓɓukan masu ƙarancin farashi. "
Tippy-tap fasaha ce mai sauƙi ta amfani da jug da aka dakatar da igiya, da kuma sandar da ke aiki da ƙafa don zuba ruwa kaɗan a kan hannuwan da sabulu.
Dryingingarfafa hannu mai inganci yana da mahimmanci na aikin tsabtace hannu, amma akwai wasu muhawara game da ingantaccen nau'in bushewa a cikin gidajen wanka na jama'a.
Ƙarin bincike da ake yi ya nuna cewa tawul ɗin takarda sun fi na'urar bushe hannu da ake samu a gidajen wanka.
A cikin 2008, an gudanar da bincike ta Jami'ar Westminster, London, kuma masana'antar takarda-twalle ta tallafawa taron Tissue Symposium na Turai, don kwatanta matakan tsabtace da aka bayar ta tawul na takarda, bushewar hannu mai iska mai zafi da kuma na'urorin bushewa na hannu na zamani.
Bayan wankewa da bushe hannaye da na'urar bushewa mai zafi, an gano cewa yawan adadin kwayoyin cuta ya karu a matsakaita akan yatsun hannu da kashi 194% da kuma a kan dabino da 254%.
Yin bushewa tare da jet-air dryer ya haifar da ƙaruwa a matsakaici na yawan adadin ƙwayoyin cuta a kan yatsun yatsunsu da kashi 42% da kuma a kan dabino da kashi 15%.
Bayan wankewa da bushewa da tawul na takarda, an rage yawan kwayoyin cuta a matsakaicin yatsunsu da kashi 76% da kuma na hannu da kashi 77%. Masana kimiyya sun kuma yi gwaje-gwaje don tabbatar da ko akwai yiwuwar gurbatawa na sauran masu amfani da gidan wanka da kuma yanayin gidan wanka sakamakon kowane irin bushewa.
Jirgin iska mai bushewa, wanda ke busa iska daga na'urar a saurin 180 m / s (650 km / h; 400 mph), yana da ikon busa ƙwayoyin cuta daga hannaye da na'urar kuma yana iya gurɓata sauran masu amfani da gidan wanka da kuma yanayin gidan wanka har zuwa mita 2.
Yin amfani da na'urar bushe hannu mai zafi yana yada kwayoyin micro-organisms har zuwa mita 0.25 daga na'urar bushewa.
Takaddun takarda ba su nuna yaduwar kwayoyin cuta ba. A cikin 2005, a cikin binciken da TÜV Produkt und Umwelt ya gudanar, an kimanta hanyoyin bushewar hannu daban-daban.
An lura da canje-canje masu zuwa a cikin ƙididdigar ƙwayoyin cuta bayan bushewar hannayen:
Akwai masana'antun masu bushe-bushe da yawa, kuma an kwatanta busassun hannu da bushewa da tawul na takarda.
Wanke hannu ta amfani da kayan wanke hannu na wanke hannu wani zaɓi ne yayin tafiya a cikin rashin sabulu da ruwa.
Mai tsabtace hannu na barasa ya kamata ya ƙunshi aƙalla kashi 60% na barasa.
Wanke hannu na likita ya zama tilas bayan likitan Hungary Ignaz Semmelweis ya gano tasirinsa (a 1846) don hana cutar a cikin yanayin asibiti.
Akwai na'urorin lantarki da ke ba da amsa don tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa an rage yawan kamuwa da cuta da amfani da su.
Wanke hannu na likita yana da aƙalla na daƙiƙa 15, ta amfani da sabulu da ruwa mai yawa ko gel don kumfa da kuma shafa kowane ɓangaren hannayen.
Ya kamata a shafa hannayen tare da yatsun hannu.
Idan akwai tarkace a ƙarƙashin ƙusa, za a iya amfani da goga mai gashi don cire shi.
Tunda ƙwayoyin cuta na iya kasancewa a cikin ruwa a hannuwan, yana da mahimmanci a wanke sosai kuma a goge su da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da tawul din takarda don kashe ruwan (kuma a bude kofar fita idan ya cancanta).
Wannan yana kauce wa sake gurɓata hannayen daga waɗancan saman.
" Manufar wanke hannu a cikin tsarin kula da lafiya shine cire ƙwayoyin cuta ("" ƙwayoyin cuta ") da kuma guje wa watsa su. "
The New England Journal of Medicine ta ba da rahoton cewa rashin wanke hannu ya kasance a matakan da ba za a yarda da su ba a yawancin wuraren kiwon lafiya, tare da yawancin likitoci da ma'aikatan jinya da ke manta da wanke hannayensu kafin su taɓa marasa lafiya, ta haka suna watsa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kyau da sauran hanyoyin sauki na iya rage yawan kamuwa da cututtukan da ke da nasaba da catheter da kashi 66 cikin dari.Kungiyar Lafiya ta Duniya ta wallafa wata takarda da ke nuna yadda ake wanke hannu da kuma shafa hannu a bangaren kiwon lafiya.
Ana kuma iya samun daftarin jagorar tsabtace hannu ta kungiyar a shafinta na yanar gizo don jama'a su yi tsokaci.
Wani bita mai dacewa da Whitby et al.
Na'urorin kasuwanci na iya auna da kuma tabbatar da tsabtace hannu, idan ana buƙatar nuna bin ƙa'idodi.
"Kungiyar Lafiya ta Duniya tana da "Lokaci Biyar" don wanke hannu: "
bayan an yi mu'amala da jini/ruwa na jiki
kafin aikin aseptic, da
" bayan kula da mai haƙuri. Ƙarin sunadarai masu kashe ƙwayoyin cuta zuwa sabulu ("" magani "ko sabulu "" anti-microbial ") yana ba da aikin kashewa ga wakilin wanke hannu. "
Irin wannan kashewa na iya zama da sha'awa kafin yin tiyata ko a wuraren da kwayoyin da ke da juriya ga maganin rigakafi suka yi yawa. Don 'yanke' hannayen mutum don aikin tiyata, ya zama dole a sami bututun da za a iya kunnawa da kashewa ba tare da taɓa shi da hannuwan ba, wasu chlorhexidine ko iodine wanke, tawul mai tsafta don bushe hannu bayan wanka, da goga mai tsafta don gogewa da wani kayan aiki mai tsafta don tsaftace ƙarƙashin yatsun hannu.
Duk kayan ado ya kamata a cire.
Wannan aikin yana buƙatar wanke hannaye da hannayen riga har zuwa gwiwoyi, yawanci 26 minti.
Ba a buƙatar tsawan tsawan lokaci (10 mintuna) ba.
Lokacin wankewa, dole ne a hana ruwan da ke kan hannu daga guduwa zuwa hannaye.
Bayan an gama wanke hannu, sai a bushe hannuwan da rigar da ba ta da kwaya kuma a sa rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, zai fi kyau a wanke hannu ko kuma a yi amfani da maganin kashe ƙwayoyin cuta kafin a kula da mutum da yake rashin lafiya da kuma bayan an gama kula da shi.
Don kula da cututtukan staphylococcal a asibitoci, an gano cewa mafi girman fa'ida daga tsabtace hannu ya zo ne daga kashi 20% na farko na wankewa, kuma cewa an sami ƙarin fa'ida kaɗan lokacin da aka ƙara yawan tsabtace hannu sama da 35%.
Wankewa da sabulu mai sauƙi yana haifar da fiye da sau uku na ƙimar cututtukan ƙwayoyin cuta da ke yaɗuwa zuwa abinci idan aka kwatanta da wankewa da sabulu mai hana ƙwayoyin cuta. Kwatanta shafa hannu da maganin barasa tare da wanke hannu da sabulun antibacterial na matsakaicin lokaci na 30 seconds kowannensu ya nuna cewa shafa hannu da barasa ya rage gurɓatar kwayoyin cuta 26% fiye da sabulun antibacterial.
Amma sabulu da ruwa sun fi tasiri fiye da shafa hannu da giya don rage ƙwayar cutar H1N1 da ƙwayar Clostridium difficile daga hannaye. Tsakanin don inganta tsabtace hannu a cikin wuraren kiwon lafiya na iya haɗawa da ilimantarwa ga ma'aikata kan wanke hannu, haɓaka wadatar shafa hannu da giya, da kuma rubuce-rubuce da ambaton magana ga ma'aikata.
Akwai bukatar ƙarin bincike a kan waɗanne daga cikin waɗannan ayyukan ne suka fi tasiri a cikin tsarin kiwon lafiya daban-daban.
A kasashe masu tasowa, wanke hannu da sabulu an gane shi a matsayin kayan aiki mai inganci, mai mahimmanci don samun lafiya mai kyau, har ma da abinci mai kyau.
Duk da haka, rashin amintaccen samar da ruwa, sabulu ko wuraren wanke hannu a gidajen mutane, a makarantu da kuma wuraren aiki na sanya shi kalubale don cimma halayen wanke hannu na duniya.
Misali, a mafi yawan yankunan karkara na Afirka, famfunan wanke hannu kusa da kowane gidan wanka mai zaman kansa ko na jama'a ba su da yawa, duk da cewa akwai zaɓuɓɓuka masu arha don gina tashoshin wanke hannu.
Koyaya, ƙarancin wanke hannu kuma na iya zama sakamakon halaye da aka yi wa ɗabi'a maimakon saboda rashin sabulu ko ruwa.
Tallafawa da kuma bayar da shawarwari game da wanke hannu da sabulu na iya yin tasiri ga yanke shawara kan manufofi, da kara wayar da kai game da fa'idodin wanke hannu da kuma haifar da sauyin hali na dogon lokaci na jama'a.
Domin wannan ya yi aiki yadda ya kamata, ana bukatar sa ido da kimantawa.
" Binciken da aka yi kan bincike 70 ya gano cewa hanyoyin da al'umma ke bi suna da inganci wajen kara wanke hannu a kananan da manyan kasashen da ba su da kudi, yayin da kamfen din tallata zamantakewar al'umma ba su da inganci. Misali daya na inganta wanke hannu a makarantu shi ne " Hanyar Taurari Uku " ta UNICEF wadda ke karfafa makarantu su dauki matakai masu sauki, marasa tsada don tabbatar da cewa dalibai suna wanke hannayensu da sabulu, a tsakanin sauran bukatun kiwon lafiya. "
Lokacin da aka cimma ƙananan ƙa'idodi, makarantu na iya motsawa daga ɗaya zuwa ƙarshe taurari uku.
Gina tashoshin wanke hannu na iya zama wani bangare na kamfen din inganta wanke hannu da ake gudanarwa domin rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen din wayar da kai wanda ke kokarin cimma canjin hali. Sakamakon cutar coronavirus ta 2019-20, UNICEF ta inganta karɓar emoji na wanke hannu.
Kadan daga cikin binciken da aka yi sun yi la'akari da tasirin kudin wanke hannu a kasashe masu tasowa dangane da DALYs da aka kauce musu.
Koyaya, wani bita ya nuna cewa inganta wanke hannu da sabulu ya fi tasiri sosai fiye da sauran ruwa da ayyukan tsabtatawa.
" Muhimmancin wanke hannu ga lafiyar mutum  musamman ga mutanen da ke cikin mawuyacin hali kamar uwaye waɗanda suka haifa ko sojoji da suka ji rauni a asibitoci  an fara ganewa ne a tsakiyar karni na 19 da biyu masu gabatarwa na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ya yi aiki a Vienna, Austria da Florence Nightingale, Ingilishi ""wanda ya kafa jinya na zamani"". "
A lokacin yawancin mutane har yanzu suna gaskata cewa ƙazamar ƙanshi da ake kira miasmas ne ke jawo ƙwayoyin cuta.
A cikin shekarun 1980, barkewar cututtukan abinci da cututtukan da ke da alaƙa da kiwon lafiya sun jagoranci Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka don haɓaka haɓaka tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar kamuwa da cuta.
Cutar cutar mura a 2009 da cutar COVID-19 a 2020 sun haifar da ƙara wayar da kan jama'a a ƙasashe da yawa game da mahimmancin wanke hannu da sabulu don kare kansu daga irin waɗannan cututtukan ƙwayoyin cuta.
" Misali, an rataye allunan talla tare da ""daidaita hanyoyin wanke hannu"" kusa da wankin wanke hannu a cikin banɗaki na jama'a da kuma cikin banɗakin gine-ginen ofis da filayen jirgin sama a Jamus. "
" Maganar" wanke hannayen mutum daga wani abu, yana nufin bayyana rashin son mutum don ɗaukar alhakin abin ko raba haɗin kai a ciki. "
Ya samo asali ne daga sashin littafi mai tsarki a cikin Matta inda Pontius Bilatus ya wanke hannunsa na yanke shawarar giciye Yesu Kristi, amma ya zama magana tare da amfani da yawa a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta a ƙoƙarin wanke wani ƙazanta mai ban mamaki, wanda ke wakiltar lamirinta mai laifi game da laifukan da ta aikata kuma ta sa mijinta ya aikata.
An kuma gano cewa mutane, bayan sun tuna ko yin tunani game da ayyukan da ba na ɗabi'a ba, suna da ƙwarewa wajen wanke hannayensu fiye da sauran mutane, kuma suna ƙwarewa wajen ƙididdige kayan wanke hannu.
" Bugu da ƙari, waɗanda aka ba su damar wanke hannayensu bayan irin wannan tunani ba su da wataƙila su shiga cikin wasu ayyukan "tsabtace" masu biyan kuɗi, kamar aikin sa kai. "
Addinai suna ba da umarnin wanke hannu don dalilai na tsabta da alamomi. Wanke hannu na alama, ta amfani da ruwa amma ba sabulu don wanke hannu, wani ɓangare ne na wanke hannu na al'ada da aka nuna a cikin addinai da yawa, gami da Baha'i Faith, Hindu, tevilah da netilat yadayim a cikin Yahudanci, Lavabo a cikin Kiristanci, da Wudhu a Islama. Addinai kuma suna ba da umarnin wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Islama sun ba da umarnin wanke hannu bayan amfani da bayan gida.
Kuma, Hindu, Buddha, Sikhism, Yahudanci da Islama sun ba da umarnin wanke hannu kafin da bayan kowane cin abinci.
Kula da haɗarin COVID-19 a wuraren aiki
Kula da haɗarin aiki don COVID-19 shine aikace-aikacen hanyoyin tsaro da kiwon lafiya na aiki don kula da haɗari don rigakafin cutar coronavirus 2019 (COVID-19).
Hanyoyin sarrafa haɗari da suka dace a wuraren aiki sun dogara ne da wurin aiki da aikin aiki, bisa ga kimanta haɗarin tushen haɗari, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin ma'aikata na mutum waɗanda za su iya zama masu saurin kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙarancin hulɗa na aiki tare da jama'a da sauran abokan aiki, wanda aka ba da shawarar matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan sun yi rashin lafiya, ladabi na numfashi, da kuma kiyaye tsaftacewa da tsabtace yanayin aiki.
Matsakaicin haɗarin haɗarin haɗari ya haɗa da waɗanda ke buƙatar tuntuɓar mutane sau da yawa ko kusanci da mutanen da ba a san ko ake zargi da COVID-19 ba, amma ana iya kamuwa da cutar saboda yaduwar al'umma mai gudana ko balaguron ƙasa da ƙasa.
Wannan ya hada da ma'aikata da suke da hulɗa da jama'a kamar a makarantu, wuraren aiki da yawan jama'a, da kuma wasu wuraren sayar da kayayyaki masu yawa.
Kula da haɗari ga wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da yin iska ta amfani da matattarar iska mai ƙwarewa, masu tsaron ƙyallen ƙyal, da kuma samun kayan kariya na mutum idan aka sami mutumin da ke da COVID-19.
OSHA tana ɗaukar ma'aikatan kiwon lafiya da masu jana'iza waɗanda aka fallasa su ga sanannen ko wanda ake zargi da COVID-19 a matsayin masu haɗarin haɗarin haɗari, wanda ke ƙaruwa zuwa haɗarin haɗari mai yawa idan ma'aikatan suna yin hanyoyin samar da aerosol, ko tattara ko sarrafa samfurori daga, sanannen ko wanda ake zargi da COVID-19.
Kula da haɗari da suka dace da waɗannan ma'aikata sun haɗa da sarrafa injiniyoyi kamar ɗakunan iska mai ɗorewa mara kyau, da kayan kariya na mutum wanda ya dace da aikin aikin.
Cutar COVID-19 na iya samun tasiri da yawa a cikin wuraren aiki.
Ma'aikata na iya yin rashin aiki saboda rashin lafiya, bukatar kula da wasu, ko kuma tsoron yiwuwar kamuwa da cutar.
Hanyoyin kasuwanci na iya canzawa, dangane da irin kayan da ake buƙata, da kuma hanyoyin samun waɗannan kayayyaki (kamar sayayya a cikin sa'o'in da ba su da yawa ko ta hanyar isar da sako ko sabis na tuki).
A ƙarshe, za a iya katse jigilar kayayyaki daga yankunan da COVID-19 ya shafa sosai. Za a iya amfani da shiri da shirin magance cututtukan cututtukan cututtuka don jagorantar ayyukan kariya.
Shirin ya shafi matakan haɗarin da ke tattare da wurare daban-daban na aiki da kuma ayyukan aiki, ciki har da tushen haɗari, abubuwan haɗari da ke fitowa daga gida da kuma yanayin al'umma, da kuma abubuwan haɗarin ma'aikata daban-daban kamar tsufa ko yanayin rashin lafiya na yau da kullum.
Sun kuma bayyana hanyoyin da za a bi don magance wadannan haɗarin, da kuma tsare-tsaren da za a yi don magance matsalolin da za su iya tasowa sakamakon barkewar cutar.
Shirye-shiryen shirye-shiryen cututtuka da shirye-shiryen amsawa na iya zama batun shawarwarin ƙasa ko ƙasa.
Manufofin mayar da martani ga barkewar cutar sun hada da rage yaduwar cutar a tsakanin ma'aikata, kare mutanen da ke da hadarin kamuwa da cututtukan rashin lafiya, ci gaba da ayyukan kasuwanci, da rage illa ga sauran bangarorin a cikin sarkar samar da su.
Matsayin cutar a cikin al'umma inda kasuwancin yake yana tasiri da amsoshin da aka ɗauka.
Tsarin kula da haɗari shine tsarin da aka yi amfani da shi a cikin aminci da kiwon lafiya don rukuni na kula da haɗari ta hanyar tasiri.
Inda ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa sune sarrafa injiniya, sannan sarrafawa, da kayan kare kai na ƙarshe.
Gudanar da aikin injiniya ya haɗa da keɓe ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da halayen ma'aikaci ba, kuma yana iya zama mafi ingancin farashi don aiwatarwa.
Gudanar da gudanarwa shine canje-canje a cikin manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya na mutum (PPE) ana ɗaukarsa ƙasa da inganci fiye da injiniya da sarrafawa na gudanarwa, amma zai iya taimakawa hana wasu fallasawa.
Duk nau'ikan PPE dole ne a zaɓa bisa ga haɗarin da ke tattare da ma'aikaci, a saka su yadda ya dace kamar yadda ya dace (misali, masu ba da numfashi), a saka su a kai a kai da kuma yadda ya kamata, a duba su a kai a kai, a kula da su, a sauya su, kamar yadda ya cancanta, a cire su, a tsabtace su, a adana su ko a zubar da su yadda ya kamata don guje wa gurɓatawa.
Bisa ga Hukumar Kula da Lafiya da Lafiya ta Amurka (OSHA), ayyuka da ke da ƙananan haɗarin haɗari suna da ƙarancin hulɗa na aiki tare da jama'a da sauran abokan aiki.
Abubuwan da ake bukata na rigakafin kamuwa da cuta a duk wuraren aiki sun haɗa da wanke hannu sau da yawa da kyau, ƙarfafa ma'aikata su zauna a gida idan ba su da lafiya, halayen numfashi ciki har da rufe tari da tari, samar da kayan aiki da kwandon shara, shirya don yin nesa ko sauye-sauye idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aikin wasu, da kuma kiyaye tsaftacewa da kashe ƙwayoyin cuta na yanayin aiki.
Ganowa da ware mutanen da ke da cutar nan da nan mataki ne mai mahimmanci wajen kare ma'aikata, kwastomomi, baƙi, da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun ba da shawarar cewa ma'aikatan da ke da alamun cututtukan cututtukan numfashi na numfashi su kasance a gida har sai sun sami zazzabi, alamun zazzabi, da duk wasu alamun aƙalla awanni 24 ba tare da amfani da rage zazzabi ko wasu magungunan da ke canza alamun ba, kuma cewa manufofin hutun rashin lafiya suna da sassauci, suna ba ma'aikata damar kasancewa a gida don kula da wani dangin da ke rashin lafiya, kuma ma'aikata sun san waɗannan manufofin.
A cewar OSHA, ayyukan haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar saduwa akai-akai ko kusa a cikin ƙafa shida (1.8 m) na mutanen da ba a san su ba ko waɗanda ake zargi da COVID-19 marasa lafiya, amma suna iya kamuwa da SARS-CoV-2 saboda ci gaba da watsawar al'umma a kusa da wurin kasuwancin, ko kuma saboda mutum yana da balaguron ƙasa da ƙasa zuwa wuri tare da yaduwar COVID-19.
Waɗannan sun haɗa da ma'aikatan da ke hulɗa da jama'a kamar a makarantu, yanayin aiki mai yawan jama'a, da wasu saitunan sayar da kayayyaki masu yawa. Kula da injiniya don wannan da manyan rukunin haɗari sun haɗa da shigar da matattarar iska mai inganci, haɓaka ƙimar iska, shigar da shingen jiki kamar masu kare filastik mai tsabta, da shigar da taga mai tuki don sabis na abokin ciniki. Kulawa na gudanarwa don wannan da manyan rukunin haɗari sun haɗa da ƙarfafa ma'aikatan da ke rashin lafiya su zauna a gida, maye gurbin ganawar fuska da fuska tare da sadarwa ta kama-da-wane, kafa sauye-sauye, dakatar da rashin mahimmanci ga wuraren da ke faruwa da COVID-19, haɓaka tsare-tsaren sadarwa na gaggawa ciki har da dandamali don amsa damuwar ma'aikata, samar da ingantaccen ilimi da horo kan COVID-19 da halaye masu haɗari, samar da ma'aikata waɗanda ke buƙatar inganta kayan aiki da kayan aiki don amfani da COVID-19 da kuma haɗarin mutum na yau da kullun, ƙuntata tsaftawar mutum, wanke hannu da matsakai, haɗuwa da wasu matakan kariya na jama'a da na'a, gami, gami da haɗuwa da abokan ciniki, gogewa, haɗuwa da fuska da hannu da kuma wasu kayan aikin kariya na kariya na kariya, gami da ke buƙatar yin amfani da goge-goge na fuska, wanke da na'a, gogewar hannu da matsakai, da sauran kayan kariya na kariya, haɗuwa da kuma haɗarin fuska da kewa na abokan ciniki a kan aiki, tare da haɗarin fuska da na jama'a.
Ma'aikata a cikin wannan rukunin haɗari ba safai suke buƙatar amfani da kayan aikin numfashi.
Idan mutum ya kamu da rashin lafiya a cikin jirgin sama, ingantattun matakan kariya don kare ma'aikata da sauran fasinjoji sun haɗa da raba mai rashin lafiya daga wasu ta hanyar nisan ƙafa 6, sanya wani ma'aikaci don yi wa mai rashin lafiya hidima, da kuma ba da abin rufe fuska ga mai rashin lafiya ko kuma neman mai rashin lafiya ya rufe bakinsa da hanci da kayan shafawa lokacin da yake tari ko yin atishawa.
Ma'aikatan jirgin ya kamata su sa safofin hannu na likita da za a iya amfani da su lokacin da suke kula da matafiyi mara lafiya ko kuma taɓa ruwan jiki ko kuma gurɓataccen farfajiyar, kuma wataƙila ƙarin kayan kariya na mutum idan matafiyin mara lafiya yana da zazzabi, tari mai ɗorewa, ko wahalar numfashi.
Ya kamata a jefar da safar hannu da sauran abubuwan da ake amfani da su a cikin jakar haɗarin ƙwayoyin cuta, kuma ya kamata a tsabtace kuma a kashe gurɓataccen farfajiyar bayan haka. Don jiragen ruwa na kasuwanci, gami da jiragen ruwa masu jigilar fasinjoji da sauran jiragen ruwa, sarrafa haɗarin ya haɗa da jinkirta tafiya lokacin da ba shi da lafiya, da keɓe kai da kuma sanar da cibiyar kiwon lafiya ta jirgin nan da nan idan mutum ya kamu da zazzabi ko wasu alamomi yayin da ke cikin jirgin.
Da kyau, bin likita ya kamata ya faru a cikin gidan da aka ware. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kashe ƙwayoyin cuta idan wanda ke da cutar ya kasance a cikin ginin makaranta ba tare da la'akari da yaduwar al'umma ba.
Lokacin da akwai ƙarancin watsawa na al'umma, za a iya aiwatar da dabarun nisantar zamantakewar jama'a kamar soke tafiye-tafiye, tarurruka, da sauran manyan tarurruka kamar ilimin motsa jiki ko azuzuwan mawaƙa ko abinci a cikin gidan abinci, ƙara tazara tsakanin tebur, saurin zuwa da sallamawa, iyakance baƙi marasa mahimmanci, da amfani da keɓaɓɓen ofishin kiwon lafiya ga yara masu alamun mura.
Lokacin da akwai babban watsawa a cikin al'umma, ban da dabarun nisantar da jama'a, za a iya yin la'akari da tsawaita korar makaranta. Ga jami'an tilasta bin doka da ke gudanar da ayyukan yau da kullun, CDC tana ganin haɗarin lafiya na nan da nan ya yi kadan.
An ba da shawarar jami'an tilasta bin doka waɗanda dole ne su tuntuɓi mutane da aka tabbatar ko ake zargi suna da COVID-19 su bi ƙa'idodi iri ɗaya kamar masu fasahar likita na gaggawa, gami da kayan kariya na sirri na sirri.
Idan kusanci ya faru yayin kamawa, ma'aikata ya kamata su tsabtace da kuma disinfect belinsu da kayan aiki kafin sake amfani da su ta amfani da tsabtace tsabtace gida ko gogewa, kuma su bi ka'idodin aiki na yau da kullun don tsarewa da zubar da PPE da aka yi amfani da shi da kuma riƙewa da wanke tufafi.
OSHA tana ɗaukar wasu ma'aikatan kiwon lafiya da masu yin jana'izar a cikin manyan ko manyan nau'ikan haɗarin haɗari.
Ayyukan haɗarin haɗari sun haɗa da isar da kiwon lafiya, tallafi, dakin gwaje-gwaje, da ma'aikatan jigilar likita waɗanda ke fuskantar sanannun ko waɗanda ake zargi da cutar COVID-19.
Waɗannan sun zama haɗarin haɗari sosai idan ma'aikata suna yin ayyukan samar da aerosol, ko tattarawa ko sarrafa samfurori daga, da aka sani ko waɗanda ake zargi da cutar COVID-19.
Hanyoyin samar da aerosol sun hada da intubation, hanyoyin haifar da tari, bronchoscopy, wasu hanyoyin hakori da bincike, ko tarin samfurin mamayewa.
Ayyukan gawawwaki masu haɗari sun haɗa da ma'aikatan da ke shirya gawawwakin mutanen da aka sani ko ake zarginsu da COVID-19 a lokacin mutuwarsu; waɗannan sun zama haɗarin haɗarin haɗari sosai idan suka yi bincike. Ƙarin sarrafa injiniya na waɗannan rukunin haɗari sun haɗa da ɗakunan keɓewa ga marasa lafiya da aka sani ko ake zargi da COVID-19, gami da lokacin da ake aiwatar da hanyoyin samar da aerosol.
Musamman na musamman na iska mai ƙarancin ƙarfi na iya zama dacewa a wasu wuraren kiwon lafiya da wuraren jana'iza.
Ya kamata a sarrafa samfuran tare da matakan kariya na Biosafety Level 3.
Kungiyar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a raba marasa lafiya masu shigowa zuwa yankuna daban daban na jiran su dangane da ko suna da wata shari'ar COVID-19 da ake zargi. Baya ga sauran PPE, OSHA ta ba da shawarar kayan numfashi ga waɗanda ke aiki a cikin ƙafa 6 na marasa lafiya da aka sani, ko ake zargi da kamuwa da SARS-CoV-2, da waɗanda ke yin hanyoyin samar da aerosol.
a Amurka, NIOSH-an amince da N95 tacewa fuska respirators ko mafi kyau dole ne a yi amfani da shi a cikin mahallin na da cikakken, rubutaccen tsarin kare numfashi wanda ya hada da fit-gwaji, horo, da kuma likita jarrabawa.
Sauran nau'ikan na'urar numfashi na iya ba da kariya mafi girma da inganta jin daɗin ma'aikaci. WHO ba ta ba da shawarar suturar rigar jiki, saboda COVID-19 cuta ce ta numfashi maimakon a watsa ta ta ruwan jiki.
WHO ta ba da shawarar kawai abin rufe fuska na tiyata ga ma'aikatan binciken a wuraren shiga.
Ga waɗanda suke tattara samfuran numfashi daga, kula da, ko jigilar marasa lafiya na COVID-19 ba tare da wani tsari na samar da aerosol ba, WHO ta ba da shawarar abin rufe fuska na tiyata, tabarau, ko abin rufe fuska, riga, da safar hannu.
Idan an yi aikin samar da aerosol, ana maye gurbin abin rufe fuska da N95 ko FFP2 na numfashi.
Ganin cewa wadatar PPE ta duniya ba ta isa ba, WHO ta ba da shawarar rage buƙata na PPE ta hanyar maganin nesa, shingen jiki kamar windows, ba da izinin waɗanda ke da hannu a cikin kulawa kai tsaye su shiga cikin ɗaki tare da mai cutar COVID-19, ta amfani da PPE kawai da ake buƙata don takamaiman aikin, ci gaba da amfani da na'urar numfashi ɗaya ba tare da cire ta ba yayin kula da marasa lafiya da yawa da ke da cutar iri ɗaya, sa ido da daidaita sarkar samar da PPE, da kuma hana amfani da abin rufe fuska ga mutane marasa alamun cutar.
Daga: Katherine Maher, Wikimedia Foundation Shugaba
Zuwa: Duk ma'aikatan Gidauniyar Wikimedia
LAYYA: [Covid-19] Sauƙaƙa nauyi da shirya don nan gaba
SEND DATE/TIME: 14 Maris, 2020, 00:24 UTC (Kwanan duniya)
CC0: Babu haƙƙin haƙƙin mallaka
Mun sami kanmu a cikin yanayi na musamman wannan watan.
Cutar COVID-19 wani abu ne da ke nuna alakarmu ta duniya da kuma nauyin da muke da shi ga juna.
Ba mu da abin da ya faru da irin wannan kalubale, amma mun san cewa mafi kyawun amsawarmu ta dogara ne da irin tausayin duniya, haɗin kai, da gina al'umma wanda ke zama a zuciyar wannan kungiya.
Abun da muke gani a tsakanin abokan aikinmu ta hanyar imel, kira, da tattaunawa na yanar gizo, ya tabbatar da irin mutanen da muke farin cikin yin aiki da su.
Ina matukar godiya da alfahari da ku duka a matsayin abokan aiki.
A makon da ya gabata, wani ya nuna min godiyarsa ga aikinmu.
Sun tunatar da ni yadda yake da ma'ana ga duniya ta iya juyawa zuwa Wikipedia a yanzu, kuma abin da alama ce mai ƙarfi don wannan muhimmiyar hanya ta kasance a kan layi kuma ta kasance ga kowa.
Aikinku ya sa wannan ya yiwu, ko kuna ci gaba da shafukan yanar gizo ko abokan aikinmu sun biya ko kuma al'ummominmu sun sami tsaro.
Duniya tana bukatar bayanin da Wikipedia ke bayarwa, yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aikin da kuma rawar da kuke takawa a ciki, za mu yi wasu gyare-gyare masu muhimmanci ga yadda muke aiki tare, farawa daga wannan makon mai zuwa.
Gyare-gyare ga aikinmu da jadawalinmu
Kamar yadda Robyn ya ambata a baya, ƙungiyar C ta haɗu a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun yi la'akari da abin da muka yi tunanin zai zama amsa mai dacewa ga abin da muke fuskanta da kuma hanya mafi kyau don kiyaye ƙungiyar ta ci gaba a wannan lokacin.
Mafi yawanci muna son cire damuwa da tallafawa aikinmu na dogon lokaci.
Idan kana bukatar ka sake kira, babu matsala.
Ga dukan ma'aikata, kwangila, da kuma kwangila ma'aikata:
aikinmu na yau da kullum zai kasance kimanin sa'o'i 4 a rana, ko sa'o'i 20 a mako har sai wani sanarwa.
Ba mu ayyana hutu ba - idan kuna iya aiki a lokutan al'ada, ofishin na iya amfani da ku.
Duk da haka, duniya ba ta da tabbas a yanzu, kuma ko kana bukatar kula da ƙaunatattunka, sayen kayan abinci, ko zuwa likita, lafiyarka ita ce fifiko.
Ba mu bin sawun lokacinku.
Idan kun yi rashin lafiya, kada ku yi aiki.
Wannan ya kamata ya tafi ba tare da cewa, amma muna ce da shi.
Babu kwanakin rashin lafiya ko PTO da ake buƙata - kawai ka gaya wa manajan ka kuma taimaka wa ƙungiyar ka sake duba kalandar da jadawalin don tabbatar da mahimman wuraren aiki an rufe su.
(Idan an gano ku da COVID-19, don Allah ku sanar da Bryan a cikin T&amp;C Ops don haka T&amp;C na iya taimakawa da tallafi kuma ku tabbatar da yanayinku ya sami kulawar da ta dace daga gudanarwa).
Za a biya ma'aikatan sa'a cikakke.
Mun riga mun fada, kuma muna sake yin alkawarin cika alkawuran da muka dauka ga 'yan kwangila da kuma ma'aikatanmu na sa'a.
Kowa za a biya shi bisa yawan sa'o'in da ya yi aiki a cikin al'amuran yau da kullum.
Wannan ya haɗa da idan ba ka da lafiya kuma ba za ka iya aiki ba.
Idan kana son yin aiki, za mu goyi bayan ka.
Mutane da yawa suna amfani da aiki a matsayin hanyar da za su kawar da alhininsu ga duniya da ke kewaye da mu.
Abin da muke yi zai iya zama da amfani sosai, musamman a lokutan da suka yi kama da wannan.
Kuma, wannan game da kula da kai ne.
Abin da muke so shi ne ku yi magana da manajan ku, saboda mu san abin da za mu yi tsammani kuma mu daidaita yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da dole ne mu ci gaba da yi.
SRE, HR Ops, Trust &amp; Safety, da kuma Fundraising teams (da sauransu) suna yin muhimmin aiki wanda zai iya buƙatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan don tantance manufofinmu na yanzu da kuma mayar da hankali ga goyon bayan abin da ke da muhimmanci ga aikinmu.
Akwai abubuwa da yawa da za a yi mana, za mu mayar da hankali kan ayyukan da suka fi muhimmanci.
Tsayawa yanzu ba zai cutar da ku ba daga baya.
Ba mu da shirin yin aiki sau biyu don kamawa da zarar annobar ta wuce.
Ba za a bukaci ka yi aiki na karin lokaci don ka cika lokacin da aka ba ka ba zai yiwu ba.
Mun yarda cewa yanayi ya canza, kuma za mu yi aiki don kafa sababbin manufofi da lokutan lokaci inda ya dace.
Menene ya faru da APP (Annual Planning)?
Don daidaitawa da sabon gaskiyarmu da tsammanin sa'o'in aiki na yau da kullun, muna da niyyar daidaita lokacin isar da shirinmu na shekara-shekara na 2020-2021.
Nufinmu shi ne mu ba da shawarar tsawaita shirinmu na 2019-2020 wanda ya ba da ƙarin lokaci don tsara kasafin kuɗi don ba wa ma'aikata damar fifita mahimman ayyuka, kulawa da kansu, da kula da ƙaunatattun su yayin da suke ɗaukar waɗanda suke buƙata ko suke son yin aiki da jadawalin da aka rage a cikin makonni masu zuwa.
Wannan tsawaita lokacin yana rage yawan aikin tsarawa na yanzu da matsin lamba a duk fadin kungiyar.
Za mu gabatar da kudirinmu ga Hukumar a mako mai zuwa kuma za mu sabunta wakilai da kungiyoyi kan matakai na gaba da zaran mun samu tabbaci.
Na gode wa tawagar APP saboda jagorancinku a wannan.
Matsayin ofishi, fallasa, da tsaftacewa
A makon da ya gabata, mun sami labarin cewa wataƙila ɗaya daga cikin abokan aikinmu da ke SF ya kamu da kwayar COVID-19.
Duk da haka, daga yawan taka tsantsan, mun yi amfani da ƙungiyar tsabtace kwayar cutar don kashe dukkan abubuwa a ofishin San Francisco.
Sun yi amfani da maganin rigakafin cutar da aka yi amfani da shi a asibiti don kashe dukkan abubuwa, har da dakunan shiga da kuma bankunan hawa da ke shiga gidanmu.
Ginin yana amfani da tsarin kula da aikinsa ta hanyar amfani da kayayyakin da ke tallafawa lafiyar masu haya.
Muna jin dadi cewa ofishin zai kasance a shirye sosai lokacin da muka yanke shawarar dawowa.
Ofishinmu na DC yana cikin WeWork, wanda ya raba tsarin COVID-19 tare da mu da duk ma'aikatan DC.
Tun daga makon da ya gabata, ofishinmu na DC ya koma wani wuri mai nisa daidai da jagorancin da aka raba tare da San Francisco.
Kamar yadda wasu daga cikin abokan aikinmu da ke NYC suka sani, mun kuma tattauna batun hayar wani wuri a Brooklyn.
Waɗannan tattaunawar suna ci gaba amma ana iya jinkirta su.
Wasu abokan aikinmu suna aiki ne daga nesa a karon farko.
Abokanmu na nesa na dogon lokaci sun san cewa zai iya zama daidaitawa, kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon lokacin tarurruka zuwa sa'a daya ko biyu a lokaci guda.
Idan ana bukatar karin lokaci, ka yi la'akari da yadda za a iya raba shi cikin kwanaki da yawa.
Ka bayyana taro sosai, ka tsara abin da za a tattauna, kuma ka aika da abin da za a karanta tun da wuri.
Ka sa bidiyo ta zama tsohuwa, tare da kayan aiki kamar Google Docs da Zoom don sauƙaƙa haɗin kai kai tsaye da haɗi.
Ka sami jagora don sauƙaƙe kowane taro, wani don kula da hira don tambayoyi da kuma bin jerin masu magana, da kuma wani don taimakawa wajen yin rubutu (ko yin haɗin gwiwa na rubutu).
Aika da email zuwa goyon bayan fasaha idan kana bukatar wani dadi lasifikan kai.
Yi amfani da kuɗin kuɗin lafiyar ku don cin abinci.
Shiga cikin #remoties channel a Slack don tattaunawa da abokan aikinka game da aikin da aka rarraba
Ƙungiyar HR Operations tana neman jagorancin ergonomics na yanar gizo don tallafawa karuwar aikin da aka rarraba a fadin Foundation.
A wannan makon da ya gabata mun nemi duk masu karɓar tallafin al'umma su soke taron jama'a da Wikimedia ta ba da kuɗi, kamar su editathons, har sai WHO ta ayyana cewa cutar ta ƙare.
Mun sanar da su cewa mun fahimci cewa buƙatarmu don sokewa da sauran ƙuntatawa na iya sa ya zama ba zai yiwu a kammala ayyukan ba da tallafi da aka amince da su ba kuma ba za a hukunta kowa ba saboda jinkirta ko canza waɗannan burin.
A wannan makon mai zuwa za mu ci gaba da ƙarin jagora kan Wikimania da sauran taron yanki da na al'umma.
Babban jin daɗin daga duk faɗin al'ummomin duniya kamar duka baƙin ciki ne a cikin rikicewar amma jin daɗi a cikin tsabta da ikon mai da hankali kan al'ummomin su, Wikimedia da sauransu.
A gaba, CRT na aiki don kafa shafi a kan Meta-Wiki don samar da sarari ga al'umma don sa ido kan tasirin da kuma bin hanyoyin sadarwa da su.
Kasancewa a cikin hulɗa game da al'amuran da suka shafi COVID-19
Za mu aika da gayyata zuwa kalandarku don ranar Alhamis mai zuwa, 14:00 UTC / 07:00 PT don taron ma'aikata na musamman.
Za mu yi amfani da wannan lokacin don raba ƙarin sabuntawa, amsa tambayoyinku kuma mu ɗan ɗan ɗan lokaci tare da juna.
Muna cikin wannan tare kuma a nan don taimakawa duk yadda za mu iya.
A halin yanzu, za ku iya ci gaba da samun bayanai daga wannan imel ɗin, da duk sauran mahimman bayanai masu alaƙa da COVID-19, a kan Office Wiki.
CRT za ta ci gaba da sabunta waɗannan shafuka da kuma duk bayanan a wuri guda.
Muna kuma aiki don ci gaba da sadarwa na yau da kullum tare da ma'aikatan da ke zaune a ƙasashen da ke fama da cutar a yanzu.
Idan kana da wasu tambayoyi game da tafiya, abubuwan da suka faru, babban aikin aiki, ko ƙalubalen ɗaukar hoto, ko wani abu da za ka iya buƙatar taimako tare da, don Allah kada ka yi shakka don sanar da aiki tare da CRT.
Muna nan don taimakawa wajen samar da tallafi da kuma tuntuba kamar yadda ake bukata.
Idan kana da wani sirri ko m al'amari, don Allah email Bryan Judan - Darektan HR International Global Operations.
Ba za a ɗauki waɗannan canje-canje a matsayin watsi da aikinmu da kuma hakkokinmu ba.
Maimakon haka, sun kasance sanarwa cewa a wannan lokacin, aikinmu da wajibai za su buƙaci daidaitawa a hanyar da ba mu da shi a baya.
Waɗannan matakai ne da muka yi imanin cewa wajibi ne don tallafawa wannan juna don mu ci gaba da aiki, samar da motsinmu da goyon baya da suke buƙata, da kuma duniya da sabis ɗin da suka dogara da shi.
Aikin da muka shirya zai kasance a wurin yana jiranmu idan lokaci ya yi.
A yanzu, lokaci ne na tallafawa juna da samar da sarari don muhimmin aikin da zai zo a cikin makonni da watannin da ke gaba.
Muna bukatar ku duka don yin hakan, kuma don haka muna bukatar ku duka ku kula da kanku da iyalanku don ku kasance mafi kyau lokacin da bukatar ta taso.
Yanzu, don Allah - wanke hannuwanku kuma kada ku taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S), da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-converting enzyme 2 (ACE2) wani enzyme ne wanda aka haɗe da farfajiyar waje (cells membranes) na ƙwayoyin cuta a cikin huhu, jijiyoyin jini, zuciya, koda, da kuma hanji.
ACE2 yana magance aikin angiotensin-converting enzyme (ACE) ta hanyar rage adadin angiotensin-II da haɓaka Ang ((1-7) yana mai da shi wata manufa mai kyau ta magani don magance cututtukan zuciya. ACE2 kuma yana aiki a matsayin shigarwa cikin ƙwayoyin don wasu coronaviruses.
Ana kiran nau'in ɗan adam na enzyme sau da yawa azaman hACE2.
Angiotensin-converting enzyme 2 wani zinc ne mai dauke da metallol enzyme wanda yake a saman endothelial da sauran kwayoyin halitta.
Furotin ACE2 ya ƙunshi yankin peptidase M2 na N-terminal da kuma yankin C-terminal na mai ɗaukar amino acid mai ɗaukar koda.
ACE2 shine furotin membrane mai wucewa guda ɗaya, tare da yankin da ke da enzyme mai aiki wanda aka fallasa a saman ƙwayoyin cuta a cikin huhu da sauran ƙwayoyin.
An raba yankin da ke cikin ACE2 daga yankin transmembrane ta wani enzyme da ake kira sheddase, kuma ana fitar da furotin mai narkewa zuwa cikin jini kuma a ƙarshe an fitar dashi cikin fitsari.
ACE2 yana nan a cikin mafi yawan gabobin: ACE2 yana haɗe da membrane na ƙwayoyin cuta na ƙwayoyin alveolar na II, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta da ƙwayoyin ƙwayoyin cuta a cikin mafi yawan gabobin.
Ana kuma samun bayyanar ACE2 mRNA a cikin ƙwayar ƙwayar cuta, striatum, hypothalamus, da kuma kwakwalwar kwakwalwa.
Babban aikin ACE2 shine yin aiki a matsayin daidaitawa ga ACE.
ACE tana raba angiotensin I hormone zuwa cikin angiotensin II mai hana jijiyoyin jini.
ACE2 a bi da bi yana rarraba amino acid carboxyl-terminal phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana shayar da shi zuwa angiotensin (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma na iya raba wasu peptides da suka hada da [des-Arg9]-bradykinin, apelin, neurotensin, dynorphin A, da ghrelin.
ACE2 kuma yana daidaita jigilar membrane na mai jigilar amino acid mai tsaka-tsaki SLC6A19 kuma an haɗa shi da cutar Hartnup.
A matsayin furotin na transmembrane, ACE2 yana aiki a matsayin babban wurin shiga cikin ƙwayoyin cuta don wasu coronaviruses, gami da HCoV-NL63; SARS-CoV (kwayar cutar da ke haifar da SARS); da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da ƙwayoyin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 a farfajiyar ƙwayoyin yana haifar da endocytosis da sauyawar duka ƙwayoyin cuta da enzyme zuwa cikin endosomes da ke cikin ƙwayoyin.
Wannan shigarwar kuma tana buƙatar farawar furotin S ta mai karɓar serine protease TMPRSS2, wanda hanawa yana ƙarƙashin binciken yanzu a matsayin mai yiwuwa magani. Wannan ya sa wasu su yi zato cewa rage matakan ACE2, a cikin ƙwayoyin cuta, na iya taimakawa wajen yaƙi da kamuwa da cuta.
Koyaya, ƙungiyoyi masu sana'a da yawa da hukumomin kulawa sun ba da shawarar ci gaba da daidaitaccen maganin ACE da ARB.
"A systematic review and meta-analysis published on July 11, 2012, found that ""yin amfani da ACE inhibitors ya kasance yana da alaƙa da raguwar 34% cikin haɗarin ciwon huhu idan aka kwatanta da masu iko."""
"Bugu da ƙari, "" haɗarin ciwon huhu ya ragu a cikin marasa lafiya da aka yi wa maganin ACE waɗanda ke cikin haɗarin ciwon huhu, musamman waɗanda ke da bugun jini da gazawar zuciya. "
"Amfani da ACE inhibitors kuma an hade da ragewa a cikin cutar huhu da ke da alaƙa, kodayake sakamakon ba shi da ƙarfi fiye da haɗarin cutar huhu. "
Ana tsammanin ACE2 na mutum (rhACE2) sabon magani ne don cutar huhu mai tsanani, kuma ya bayyana don inganta hawan jini na huhu da kuma saturation na oxygen a cikin alade tare da ciwon ƙwayar cuta mai numfashi mai numfashi.
Rabin rabi na rhACE2 a cikin mutane kusan awa 10 ne kuma farkon aikin yana da mintuna 30 ban da tsawon lokacin aiki (tsawon lokaci) na awanni 24.
Abubuwa da dama sun nuna cewa rhACE2 na iya zama magani mai alfanu ga wadanda ke da rashin haƙuri ga masu hana tsarin renin-angiotensin na gargajiya (RAS inhibitors) ko kuma a cikin cututtukan da ke kewaya angiotensin II ya tashi. An kimanta rhACE2 a cikin gwaji na asibiti don maganin cututtukan cututtukan numfashi na numfashi.
"b'COVID-19 apps aikace-aikacen software ne na wayar hannu da aka tsara don taimakawa gano hanyoyin tuntuɓar don amsa cutar ta coronavirus ta 2019-20, watau tsarin gano mutane ("" abokan hulɗa ") waɗanda ƙila sun yi hulɗa da mutum mai kamuwa da cutar. "
An samar da aikace-aikace da yawa ko kuma an gabatar da su, tare da tallafin gwamnati a wasu yankuna da yankuna.
An samar da tsarin da dama don gina aikace-aikacen ganowa.
An gabatar da damuwar sirri, musamman game da tsarin da ke dogara da bin diddigin wurin da masu amfani da app suke.
Sauran hanyoyin da ba su da matsala sun haɗa da amfani da sigina na Bluetooth don yin rikodin kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu 2020, Google da Apple sun sanar da cewa za su haɗa aikin don tallafawa irin waɗannan ƙa'idodin tushen Bluetooth kai tsaye a cikin tsarin aikin Android da iOS.
A China, gwamnatin China, tare da Alipay, sun tura wata manhaja da ke ba 'yan kasa damar duba ko sun yi mu'amala da mutanen da ke dauke da COVID-19.
Ana amfani da shi a cikin birane na kasar Sin fiye da 200. A Singapore, ana amfani da wata manhaja da ake kira TraceTogether.
"An haɓaka app ɗin ta hanyar ƙungiyar IT ta gida, an sake shi a matsayin tushen buɗewa kuma za a miƙa shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da ""StopKorona! ", aikace-aikacen da ke amfani da Bluetooth don bin diddigin kamuwa da mutane masu cutar da kuma samar da saurin amsawa ga hukumomin kiwon lafiya. "
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka kirkiro manhajar.
Ya zuwa 14 ga Afrilu 2020, app ɗin yana jiran amincewa daga Google Play Store da Apple App Store.
"A 12 ga Afrilu, gwamnati ta bayyana cewa app na gano masu hulda yana cikin ci gaba, kuma zai kasance don turawa cikin makonni. An shirya irin wannan app a Ireland, da Faransa (""StopCovid"")."
Dukansu Ostiraliya da New Zealand suna la'akari da aikace-aikace bisa ƙa'idar TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha na da niyyar gabatar da aikace-aikacen geofencing ga marasa lafiya da aka gano da COVID-19 da ke zaune a Moscow, wanda aka tsara don tabbatar da cewa ba su fita daga gida ba.
Ross Anderson, farfesa a fannin injiniyan tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli masu yiwuwa da ke tattare da tsarin da ke amfani da manhajoji, ciki har da kuskuren da ya faru da kuma yiwuwar rashin tasiri idan an takaita amfani da manhajar zuwa wani karamin bangare na jama'a.
"Da yake magance damuwa game da yaduwar yaudarar ko cutarwa ""coronavirus"" apps, Apple ya kafa iyakoki kan waɗanne nau'ikan ƙungiyoyi za su iya ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store, yana iyakance su ga ƙungiyoyi ""na hukuma"" ko kuma masu mutunci kawai. "
Google da Amazon sun aiwatar da irin wannan takunkumin.
Masu fafutukar kare sirri sun nuna damuwarsu game da illar amfani da manhajojin kula da cutar korona, musamman game da ko za a rushe kayayyakin aikin sa ido da aka kirkira don magance annobar coronavirus da zarar barazanar ta wuce.
Amnesty International da kuma wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke kira da a takaita irin wannan sa ido.
Kungiyoyin sun bayyana sharuɗɗa takwas kan ayyukan gwamnati:
"Dole ne a yi sa ido a kan "doka, da bukata da kuma dacewa".
Ƙaddamar da saka idanu da kuma kulawa zai yi amfani da sassan sunaye;
amfani da bayanai zai zama iyakance ga dalilai na COVID-19;
Dole ne a kare tsaro da rashin mutuncin bayanai kuma a nuna cewa an kare su bisa hujja;
Kulawa ta dijital zai kauce wa nuna bambanci da kuma yin watsi da shi;
duk wani raba bayanai tare da wasu kamfanoni na uku dole ne a bayyana shi a cikin doka;
dole ne a sami kariya daga cin zarafi da kuma haƙƙin 'yan ƙasa don amsawa ga cin zarafi;
"Za a buƙaci halartar ma'ana daga dukkan" masu ruwa da tsaki masu dacewa ", gami da na ƙwararrun masana kiwon lafiyar jama'a da ƙungiyoyi marasa galihu.Kungiyar Kwamfuta ta Chaos ta Jamus (CCC) da 'Yan Jarida ba tare da Iyaka ba (Reporter ohne Grenzen) (RSF) suma sun ba da jerin abubuwan bincike. "
Tsarin da aka gabatar na Google/Apple yana da niyyar magance matsalar sa ido ta hanyar cire tsarin bin diddigin daga tsarin aikin na'urorin su da zarar ba a buƙatarsa.
Wasu ƙasashe sun yi amfani da hanyar sadarwar da ke kan hanyar sadarwa maimakon aikace-aikace, suna kawar da buƙatun sauke aikace-aikace da kuma ikon kauce wa sa ido.
A Isra'ila, an yarda da bin hanyar sadarwa.
Hanyoyin sadarwa da ke da damar samun bayanai na wuri suna da mahimman matsalolin sirri.
Duk da haka, ba duk tsarin da ke da uwar garken tsakiya ba dole ne ya sami damar yin amfani da bayanan wurin mutum; an ƙirƙiri wasu tsarin tsare sirri waɗanda ke amfani da uwar garken tsakiya don sadarwa kawai (duba sashin da ke ƙasa).
A Koriya ta Kudu, an yi amfani da tsarin da ba na app ba don bin diddigin masu hulda.
Maimakon amfani da keɓaɓɓen app, tsarin ya tattara bayanan bin diddigin daga tushe daban-daban ciki har da bayanan bin diddigin na'urar hannu da bayanan ma'amala na katin, kuma ya haɗa waɗannan don samar da sanarwa ta hanyar saƙonnin rubutu ga mutanen da ke iya kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da masu hulɗa da su, gwamnati ta kuma sanya bayanin wurin a bayyane, wani abu da aka ba da izini saboda canje-canje masu yawa ga dokokin tsare sirri na bayanan bayan barkewar cutar MERS a wannan ƙasar.
Wannan bayanin yana samuwa ga jama'a ta hanyar aikace-aikace da shafukan yanar gizo da yawa. Kasashe ciki har da Jamus sun yi la'akari da amfani da tsarin tsakiya da kuma tsare sirri.
Ya zuwa 6 ga Afrilu 2020, ba a ba da cikakken bayani ba tukuna.
Kula da tuntuɓar masu kiyaye sirri yana da kyakkyawar ma'ana, tare da mahimmin littattafan bincike da aka fara tun aƙalla 2013.Kamar 7 ga Afrilu 2020, sama da ƙungiyoyin ƙwararrun ƙwararru goma sha biyu suna aiki kan hanyoyin da ke ba da damar sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rajistar kusancin mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT wani aiki ne na hadin kai wanda ya kunshi tsarin da aka tsara da kuma rarraba, kuma ba wata yarjejeniya ba. Ka'idojin da aka rarraba sun hada da Tsaro na Tsaro na Tsaro na Tsaro (DP-PPT / DP-3T), Lambobi na Waya (TCN, fka Contact Event Numbers, CEN), Ka'idojin Tsaro na Tsaro da Tsarin Tsarin Waya na Waya (PACT) da sauransu.
A cikin waɗannan ladabi, bayanan sirri masu ganowa ba sa barin na'urar, kuma duk daidaitawa yana faruwa akan na'urar.
Ƙungiyar Tsare Sirri a MIT Media Lab ta haɓaka SafePaths, wani dandamali don amfani da dabarun kiyaye sirri lokacin tattarawa da amfani da wuri ko hanyar ƙetare bayanai don bin diddigin yaduwar COVID-19.
"Ya dogara ne da bincike daga farar takarda ""Apps Gone Rogue: Kula da Sirrin Mutum a cikin Cutar Kwayar cuta"" da aka fitar a watan Maris 2020. Wani irin wannan ƙoƙari shine dandalin SafeTrace ta Enigma MPC, wani kamfani da ke haɓaka fasahohin sirri wanda kuma aka fara kafa shi a MIT Media Lab".
SafeTrace yana amfani da fasahar kayan aiki masu aminci don ba masu amfani damar raba bayanan wuri da bayanan lafiya tare da sauran masu amfani da jami'ai, ba tare da yin sulhu da sirrin wannan bayanan ba.
A ranar 5 ga Afrilu 2020, an kafa TCN Coalition na duniya ta hanyar ƙungiyoyin da suka haɗu a kusa da abin da yake daidai da hanya ɗaya da manyan ladabi masu ɗorawa, tare da maƙasudin rage rarrabuwa, da kuma ba da damar haɗin gwiwar duniya na bin diddigin da faɗakarwa aikace-aikace, babban mahimmin al'amari na cimma nasarar tallafi.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta buɗe tushen yarjejeniyar BlueTrace da aka yi amfani da ita ta hanyar aikin gwamnati.
A ranar 10 ga Afrilu 2020, Google da Apple, kamfanonin da ke kula da dandamali na wayoyin hannu na Android da iOS, sun ba da sanarwar wani shiri don bin diddigin abokan hulɗa, wanda suka yi iƙirarin zai kiyaye sirri, bisa ga haɗuwa da fasahar Bluetooth Low Energy da kuma ɓoye ɓoye.
Sun kuma wallafa bayanai na ainihin fasahar da aka yi amfani da ita a tsarin.
A cewar Apple da Google, ana nufin a fitar da tsarin a matakai uku:
ƙaddamar da kayan aiki don ba da damar gwamnatoci su ƙirƙiri ƙa'idodin bin diddigin coronavirus na tsare sirri na sirri
Google da Apple na shirin magance matsalar da kuma ci gaba da sa ido ta hanyar rarraba tsarin ta hanyar sabunta tsarin aiki, sannan daga baya cire shi ta wannan hanyar da zarar barazanar ta wuce.
b'Rubutun magunguna (wanda aka fi sani da sake amfani da magani, sake sakewa, sake sakewa ko sauyawar magani) shine sake amfani da magani da aka amince don maganin cutar da ta bambanta da wacce aka fara kirkirar ta.
Wannan layin bincike ne na kimiyya wanda a halin yanzu ake bi don haɓaka amintattu da ingantattun magungunan COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar rigakafin COVID-19 da kuma canjawar jini na convalescent. SARS-CoV-2 yana da kusan sunadarai 66 masu maganin ƙwayoyi, kowannensu yana da wuraren haɗin ligand da yawa.
Binciken waɗannan wuraren da ke da alaƙa yana ba da kyakkyawan tsari na haɓaka ingantaccen maganin rigakafin ƙwayoyin cuta na COVID-19.
Daga cikin mahimman sunadarai masu manufa na SARS-CoV-2 sune sunadarai masu kama da papain, RNA mai dogaro da RNA RNA polymerase, helicase, S protein, da ADP ribophosphatase.
Hussein A, et al sun yi nazarin mahaɗan da ke takara da yawa waɗanda daga baya suka inganta kuma suka bincika kamannin kwarangwal ɗin su tare da magungunan da aka amince da su mafi girma don hanzarta haɓaka ingantaccen maganin anti-SARS-CoV-2 a cikin binciken sa na farko don a ba da shawarar a cikin ƙirar binciken asibiti.
Chloroquine magani ne na anti-malaria wanda kuma ake amfani da shi akan wasu cututtukan autoimmune.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine da ke da alaƙa za su kasance cikin magungunan guda huɗu da za a yi nazari a matsayin wani ɓangare na gwajin asibiti na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York na chloroquine da hydroxychloroquine zai fara ne a ranar 24 ga watan Maris. A ranar 28 ga watan Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a karkashin Amincewa da Amfani da Gaggawa (EUA).
Ba a amince da maganin ba ta hanyar tsarin gwaji na FDA kuma an ba da izini a ƙarƙashin EUA kawai a matsayin magani na gwaji don amfani na gaggawa a cikin marasa lafiya da aka kwantar amma ba su iya karɓar magani a cikin gwajin asibiti ba.
CDC ta ce har yanzu ba a tabbatar da "amfani, sashi, ko tsawon lokacin hydroxychloroquine don rigakafi ko maganin cutar SARS-CoV-2 ba".
"Laibobi sun ce suna amfani da maganin ne lokacin da "" babu wani zaɓi ""."
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana gudanar da wani ƙaramin bincike kan amfani da chloroquine a hade da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da manyan karatu a Jami'ar Duke da Jami'ar Oxford.
Makarantar Kiwon Lafiyar NYU Langone tana gudanar da gwaji kan aminci da ingancin amfani da rigakafin hydroxychloroquine.
"Gwajin gwaji na kasar Sin a Wuhan da Shenzhen sun yi iƙirarin nuna favipiravir ya kasance ""a fili yana da tasiri"."
35 marasa lafiya a Shenzhen sun gwada mummunan a cikin tsaka-tsakin kwanaki 4, yayin da tsawon lokacin rashin lafiya ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓa ba.
A wani bincike da aka gudanar a Wuhan a kan marasa lafiya 240 da ciwon huhu, rabi an ba su favipiravir kuma rabi sun sami umifenovir.
Hukumar Kula da Magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke goyan bayan maganin ba ta da yawa kuma na farko ne.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don adana shi, kuma za ta yi amfani da sojoji don isar da maganin zuwa asibitocin jami'a, inda za a yi amfani da maganin don magance marasa lafiya na COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya yi kira ga gwamnatin Trump game da sayen maganin. Maganin na iya zama ba shi da tasiri a cikin cututtukan cututtuka masu tsanani inda kwayar cutar ta riga ta ninka.
Ba zai zama lafiya ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki ba.
"Wani binciken lopinavir/ritonavir (Kaletra), hadewar magungunan antiviral lopinavir da ritonavir, ya kammala da cewa" ba a ga fa'ida ba".
An tsara magungunan don hana kwayar cutar HIV daga yin kwaya ta hanyar ɗaure ga protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin gyara magungunan don nemo wani fili wanda zai haɗu da protease na SARS-CoV-2. Akwai suka a cikin al'ummar kimiyya game da tura albarkatu don sake amfani da magungunan da aka haɓaka musamman don HIV / AIDS.
WHO ta haɗa lopinavir/ritonavir a cikin gwajin Solidarity na kasa da kasa.
Gilead Sciences ne ya ƙirƙira shi kuma ya haɓaka shi azaman magani don cutar cutar Ebola da cutar Marburg. Gilead Sciences daga baya ya gano cewa Remdesivir yana da aikin antiviral a cikin vitro a kan filo-, pneumo-, paramyxo-, da corona-virus da yawa.
Matsala daya da maganin antiviral shine ci gaban juriya ta hanyar maye gurbi wanda zai iya haifar da cutar da watsawa mai tsanani.
Wasu binciken farko na gwaji sun nuna cewa remdesivir na iya samun shinge mai yawa na kwayar halitta don juriya. Akwai gwaji na asibiti da yawa da ke gudana, gami da biyu da Asibitocin Jami'ar Cleveland ke gudanarwa; daya ga mutanen da ke da rashin lafiya mai tsaka-tsaki da kuma wani ga waɗanda ke da rashin lafiya mai tsanani.
Akwai gwaji na asibiti guda uku na maganin bitamin C na yau da kullun ga mutanen da ke asibiti da kuma masu cutar COVID-19; biyu da aka sarrafa su (China, Kanada) da kuma wanda ba a sarrafa shi ba (Italiya).
Jihar New York ta fara gwajin maganin rigakafin azithromycin a ranar 24 ga Maris 2020.
Cibiyar Kula da Lafiya da Magunguna ta Duniya ta Japan (NCGM) tana shirin gwajin asibiti don Alvesco na Teijin (ciclesonide), corticosteroid na numfashi don asma, don kula da marasa lafiya masu cutar da suka kamu da cutar coronavirus.
Wani nau'i na angiotensin-converting enzyme 2, gwajin Mataki na II yana gudana tare da marasa lafiya 200 da za a dauka daga mawuyacin hali, wadanda aka kwantar da su a asibiti a Denmark, Jamus, da Austria don tantance ingancin maganin.
Masu bincike daga Cibiyar Kula da Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine a rage kumburi da rikitattun huhu a cikin marasa lafiya da ke fama da alamun COVID-19.
Binciken, mai suna COLCORONA, yana ɗaukar manya 6000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna fuskantar alamun rashin lafiya waɗanda ba sa buƙatar asibiti.
Mata masu juna biyu ko masu shayarwa ko kuma waɗanda ba su da ingantacciyar hanyar hana haihuwa ba su cancanci ba.
Ana gwajin magungunan anticoagulants da yawa a Italiya.
Ana amfani da heparin mai ƙananan ƙwayar ƙwayar ƙwayar cuta don magance marasa lafiya, wanda ya sa Hukumar Kula da Magunguna ta Italiya ta buga jagororin game da amfani da shi.
An sanar da wani bincike mai yawa a kan marasa lafiya 300 da ke binciken amfani da enoxaparin sodium a cikin rigakafi da magungunan magani a Italiya a ranar 14 ga Afrilu.
Tun da SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga ilimin kimiyya kan sake amfani da magungunan da aka amince da su na maganin kwayar cuta da aka samar don barkewar cutar kamar MERS, SARS, da kwayar cutar West Nile.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19 bisa ga jagororin fitowar na 7 na kasar Sin
Umifenovir: an ba da shawarar umifenovir don maganin COVID-19 bisa ga jagororin bugu na 7 na kasar Sin
Wasu kwayoyin cuta da aka gano a matsayin masu iya sake amfani da su a matsayin magungunan COVID-19:
Tocilizumab (Anti-IL-6 mai karɓar): An amince da shi ta China.
Hakanan ana gwaji a Italiya da China. da kuma duba Tocilizumab#COVID-19.
b'A COVID-19 rigakafi shine maganin alurar riga kafi na cutar coronavirus 2019 (COVID-19).
Kodayake babu wata rigakafin da ta kammala gwajin asibiti, akwai ƙoƙari da yawa a ci gaba don samar da irin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin allurar rigakafin cutar SARS-CoV-2 ba, kwayar cutar da ke haifar da cutar, za ta kasance a cikin ƙasa da watanni 18.
An yi nazarin rigakafi biyar a cikin binciken lafiya na Phase I a watan Afrilu.
An gano COVID-19 a cikin Disamba 2019.
Wani babban barkewar cutar ya bazu a duniya a cikin 2020, wanda ya haifar da babban saka hannun jari da ayyukan bincike don haɓaka allurar rigakafi.
Kungiyoyi da yawa suna amfani da bayanan kwayoyin halitta da aka wallafa don samar da alluran rigakafin cutar SARS-CoV-2.
An bayyana a watan Afrilu, abubuwan da ke cikin shirin CEPI don ci gaban allurar rigakafi sune saurin, karfin masana'antu, turawa a sikelin, da kuma samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa dandamali na fasaha daban-daban 10 suna ƙarƙashin bincike da ci gaba a farkon 2020 don ƙirƙirar ingantaccen allurar rigakafi game da COVID-19.
Babban burin dandamali da aka ci gaba zuwa Nazarin Tsaro na Mataki na I sun haɗa da:
nucleic acid (DNA da RNA) (Mai haɓaka Phase I da kuma mai neman allurar rigakafi: Moderna, mRNA-1273)
kwayar cutar (mai haɓaka lokaci na I da kuma mai neman allurar rigakafi: CanSino Biologics, adenovirus nau'in 5 vector)
Kamar yadda masana kimiyyar CEPI suka ruwaito a watan Afrilu, jimillar allurar rigakafi 115 tana cikin farkon matakan ci gaba, tare da 78 da aka tabbatar a matsayin ayyukan aiki (79, a cewar Cibiyar Milken), da kuma wasu 37 da aka sanar, amma tare da karancin bayanan jama'a (wanda ake ɗauka a cikin shirin ko ana tsara shi).
Gwajin I-II na gwaji yana gudanar da gwajin farko na aminci da immunogenicity, yawanci ana yin saurin, ana sarrafa placebo, kuma a wurare da yawa, yayin tantance madaidaitan madaidaitan magunguna.
Gwajin na Mataki na III yawanci ya ƙunshi mahalarta da yawa, gami da ƙungiyar kulawa, da gwajin ingancin allurar rigakafin don hana cutar, yayin da ake sa ido don illa mai illa a mafi kyawun sashi.
"Daga cikin alluran rigakafi 79 a cikin ci gaba mai aiki (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su kasance a cikin kimantawar ɗan adam ba tukuna (har yanzu suna cikin binciken "" preclinical "). "
A kusan 24 ga Janairu 2020 a Ostiraliya, Jami'ar Queensland ta ba da sanarwar cewa tana binciken yiwuwar allurar rigakafin ƙwayar cuta wanda zai iya canza sunadarai na kwayar cuta don ƙarfafa halayen rigakafi.
A kusan 24 Janairu 2020 a Kanada, Cibiyar rigakafin duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta ba da sanarwar fara aiki a kan rigakafi, da nufin fara gwajin mutum a 2021.
An sanar da ayyukan ci gaban allurar rigakafi a Cibiyar Kula da Cututtuka da Cututtuka ta China a ranar 26 ga Janairu, 2020, da Jami'ar Hong Kong a ranar 28 ga Janairu.
A kusan 29 ga Janairu 2020, Kamfanonin Magunguna na Janssen, wanda Hanneke Schuitemaker ke jagoranta, ya ba da sanarwar cewa ya fara aiki don haɓaka allurar rigakafi.
Janssen yana haɓaka allurar rigakafin baki tare da abokin haɗin biotechnology, Vaxart.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka rigakafin.
A ranar 8 ga Fabrairu 2020, dakin gwaje-gwaje OncoGen a Romania ya wallafa wata takarda kan ƙirar allurar rigakafi tare da fasaha mai kama da wanda ake amfani da shi don maganin rigakafin cutar kansa.
A ranar 25 ga watan Maris shugaban cibiyar bincike ya sanar da cewa sun kammala hada maganin rigakafin kuma suna fara gwajin.
A ranar 27 ga Fabrairu, 2020, wani kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna fara aikin allurar rigakafi don ƙirƙirar allurar rigakafin Ii-Key peptide akan COVID-19.
"Suna son samar da wanda za a iya gwada shi a cikin mutane ""a cikin kwanaki 90".
A ranar 5 ga Maris 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta don haɓaka allurar rigakafi.
A ranar 5 ga Maris 2020, Hukumar Kula da Kiwon Lafiya da Kula da Kayan Aikin Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, dukansu a yammacin Maryland, sun ba da sanarwar cewa suna aiki a kan rigakafi.
A kusan 10 ga Maris 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
a cikin ci gaba da kuma samar da rigakafi.
Abokan haɗin gwiwar sun kuma sanar da shirye-shiryen don gwajin gwaji da gwajin asibiti na Phase I a watan Yuli 2020.
A ranar 12 ga Maris 2020, Ma'aikatar Lafiya ta Indiya ta ba da sanarwar cewa suna aiki tare da keɓewa 11, kuma cewa ko da a kan saurin hanya zai ɗauki aƙalla kusan shekara ɗaya da rabi zuwa shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris 2020, Medicago, wani kamfanin kere-kere na kere-kere a Quebec City, Quebec, ya ba da rahoton ci gaban wani abu mai kama da kwayar cutar coronavirus a ƙarƙashin wani ɓangare na kudade daga Cibiyoyin Kanada don Binciken Kiwon Lafiya.
Ana yin bincike a cikin dakin gwaje-gwaje, tare da gwajin ɗan adam da aka tsara don Yuli ko Agusta 2020.
"A farkon wannan makon, The Guardian ta ba da rahoton cewa Shugaban Amurka Donald Trump ya ba CureVac "" "" 'babban kudade' don samun damar keɓaɓɓiyar damar yin allurar rigakafin Covid-19"", wanda gwamnatin Jamus ta yi zanga-zangar".
A ranar 17 ga Maris 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Mai neman allurar mRNA BNT162, a halin yanzu ana cikin gwajin gwaji tare da gwajin asibiti da ake sa ran farawa a watan Afrilu 2020.
A Italiya a ranar 17 Maris 2020, Takis Biotech, wani kamfanin fasahar kere-kere na kasar Italiya ya sanar da cewa za su sami sakamakon gwajin kafin a yi amfani da shi a watan Afrilun 2020 kuma wanda zai zama na karshe na maganin zai iya fara gwajin mutum a kaka.
A Faransa a ranar 19 ga Maris 2020, Coalition for Epidemic Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin hadaddiyar kungiyar bincike kan allurar rigakafin COVID-19 da ta haɗa da Institut Pasteur, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya kawo jimillar saka hannun jari na CEPI a ci gaban rigakafin COVID-19 zuwa dala miliyan 29.
Sauran abokan haɗin gwiwar CEPI don ci gaban allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na nau'ikan allurar rigakafi shida.
Masu binciken Kwalejin Kwalejin London sun sanar a ranar 20 ga Maris 2020 cewa suna haɓaka rigakafin RNA mai haɓaka kansa don COVID-19.
An samar da maganin rigakafin cikin kwanaki 14 da karbar jerin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da C$275 miliyan a cikin kudade don ayyukan bincike 96 kan matakan kariya na likita game da COVID-19, gami da yawancin masu neman allurar rigakafi a kamfanonin Kanada da jami'o'i, kamar ayyukan Medicago da Jami'ar Saskatchewan.
"Kusan lokaci guda, gwamnatin Kanada ta sanar da C$192 miliyan musamman don haɓaka rigakafin COVID-19, tare da shirye-shiryen kafa "" bankin rigakafi "" na sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan wata cutar coronavirus ta sake faruwa. "
"A ranar 2 ga Afrilu 2020, masu bincike a Jami'ar Pittsburgh School of Medicine sun ba da rahoton gwajin PittCoVacc, wata rigakafin COVID-19 mai yiwuwa a beraye, suna cewa ""MNA ya ba da rigakafin SARS-CoV-2 S1 na ƙaramin rukuni wanda ya haifar da amsoshin ƙwayoyin cuta na musamman na antigen-musamman [a cikin berayen] waɗanda suka bayyana farawa makonni 2 bayan rigakafi. """
A Kanada a ranar 16 ga Afrilu 2020, Jami'ar Waterloo School of Pharmacy ta sanar da tsara wani takaddar allurar rigakafin da ke da tushen DNA a matsayin mai yuwuwar fesa hanci.
Ta amfani da bacteriophages, za a tsara DNA don yin kwafi a cikin ƙwayoyin cuta na ɗan adam don samar da ƙwayoyin cuta masu kama da ƙwayoyin cuta, wanda zai iya ƙarfafa tsarin garkuwar jiki don samar da ƙwayoyin cuta da ke ƙin ƙwayar SARS-CoV-2.
A watan Maris na 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗu da albarkatu don samun damar yin amfani da kwamfutoci masu ƙwarewa daga IBM, haɗe da albarkatun ƙididdigar girgije daga Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira tasirin da ba na musamman ba.
Wannan yana nufin za su iya samun fa'ida fiye da cutar da suke hanawa.
Wani ƙarin gwaji da aka yi a Australia yana neman shiga ma'aikatan kiwon lafiya 4,170.
Zai yiwu alluran rigakafin da ake haɓaka ba zai zama mai aminci ko tasiri ba.
Binciken farko don tantance ingancin allurar rigakafin ta amfani da ƙirar dabbobi na musamman na COVID-19, kamar ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararru, da sauran dabbobi masu gwajin gwaji, da kuma ba-mutane ba, sun nuna buƙatar matakan kiyaye matakan 3 na biosafety don sarrafa ƙwayoyin cuta masu rai, da haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitaccen matakan aminci.
An gwada allurar rigakafin SARS da MERS a kan dabbobi da ba na mutane ba.
Ya zuwa 2020, babu magani ko rigakafin kariya ga SARS wanda aka nuna cewa yana da aminci da inganci a cikin mutane.
Dangane da takardun bincike da aka buga a 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya na duniya. Haka kuma babu ingantaccen allurar rigakafin MERS.
Lokacin da MERS ya zama gama gari, an yi imanin cewa binciken SARS na yanzu na iya samar da samfurin da zai iya zama mai amfani don haɓaka allurar rigakafi da magunguna don kamuwa da cutar MERS-CoV.
Ya zuwa Maris 2020, akwai rigakafin MERS guda ɗaya (wanda ya dogara da DNA) wanda ya kammala gwajin asibiti na farko a cikin mutane, da kuma wasu uku a ci gaba, dukkansu rigakafin da aka yi wa kwayar cutar, biyu da aka yi wa adenoviral (ChAdOx1-MERS, BVRS-GamVac), da kuma MVA-vectored (MVA-MERS-S).
Rubutun kafofin watsa labarun sun inganta ka'idar makirci da ke da'awar cewa an san kwayar cutar COVID-19 kuma cewa riga an riga an sami rigakafi.
Takardun haƙƙin mallaka da aka ambata ta hanyar kafofin watsa labarun daban-daban suna komawa ga takardun haƙƙin mallaka na yau da kullun don jerin kwayoyin halitta da alluran rigakafi ga sauran nau'ikan coronavirus kamar SARS coronavirus.
b'Cutar Coronavirus ta 2019 (COVID-19) cuta ce mai yaduwa da ke haifar da cutar sankara mai saurin numfashi coronavirus 2 (SARS-CoV-2).
Alamomin yau da kullun sun haɗa da zazzabi, tari, da wahalar numfashi.
Sauran alamun na iya haɗawa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin ƙanshi, da ciwon ciki.
Lokacin daga bayyanar zuwa bayyanar cututtuka yawanci kusan kwanaki biyar ne amma na iya kasancewa daga kwana biyu zuwa sha huɗu.
Yayinda yawancin lokuta ke haifar da alamun rashin ƙarfi, wasu suna ci gaba zuwa cutar huhu da gazawar gabobin jiki da yawa.
Ya zuwa ranar 17 ga Afrilu 2020, an ba da rahoton sama da mutane miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar tsakanin mutane a yayin da suke kusanci, sau da yawa ta hanyar kananan digo da ake samu ta hanyar tari, tari, ko magana.
Duk da yake ana samar da waɗannan ɗigon lokacin da suke numfashi, yawanci suna faɗuwa ƙasa ko saman ƙasa maimakon su kasance masu kamuwa da cuta a kan nesa mai nisa.
Mutane kuma za su iya kamuwa ta hanyar taɓa wani abu da ke da cutar kuma su taɓa idanunsu, hanci, ko bakinsu.
Kwayar cutar na iya rayuwa a saman abubuwa har zuwa awanni 72.
Yana da mafi saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yaduwa na iya yiwuwa kafin bayyanar cututtuka da kuma a cikin matakan baya na cutar.Hanyar daidaitaccen hanyar ganewar asali ita ce ta hanyar sake fasalin rikodin polymerase jerin reaction (rRT-PCR) daga swab nasopharyngeal.
Ana bada shawarar amfani da abin rufe fuska ga waɗanda suke zaton suna da kwayar cutar da kuma masu kula da su.
Shawarwarin da aka bayar na amfani da abin rufe fuska a tsakanin jama'a sun bambanta, tare da wasu hukumomi suna ba da shawarar yin amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar yin amfani da su.
A halin yanzu, babu wani allurar rigakafi ko takamaiman maganin rigakafin cutar COVID-19.
An samu kamuwa da cutar a gida a mafi yawan ƙasashe a duk yankuna shida na WHO.
Wadanda suka kamu da kwayar cutar na iya zama marasa alamun cutar ko kuma su sami alamun kama da mura kamar zazzabi, tari, gajiya, da rashin numfashi.
Alamomin gaggawa sun hada da wahalar numfashi, ciwo a kirji ko matsi, rikicewa, wahalar farkawa, da fuska ko lebe mai launin shuɗi; ana ba da shawarar gaggawa ga likitan idan waɗannan alamomin suna nan.
A cikin yanayi mai saurin faruwa, ana iya ganin alamun cutar na sama kamar yin fitsari, hanci mai gudana ko ciwon makogwaro.
An lura da alamun cututtukan gastrointestinal kamar su tashin zuciya, amai da zawo a cikin kashi daban-daban.
Wasu lokuta a China da farko sun gabatar ne kawai tare da bugun kirji da kuma bugun zuciya.
A wasu, cutar na iya ci gaba zuwa ciwon huhu, gazawar gabobin jiki da yawa, da mutuwa.
Wannan shi ake kira lokacin da ake ciki.
Lokacin shiryawa don COVID-19 yawanci kwanaki biyar zuwa shida amma na iya zuwa daga kwanaki biyu zuwa 14.
97.5% na mutanen da suka kamu da alamun cutar za su kamu da su a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba duk wadanda suka kamu da cutar ba ne suke kamuwa da alamun cutar.
Ba a san rawar da waɗannan masu ɗaukar hoto ba a cikin watsawa ba tukuna; duk da haka, hujjoji na farko sun nuna cewa suna iya ba da gudummawa ga yaduwar cutar.
Adadin mutanen da ke da cutar amma ba su nuna alamun cutar ba a sani ba kuma ana binciken su, tare da Cibiyar Kula da Cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da cutar ba su nuna alamun cutar ba a lokacin da suke kwance a asibiti.
Hukumar Lafiya ta Kasa ta China ta fara haɗa da wadanda ba su da alamun cutar a cikin shari'un ta na yau da kullun a ranar 1 ga Afrilu; na kamuwa da mutane 166 a wannan rana, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Dukkanin sputum da saliva na iya ɗaukar manyan nau'ikan ƙwayoyin cuta.
Yin magana da ƙarfi yana sa a saki ɗigo da yawa fiye da yadda ake yi a magana da baki.
Wani bincike a Singapore ya gano cewa tari da ba a rufe ba zai iya haifar da saukad da ruwa har zuwa mita 4.5.
Kodayake kwayar cutar ba ta da iska, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa watsawar bioaerosol na iya yiwuwa kuma masu tattara iska da aka sanya a cikin hallway a waje da ɗakunan mutane sun ba da samfuran tabbatacce don RNA na kwayar cutar.
Wasu hanyoyin kiwon lafiya kamar intubation da cardiopulmonary resuscitation (CPR) na iya haifar da ɓoyewar numfashi don aerosol kuma don haka ya haifar da yaduwar iska.
Duk da yake akwai damuwa cewa zai iya yaduwa ta hanyar kwandon, ana ganin wannan haɗarin ya yi kadan. Cutar ta fi kamuwa yayin da mutane ke nuna alamun; yayin da yaduwa na iya yiwuwa kafin bayyanar cututtuka ta bayyana, haɗarin ba shi da yawa.
Cibiyar hana yaduwar cututtuka ta Turai (ECDC) ta ce, ko da yake ba a san yadda cutar ke yaduwa ba, mutum daya yakan harbi mutum biyu zuwa uku. Kwayar cutar tana rayuwa na tsawon sa'o'i ko kwanaki a kan wani abu.
Musamman, an gano cewa ana iya gano kwayar cutar har tsawon kwana daya a kan kwali, har zuwa kwanaki uku a kan filastik (polypropylene) da bakin karfe (AISI 304), kuma har zuwa awanni hudu a kan jan ƙarfe 99%.
Wannan, duk da haka, ya bambanta dangane da zafi da zafin jiki.
Sabulu da na'urar wankewa suma suna da tasiri idan aka yi amfani da su daidai; kayayyakin sabulu suna lalata fatar mai kare kwayar cutar, yana kashe ta, da kuma 'yantar da su daga fata da sauran farfajiyoyi.
Sauran mafita, kamar su benzalkonium chloride da chlorhexidine gluconate (mai kashe kwayoyin cutar tiyata), ba su da tasiri sosai.A cikin wani binciken Hong Kong, an dauki samfurin sauro a cikin kwanaki biyu bayan fara asibiti.
A cikin biyar daga cikin shida, samfurin farko ya nuna mafi girman nauyin kwayar cutar, kuma mai haƙuri na shida ya nuna mafi girman nauyin kwayar cutar a rana ta biyu da aka gwada.
Cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na 2 (SARS-CoV-2) wani sabon labari ne mai cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka na cututtukan cututtukan cututtuka, wanda aka fara warewa daga mutane uku da cutar huhu da ke da alaƙa da tarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuka a Wuhan.
Dukkanin siffofin sabon kwayar cutar SARS-CoV-2 suna faruwa ne a cikin kwayar cutar coronaviruses da ke da alaka a cikin yanayi.
A waje da jikin mutum, ana kashe kwayar ta sabulu na gida, wanda ke fashe kumfar kariya.SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Fuka-fuki sune gabobin da COVID-19 ya fi shafa saboda kwayar cutar tana shiga cikin kwayoyin da ke dauke da kwayoyin angiotensin-converting enzyme 2 (ACE2), wanda ya fi yawa a cikin nau'in II alveolar cells na huhu.
"Cutar tana amfani da glycoprotein na musamman wanda ake kira "" spike "" (peplomer) don haɗawa da ACE2 kuma shiga cikin tantanin mai gida".
An sami raunin zuciya mai tsanani a cikin kashi 12% na mutanen da ke da cutar da aka kwantar a asibiti a Wuhan, China, kuma ya fi yawa a cikin cututtuka masu tsanani.
Yawan cututtukan zuciya yana da yawa, saboda tsarin ƙwayar cuta da kuma tsarin tsarin rigakafi a yayin ci gaba da cutar, amma mummunan rauni na myocardial na iya kasancewa da alaƙa da masu karɓar ACE2 a cikin zuciya.
Masu karɓar ACE2 suna da yawa a cikin zuciya kuma suna da hannu cikin aikin zuciya.
An sami babban kamuwa da cutar thrombosis (31%) da kuma thromboembolism (25%) a cikin marasa lafiya na ICU tare da kamuwa da COVID-19 kuma ana iya danganta shi da rashin lafiya.Autopsies na mutanen da suka mutu daga COVID-19 sun sami lalacewar alveolar (DAD), da kuma ƙwayoyin lymphocyte masu ƙonewa a cikin huhu.
Kodayake SARS-COV-2 yana da tropism don ACE2-yana bayyana ƙwayoyin epithelial na hanyoyin numfashi, marasa lafiya da COVID-19 mai tsanani suna da alamun cutar hyperinflammation.
Musamman, an nuna cewa ƙwayoyin T-cells masu ɓoyewar GM-CSF suna da alaƙa da ɗaukar ƙwayoyin monocytes masu ɓoye IL-6 masu ƙonewa da kuma cututtukan huhu mai tsanani a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton infiltrates na lymphocytic a lokacin binciken gawa.
WHO ta wallafa wasu hanyoyin gwaji na cutar.
Hanyar gwaji ta yau da kullun shine ainihin lokacin sake fasalin polymerase sarkar amsa (rRT-PCR).
Ana yin gwajin ne akan samfuran numfashi da aka samu ta hanyar nasopharyngeal swab; duk da haka, ana iya amfani da samfurin hanci ko samfurin sputum.
Ana samun sakamakon a cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya amfani da gwajin jini, amma waɗannan suna buƙatar ɗaukar samfuran jini guda biyu a cikin makonni biyu kuma sakamakon ba shi da ƙima nan da nan.
Masana kimiyya na kasar Sin sun iya ware wani nau'in kwayar cutar coronavirus da kuma buga tsarin kwayoyin halittar don haka dakunan gwaje-gwaje a duk duniya za su iya ci gaba da gwajin sarkar polymerase (PCR) don gano kamuwa da cutar ta kwayar cutar.
A ranar 4 ga Afrilu 2020, gwaje-gwajen antibody (wanda zai iya gano cututtukan da ke aiki da kuma ko mutum ya kamu da cutar a baya) ana ci gaba, amma har yanzu ba a yi amfani da shi sosai ba.
Kwarewar Sin a gwaji ta nuna cewa daidaito ya kai kashi 60 zuwa 70 ne kawai.
FDA a Amurka ta amince da gwajin farko na kulawa a ranar 21 ga Maris 2020 don amfani a ƙarshen wannan watan. Jagororin bincike da Asibitin Zhongnan na Jami'ar Wuhan ya bayar sun ba da shawarar hanyoyin gano kamuwa da cuta dangane da halayen asibiti da haɗarin cututtuka.
Rashin haske na gilashin ƙasa mai yawa tare da rarraba, asymmetrical da kuma rarraba baya na yau da kullun a cikin kamuwa da cuta.
Subpleural rinjaye, crazy paving (lobular septal thickening tare da canji alveolar cika), da kuma ƙarfafawa na iya bayyana kamar yadda cutar take ci gaba.
Kadan bayanai ne ke akwai game da raunuka masu ƙanƙanci da kuma ilimin cututtukan COVID-19.
Babban binciken ilimin cututtuka a autopsy sune:
Macroscopy: pleurisy, pericarditis, ƙarfafawar huhu da kuma kumburin huhu
Za a iya lura da nau'ikan nau'ikan nau'ikan cututtuka na cututtuka na cututtuka na cututtuka na cututtuka:
huhu mai sauki: kumburin huhu, hyperplasia na huhu, manyan pneumocytes na yau da kullun, kumburin kumburi na tsakanin tare da kutsawar lymphocytic da kuma samar da kwayar cuta mai yawa
mai tsanani na huhu: lalacewar alveolar (DAD) tare da watsawar alveolar exudates.
DAD shine sanadin cutar cututtukan numfashi mai tsanani (ARDS) da kuma rashin karfin jini mai tsanani.
warkar da ciwon huhu: ƙungiyar exudates a cikin alveolar cavities da kuma na huhu interstitial fibrosis
Jini: watsawa cikin jini (DIC); halayen leukoerythroblastic
Matakan kariya don rage yiwuwar kamuwa da cuta sun haɗa da zama a gida, guje wa wuraren da mutane ke da yawa, wanke hannu da sabulu da ruwa sau da yawa kuma aƙalla na dakika 20, yin kyakkyawan tsabtace hanyoyin numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannaye marasa wankewa.
CDC ta ba da shawarar rufe baki da hanci da zane yayin tari ko yin hancin kuma ya ba da shawarar yin amfani da ciki na gwiwar hannu idan babu zane.
Ana ƙarfafa tsaftace hannu da kyau bayan wani tari ko hancin.
CDC ta ba da shawarar yin amfani da suturar fuska a wuraren jama'a, a wani bangare don iyakance watsawa ta mutanen da ba su da alamun cutar. Dabarun nisantar da jama'a na nufin rage hulda da mutanen da suka kamu da cutar tare da manyan kungiyoyi ta hanyar rufe makarantu da wuraren aiki, taƙaita tafiye-tafiye da kuma soke manyan tarurruka na jama'a.
Ka'idojin nisantawa sun hada da cewa mutane su kasance aƙalla ƙafa 6 (mita 1.8).
"Babu wani magani da aka sani da zai iya hana COVID-19.Kamar yadda ba a sa ran samun rigakafi ba har sai 2021 a farkon, wani muhimmin bangare na kula da COVID-19 yana ƙoƙarin rage ƙwanƙwasawar annobar, wanda aka sani da ""sawaita lanƙwasawa"."
CDC ta kuma bada shawarar cewa mutane su wanke hannayensu sau da yawa da sabulu da ruwa na akalla dakika 20, musamman bayan sun je banɗaki ko kuma idan hannayensu sun yi datti, kafin su ci abinci da kuma bayan sun busa hanci, da tari ko hancin.
Ya kuma ba da shawarar yin amfani da maganin wanke hannu mai dauke da barasa wanda ya kai aƙalla kashi 60 cikin ɗari na barasa, amma sai a lokacin da ba a samun sabulu da ruwa. Don yankunan da ba a samun maganin wanke hannu na kasuwanci, WHO ta samar da tsari biyu don samarwa na gida.
A cikin waɗannan abubuwan, aikin antimicrobial ya fito ne daga ethanol ko isopropanol.
"Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin ƙwayoyin cuta a cikin giya; ba "" abu ne mai aiki ba don maganin antisepsis na hannu ""."
Glycerol an kara shi azaman humectant.
Ana kula da mutane ta hanyar kulawa mai goyan baya, wanda zai iya haɗawa da maganin ruwa, tallafin oxygen, da tallafawa sauran gabobin da ke da matsala.
CDC ta ba da shawarar cewa waɗanda suke zargin suna ɗauke da cutar su sa abin rufe fuska mai sauƙi.
An yi amfani da oxygenation na membrane na waje (ECMO) don magance matsalar gazawar numfashi, amma fa'idodin sa har yanzu suna cikin la'akari.
An ba da shawarar tsaftacewar mutum da kuma salon rayuwa mai kyau da abinci don inganta rigakafi.
Magungunan tallafi na iya zama da amfani ga waɗanda ke da alamun rashin ƙarfi a farkon matakin kamuwa da cutar. WHO da Hukumar Lafiya ta Kasa ta Sin sun ba da shawarwari don kula da mutanen da ke asibiti da COVID-19.
Masana da ke kula da cututtuka masu tsanani da kuma cututtuka na huhu a Amirka sun tattara shawarwarin magani daga hukumomi dabam dabam zuwa cikin wani tushe na kyauta, IBCC.
Ya zuwa Afrilu 2020, babu takamaiman magani don COVID-19.
Don alamomi, wasu ƙwararrun likitoci suna ba da shawarar paracetamol (acetaminophen) a kan ibuprofen don amfani da layi na farko.
Dole ne a dauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a wuraren kiwon lafiya lokacin aiwatar da hanyoyin da zasu iya samar da aerosols, kamar intubation ko iska mai hannu.
Ga ƙwararrun likitocin da ke kula da mutanen da ke da COVID-19, CDC ta ba da shawarar sanya mutumin a cikin ɗakin keɓewa na Cutar Cutar Cutar Cutar (AIIR) ban da amfani da daidaitattun matakan kariya, matakan kariya daga tuntuɓar da kuma matakan kariya na iska. CDC ta ba da jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Abubuwan da aka ba da shawarar sune: PPE gown, respirator ko fuskar fuska, kariya na ido, da safar hannu na likita. Idan akwai, ana fifita respirators (maimakon fuskar fuska).
An amince da N95 respirators don wuraren masana'antu amma FDA ta ba da izinin amfani da masks a ƙarƙashin Izinin Amfani da Gaggawa (EUA).
An tsara su don karewa daga ƙwayoyin iska kamar ƙura amma ba a tabbatar da inganci game da takamaiman ƙwayoyin halitta ba don amfani da lakabi.
Lokacin da ba a samun abin rufe fuska, CDC ta ba da shawarar yin amfani da garkuwar fuska ko, a matsayin mafita ta ƙarshe, abin rufe fuska da aka yi a gida.
Yawancin lokuta na COVID-19 ba su da tsanani sosai don buƙatar aikin iska ko madadin, amma kashi na shari'ar suna.
Ana nazarin nau'in tallafin numfashi ga mutanen da ke fama da cutar COVID-19 da ke da alaƙa da rashin numfashi ga mutanen da ke asibiti, tare da wasu shaidu da ke nuna cewa ana iya guje wa intubation tare da babban canjin hanci mai gudana ko kuma matsin lamba mai kyau na iska.
Ko ko ɗaya daga cikin waɗannan biyun ya haifar da fa'ida iri ɗaya ga mutanen da ke da mummunan rashin lafiya ba a sani ba.
Wasu likitoci sun fi son kasancewa tare da ventilation na inji mai haɗari lokacin da ya kasance saboda wannan fasaha yana iyakance yaduwar ƙwayoyin aerosol idan aka kwatanta da cannula na hanci mai girma.Matsanancin lamura sun fi yawa a cikin tsofaffi (wadanda suka wuce shekaru 60, kuma musamman waɗanda suka wuce shekaru 80).
Yawancin ƙasashe masu tasowa ba su da isassun gadaje na asibiti da ke da yawan jama'a, wanda ke iyakance damar tsarin kiwon lafiya don magance hauhawar kwatsam a cikin adadin COVID-19 da ke da tsanani don buƙatar asibiti.
Wani bincike a China ya gano cewa kashi 5% an shigar da su cikin rukunin kulawa mai tsanani, kashi 2.3% suna buƙatar tallafin na'urar ta iska, kuma kashi 1.4% sun mutu.
A China, kusan kashi 30% na mutanen da ke asibiti da COVID-19 a ƙarshe an shigar da su ICU.
Hanyar samun iska ta zama mai rikitarwa yayin da cutar COVID-19 ke haifar da cutar ta cututtukan numfashi (ARDS) kuma samun isasshen iskar oxygen ya zama da wuya.
Ana buƙatar masu amfani da iska masu iya sarrafa yanayin matsin lamba da kuma babban PEEP don ƙara yawan isar da iskar oxygen yayin rage haɗarin cutar huhu da ke da alaƙa da injin iska da kuma pneumothorax.
Ba za a iya samun babban PEEP a kan tsofaffin masu ba da iska ba.
Bincike kan yiwuwar magani ya fara ne a watan Janairun 2020, kuma wasu magungunan antiviral suna cikin gwaji na asibiti.
Remdesivir ya bayyana ya zama mafi alƙawarin.
Kodayake sabbin magunguna na iya ɗaukar har zuwa 2021 don haɓaka, da yawa daga cikin magungunan da ake gwaji sun riga an yarda da su don sauran amfani ko kuma sun riga sun kasance a cikin gwaji na ci gaba.
Za a iya gwada maganin rigakafin kwayar cuta a cikin mutanen da ke da cutar mai tsanani.
WHO ta ba da shawarar masu sa kai su shiga cikin gwaji na inganci da amincin maganin da ake iya yi. FDA ta ba da izinin izini na ɗan lokaci don amfani da plasma na convalescent a matsayin gwaji a cikin yanayin da rayuwar mutum ke cikin haɗari mai tsanani ko nan da nan.
Ba a yi nazarin asibiti ba don nuna cewa yana da lafiya da tasiri ga cutar.
A watan Fabrairun 2020, China ta kaddamar da manhajar wayar hannu don magance barkewar cutar.
Ana tambayar masu amfani da su shigar da sunansu da lambar ID.
Aikace-aikacen na iya gano " kusanci " ta amfani da bayanan sa ido kuma saboda haka yuwuwar kamuwa da cuta.
Kowane mai amfani kuma na iya duba matsayin wasu masu amfani guda uku.
Idan aka gano wata haɗari mai haɗari, app ɗin ba kawai yana ba da shawarar keɓe kai ba, har ma yana faɗakar da jami'an kiwon lafiya na gida. Ana amfani da babban bayanan bayanai akan bayanan wayar salula, fasahar gane fuska, bin diddigin wayar hannu da hankali na wucin gadi don bin diddigin mutanen da suka kamu da cutar da kuma mutanen da suka tuntuɓi a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba da damar hukumomin tsaro su bi diddigin bayanan wayar salula na mutanen da ake tsammanin suna da cutar coronavirus.
An dauki matakin ne don tilasta killacewa da kuma kare wadanda za su iya hulda da 'yan kasar da suka kamu da cutar.
Hakanan a cikin Maris 2020, Deutsche Telekom ya raba bayanan wurin wayar tarho tare da hukumar gwamnatin tarayya ta Jamus, Cibiyar Robert Koch, don yin bincike da hana yaduwar kwayar cutar.
Rasha ta tura fasahar gane fuska don gano masu karya dokar killacewa.
"Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce masu amfani da wayar salula sun sanar da shi cewa ""40% na mutane suna ci gaba da motsawa ko ta yaya"."
Gwamnatin Jamus ta gudanar da wani taron hackathon na karshen mako na sa'o'i 48 tare da mahalarta sama da 42.000.
Har ila yau, shugaban Estonia, Kersti Kaljulaid, ya yi kira ga duniya don samar da hanyoyin samar da hanyoyin magance yaduwar kwayar cutar coronavirus.
Mutane na iya fuskantar damuwa daga killacewa, takunkumin tafiye-tafiye, illar magani ko tsoron kamuwa da cutar kanta.
"BBC ta nakalto Rory O'Connor yana cewa, "" Ƙara yawan rashin zaman jama'a, kadaici, damuwa da lafiyar jiki, damuwa da kuma koma bayan tattalin arziki sune hadari mai kyau don cutar da lafiyar hankali da lafiyar mutane. ""
Cutar na iya ɗaukar hanya mai sauƙi tare da alamomi kaɗan ko babu alamomi, kama da sauran cututtukan numfashi na sama kamar sanyi na yau da kullun.
Cutar da ba ta da tsanani ba yawanci tana warkewa cikin makonni biyu, yayin da wadanda ke da cututtukan masu tsanani ko masu tsanani na iya daukar makonni uku zuwa shida kafin su warke.
Mata masu juna biyu na iya zama cikin haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanai daga wasu ƙwayoyin cuta masu kama da su, kamar SARS da MERS, amma bayanai na COVID-19 sun rasa. A wasu mutane, COVID-19 na iya shafar huhu yana haifar da ciwon huhu.
A cikin waɗanda suka fi fama da cutar, COVID-19 na iya saurin ci gaba zuwa cutar ta numfashi mai tsanani (ARDS) wanda ke haifar da gazawar numfashi, damuwa ko gazawar gabobin jiki da yawa.
Abubuwan da ke tattare da COVID-19 sun haɗa da cutar sankara, ƙarancin jini da lalacewar zuciya, koda da hanta.
An bayyana rashin daidaituwa na clotting, musamman karuwar lokacin prothrombin, a cikin 6% na waɗanda aka shigar da su asibiti tare da COVID-19, yayin da aka ga aikin koda mara kyau a cikin 4% na wannan rukunin.
Kimanin kashi 20-30% na mutanen da ke da COVID-19 suna nuna hawan enzymes na hanta (transaminases).
A cewar wannan rahoto, matsakaicin lokacin da ya wuce tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, tare da kwana biyar da aka kwantar da shi a asibiti.
Koyaya, marasa lafiya da aka tura zuwa ICU suna da matsakaicin lokacin kwana bakwai tsakanin asibiti da mutuwa.
A cikin binciken da aka yi kan mutanen da suka kamu da cutar a farkon lokaci, matsakaicin lokacin da suka nuna alamun cutar har zuwa mutuwa ya kai kwanaki 14, tare da cikakken zangon kwanaki 6 zuwa 41.
A wani bincike da Hukumar Kula da Lafiya ta Kasa (NHC) ta kasar Sin ta yi, maza sun yi mutuwar kashi 2.8% yayin da mata ke da kashi 1.7%.
Gwajin ilimin lissafi na gwajin huhu bayan mutuwa ya nuna lalacewar alveolar tare da ƙwayoyin fibromyxoid a cikin huhu biyu.
An lura da canje-canje na cytopathic na kwayar cutar a cikin pneumocytes.
Hoton na huhu ya yi kama da cutar cututtukan numfashi mai tsanani (ARDS).
A cikin kashi 11.8% na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta ruwaito, an lura da lalacewar zuciya ta hanyar yawan troponin ko kuma bugun zuciya.
Bisa ga bayanan watan Maris daga Amurka, kashi 89% na wadanda aka kwantar da su a asibiti suna da yanayin da suka rigaya. Samun kayan kiwon lafiya da yanayin zamantakewar tattalin arziki na yankin na iya shafar mutuwar.
Bayani na mutuwar daga yanayin ya bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda wahalar da ake samu.
Rashin ƙididdigar ƙananan cututtuka na iya haifar da ƙimar mutuwa.
Koyaya, gaskiyar cewa mutuwar sakamakon sakamakon lamuran da aka samu a baya na iya nufin cewa an rage darajar mutuwar yanzu.
Masu shan sigari sun ninka sau 1.4 na samun alamun cutar COVID-19 mai tsanani kuma kusan sau 2.4 na iya buƙatar kulawa mai tsanani ko mutuwa idan aka kwatanta da waɗanda ba masu shan sigari ba. An nuna damuwa game da dogon lokaci na cutar.
Hukumar asibitin Hong Kong ta gano raguwar kashi 20% zuwa 30% a cikin ƙarfin huhu a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar sashe.
Wannan kuma na iya haifar da ciwon bayan kulawa mai tsanani bayan dawowa.
Ya zuwa watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata ta ba da inganci da na dogon lokaci ba a cikin mutanen da suka warke daga cutar.
Ana ganin rigakafi kamar mai yiwuwa ne, bisa halayyar wasu coronaviruses, amma an ba da rahoton shari'o'in da aka warke daga COVID-19 wanda aka biyo baya da gwajin tabbatacce na coronavirus a wani lokaci na gaba.
Ana ganin wadannan lokuta na kara tsanantawa ne na kamuwa da cutar da ta dade ba wai sake kamuwa da cutar ba.
Ana tunanin cewa kwayar cutar ta zama ta halitta kuma ta samo asali ne daga dabbobi, ta hanyar yaduwar cutar.
Ba a san ainihin asalin ba, amma a watan Disamba na 2019 yaduwar kamuwa da cutar kusan gaba ɗaya ta hanyar watsawa daga mutum zuwa mutum.
Nazarin farko na 41 na tabbatar da cutar COVID-19, wanda aka buga a watan Janairun 2020 a cikin The Lancet, ya bayyana ranar farko ta bayyanar cututtuka a ranar 1 ga Disamba 2019.
Bugawa na hukuma daga WHO sun ba da rahoton farkon bayyanar cututtuka a ranar 8 ga Disamba 2019.
Ana amfani da matakai da yawa don ƙididdige yawan mutuwa.
Wadannan lambobin sun bambanta ta yankin da kuma tsawon lokaci kuma suna da tasiri ta yawan gwajin, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, lokaci tun farkon barkewar cutar da halaye na yawan jama'a kamar shekaru, jinsi da kuma lafiyar gaba ɗaya.
A ƙarshen 2019, WHO ta sanya lambobin cutar ICD-10 na gaggawa U07.1 don mutuwar daga ƙwayar cutar SARS-CoV-2 da aka tabbatar da lab da U07.2 don mutuwar daga asibiti ko ƙwarewar cutar COVID-19 ba tare da ƙwayar cutar SARS-CoV-2 da aka tabbatar da lab ba. Halin mutuwar-zuwa-la'akari yana nuna yawan mutuwar da aka raba ta yawan adadin da aka gano a cikin wani lokaci.
Dangane da ƙididdigar Jami'ar Johns Hopkins, yawan adadin mutuwar duniya ya kai 6.9% (153,822/2,240,191) kamar yadda aka samu a ranar 17 ga Afrilu 2020.
Yawan ya bambanta da yankin. Sauran matakan sun hada da yawan mutuwar mutum (CFR), wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar, da yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan mutanen da suka kamu da cutar (wanda aka gano da wanda ba a gano ba) da suka mutu daga cutar.
Wadannan kididdiga ba su da iyaka a lokaci kuma suna bin wani takamaiman yawan mutane daga kamuwa da cutar ta hanyar warware matsalar.
Duk da yake ba duk masu kamuwa da cutar ke samun kwayoyin cutar ba, kasancewar kwayoyin cutar na iya ba da bayani game da yawan mutanen da suka kamu da cutar.
A tsakiyar barkewar cutar a Italiya, Castiglione d'Adda, wani karamin kauye na 4600, 80 (1.7%) sun riga sun mutu.
A Gangelt, cutar ta bazu ne ta hanyar bukukuwan Carnival, kuma ta bazu zuwa ga matasa, wanda ya haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 ba za a iya rarraba su a matsayin irin wannan.
Bugu da ƙari, ba a mamaye tsarin kiwon lafiya na Jamus ba.
A cikin Netherlands, kusan kashi 3% na iya samun kwayoyin cuta, kamar yadda aka tantance daga masu ba da jini.
69 (0.004% na yawan) an tabbatar da cewa sun mutu daga COVID-19.
Tasirin annobar da yawan mace-macen ta daban ne ga maza da mata.
Mutuwa ta fi haka a cikin maza a cikin binciken da aka gudanar a China da Italiya.
Mafi girman haɗarin ga maza yana cikin shekarunsu na 50, tare da rata tsakanin maza da mata yana kusa da 90 kawai.
A China, yawan mutuwar ya kai kashi 2.8 cikin dari ga maza da kashi 1.7 cikin dari ga mata.
Ba a san ainihin dalilan da ke haifar da wannan bambancin jinsi ba, amma abubuwan da suka shafi hali da dabi'a na iya zama dalili.
Bambancin rigakafi na jima'i, ƙananan yawan shan taba a cikin mata da maza masu tasowa da cututtukan cututtuka irin su hawan jini a cikin shekarun da suka fi girma fiye da mata na iya taimakawa wajen mutuwar maza.
A Turai, 57% na mutanen da suka kamu da cutar maza ne kuma 72% na waɗanda suka mutu da COVID-19 maza ne.
Tun daga watan Afrilu 2020, gwamnatin Amurka ba ta bin diddigin bayanan da suka shafi jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan ƙwayar cuta kamar Ebola, HIV, mura da SARS suna shafar maza da mata daban.
Mafi yawan ma'aikatan kiwon lafiya, musamman ma'aikatan jinya, mata ne, kuma suna da mafi girman damar kamuwa da kwayar cutar.
"Kungiyar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairun 2020 cewa sunan hukuma na cutar zai zama "" COVID-19. ""."
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO yana nufin corona, VI na cutar, D na cuta, kuma 19 don lokacin da aka fara gano barkewar cutar: 31 ga Disamba 2019.
An zaɓi sunan don kauce wa ambato zuwa takamaiman wuri na ƙasa (misali China), jinsin dabbobi ko ƙungiyar mutane, daidai da shawarwarin ƙasashen duniya don suna da nufin hana ƙazantawa. An kira kwayar cutar da ke haifar da COVID-19 mai suna coronavirus mai saurin numfashi mai saurin gaske 2 (SARS-CoV-2).
"WHO tana amfani da "" kwayar COVID-19 "" da kuma "" kwayar cutar da ke da alhakin COVID-19 "" a cikin sadarwa ta jama'a. "
"Ana kiran cutar da kwayar cutar a matsayin ""coronavirus"."
"A lokacin barkewar cutar a Wuhan, China, ana kiran kwayar cutar da cutar a matsayin ""coronavirus"" da kuma ""Wuhan coronavirus"."
A cikin Janairu 2020, WHO ta ba da shawarar 2019-nCov da 2019-nCoV na cututtukan numfashi na gaggawa a matsayin sunayen wucin gadi na kwayar cuta da cuta daidai da jagorar 2015 game da amfani da wurare a cikin cututtukan da sunayen ƙwayoyin cuta.
An bayar da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu 2020.
Saboda iyakancewar iya aiki a cikin daidaitattun hanyoyin samar da kayayyaki, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar su hanci da sassan ventilator.
A wani misali, lokacin da wani asibitin Italiya ya buƙaci bawul na iska, kuma mai ba da kaya bai iya isar da shi a cikin lokacin da ake buƙata ba, wani kamfanin da aka fara aiki a cikin gida ya sake yin injiniya kuma ya buga bawul 100 da ake buƙata cikin dare.
Bayan barkewar COVID-19, ka'idojin makirci, rashin fahimta da kuma rashin fahimta sun bayyana game da asali, sikelin, rigakafi, magani da sauran fannoni na cutar kuma cikin sauri ya yadu a kan layi.
Mutane suna iya yada kwayar cutar ga wasu dabbobi.
Binciken ya kasa samun shaidar kwayar cutar a cikin aladu, ducks, da kaji.
Babu magani ko allurar rigakafi da aka amince da ita don magance cutar.
Bincike na kasa da kasa kan alluran rigakafi da magunguna a cikin COVID-19 ana gudanawa ta ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu.
"A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da ""SOLIDARITY Trial"" don tantance tasirin maganin magungunan rigakafin cutar guda hudu da ke da karfin gaske".
Babu maganin da ake da shi, amma hukumomi daban-daban suna ci gaba da samar da allurar rigakafi.
Ana amfani da aikin da aka yi a baya akan SARS-CoV saboda SARS-CoV da SARS-CoV-2 duka suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Akwai dabarun rigakafi guda uku da ake bincike.
Na farko, masu bincike suna da burin gina cikakkiyar allurar rigakafin cutar.
Amfani da irin wannan ƙwayoyin cuta, ko ba a aiki ko matacce, yana da nufin haifar da saurin amsa rigakafin jikin mutum zuwa sabon kamuwa da cutar COVID-19.
Dabara ta biyu, allurar rigakafin subunit, na da nufin ƙirƙirar allurar rigakafin da ke sa tsarin garkuwar jiki ya zama mai saurin kamuwa da wasu ƙananan sassan kwayar cutar.
A cikin yanayin SARS-CoV-2, irin wannan binciken ya maida hankali ne kan furotin S-spike wanda ke taimakawa kwayar cutar ta shiga cikin mai karɓar enzyme ACE2.
Dabara ta uku ita ce ta allurar rigakafin nucleic acid (allurar rigakafin DNA ko RNA, sabuwar dabara don ƙirƙirar allurar rigakafi).
Dole ne a gwada alluran gwaji daga kowane ɗayan waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, gwajin asibiti na farko na allurar rigakafi ya fara tare da masu sa kai huɗu a Seattle.
Allurar ta ƙunshi lambar kwayar halitta mara lahani da aka kwafa daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka mai dogaro da antibody a matsayin ƙalubale mai yuwuwa don haɓaka allurar rigakafin SARS-COV-2, amma wannan yana da rikici.
Akwai gwaji na asibiti sama da 300 da ke gudana har zuwa Afrilu 2020.
Gwaje-gwaje bakwai sun kimanta maganin da aka riga aka amince da shi na zazzabin cizon sauro, ciki har da nazarin hudu akan hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar da aka sake amfani da su sun fi yawan binciken da kasar Sin ke yi, tare da gwaji na uku na uku a kan remdesivir a cikin kasashe da dama wanda ake sa ran rahoto a karshen watan Afrilu.
An gudanar da nazarin ci gaban asibiti don allurar rigakafin COVID-19 da masu neman magani, kamar na Afrilu 2020. Ana tantance magungunan rigakafin cutar da yawa na yanzu don maganin COVID-19, gami da remdesivir, chloroquine da hydroxychloroquine, lopinavir / ritonavir da lopinavir / ritonavir haɗe tare da interferon beta.
Akwai shaidar gwaji don inganci ta hanyar remdesivir, kamar yadda aka yi a watan Maris 2020.
An lura da ingantaccen asibiti a cikin marasa lafiya da aka yi wa magani tare da jinƙai-amfani remdesivir.
Ana gudanar da gwajin asibiti na Phase III a Amurka, China da Italiya. Chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, an yi nazari a China a watan Fabrairun 2020, tare da sakamakon farko.
Duk da haka, akwai kira don nazarin takwarorina na binciken.
kuma Hukumomin Kiwon Lafiya na kasar Sin sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kula da Kwayoyin Cutar Wuhan, yayin da take ba da shawarar kashi na gram ɗaya a kowace rana, ta lura cewa sau biyu wannan kashi yana da haɗari sosai kuma yana iya zama mai haɗari.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa don hydroxychloroquine da chloroquine a cikin shawarar likitocin da ke kula da mutanen da ke fama da COVID-19. Ka'idojin fitowar na 7 na kasar Sin sun hada da interferon, ribavirin ko umifenovir don amfani da COVID-19.
Bayanai na farko sun nuna cewa ana bukatar ribavirin mai yawa don hana SARS-CoV-2 a cikin in vitro.
An ba da shawarar Nitazoxanide don ƙarin nazarin in vivo bayan nuna ƙarancin ƙuntatawa na SARS-CoV-2. Nazarin ya nuna cewa farkon ƙwallon furotin ta hanyar transmembrane protease serine 2 (TMPRSS2) yana da mahimmanci don shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da ko ba tare da azithromycin ba suna da manyan iyakoki waɗanda suka hana likitocin karɓar waɗannan hanyoyin ba tare da ƙarin bincike ba.Oseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba shi da sananniyar rawa a cikin maganin COVID-19.
Guguwar cytokine na iya zama rikitarwa a cikin matakai na baya na COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kaddarorin guguwar anti-cytokine. Tocilizumab an saka shi cikin jagororin magani ta Hukumar Lafiya ta Kasa ta China bayan an kammala karamin binciken.
Ana gudanar da gwajin gwaji na 2 ba tare da bazuwar ba a matakin ƙasa a Italiya bayan nuna sakamako mai kyau a cikin mutanen da ke da mummunan cuta.
Haɗe da gwajin jini na serum ferritin don gano guguwar cytokine, an yi niyya don magance irin waɗannan ci gaban, waɗanda ake tsammanin sune sanadin mutuwa a cikin wasu mutanen da ke fama da cutar.
An amince da mai karɓar interleukin-6 mai karɓar FDA bisa la'akari da nazarin yanayin yanayin retrospective don maganin steroid refractory cytokine release syndrome wanda aka haifar da wani dalili daban, maganin CAR T cell, a cikin 2017.
Har zuwa yau, babu wani shaida, da aka sarrafawa, da aka sarrafa cewa tocilizumab yana da tasiri ga maganin CRS.
Canja wurin tsarkakakken da kuma tattarawar kwayoyin cutar da tsarin garkuwar jiki na waɗanda suka warke daga COVID-19 ga mutanen da suke buƙatar su ana bincika su azaman hanyar rigakafin rigakafin marasa amfani.
An gwada wannan dabarar don SARS tare da sakamako mara kyau.
Rashin kamuwa da kwayar cutar shine tsarin aikin da ake tsammani wanda maganin rigakafin jiki na iya shiga tsakani don kare kariya daga SARS-CoV-2.
Duk da haka wasu hanyoyin, kamar su antibody-dogara cell cytotoxicity da / ko phagocytosis, na iya zama mai yiwuwa.
Ana kuma samun ci gaba a wasu hanyoyin maganin rigakafin kwayoyin cuta, misali, ta amfani da kwayoyin cuta na monoclonal da aka kera.
Za a iya ƙara samar da ƙwayar cuta mai warkewa, wanda ya ƙunshi ɓangaren ruwa na jini daga marasa lafiya da suka warke kuma yana ƙunshe da ƙwayoyin cuta na musamman ga wannan ƙwayar cuta, don saurin saurin saurin.
Cututtukan Coronavirus, ƙungiyar magungunan da ke da alaƙa da juna
Li Wenliang, likita ne a Asibitin Tsakiya na Wuhan, wanda daga baya ya kamu da cutar COVID-19 kuma ya mutu bayan ya wayar da kan jama'a game da yaduwar cutar.
